Structural and Biochemical Studies of the Human DEAD-box Helicase Dbp5 and Nucleoporin Nup214 Involved in mRNA Export by Moeller, Holger von
Dissertation zur Erlangung des Doktorgrades 
der Fakultät für Chemie und Pharmazie 
der Ludwig-Maximilians-Universität München 
 
 
Structural and Biochemical Studies of the Human  
DEAD-box Helicase Dbp5 and Nucleoporin Nup214  
Involved in mRNA Export 
 
 
 
 
 
Holger von Moeller 
aus Leverkusen 
 
2009 
   
Erklärung 
Diese Dissertation wurde im Sinne von §13 Abs. 3 der Promotionsordnung vom  
29. Januar 1998 von Frau Prof. Dr. Elena Conti betreut. 
 
 
Ehrenwörtliche Versicherung 
Diese Dissertation wurde selbständig, ohne unerlaubte Hilfe erarbeitet. 
 
München, am 28.05.2009 
 
 
 
Holger von Moeller 
 
 
Dissertation eingereicht am: 29.05.2009 
 
1. Gutachter Prof. Dr. Elena Conti 
 
2. Gutachter Prof. Dr. Patrick Cramer 
 
Mündliche Prüfung am: 30.09.2009 
  
   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Meinen Eltern
 
 
 Abstract 
The hallmark of eukaryotic evolution was the development of the nucleus in 
cells. This compartmentalization requires the nucleocytoplasmic transport of 
thousands of molecules. The gate into and out of the nucleus is the nuclear pore 
complex (NPC). One of the molecules that needs to be exported from the nucleus is 
messenger RNA (mRNA). mRNA associates with proteins in the nucleus forming a 
messenger ribonucleoprotein particle (mRNP). mRNPs bind to dedicated transport 
factors that facilitate movement through the NPC. One protein that associates to 
mRNPs is the helicase Dbp5, which belongs to the DEAD-box family of RNA 
helicases. Dbp5 is essential for mRNA export in both yeast and humans. It binds 
RNA and is concentrated and locally activated at the cytoplasmic side of the nuclear 
pore complex, where it interacts with the cytoplasmic nucleoporin Nup214. In my PhD 
work, I have determined the crystal structures of human Dbp5 bound to RNA and 
AMPPNP, and bound to Nup214. I designed and performed in vitro assays, which 
show that binding of Dbp5 to nucleic acid and to Nup214 is mutually exclusive. The 
interactions are mediated by conserved residues, implying a conserved recognition 
mechanism. These results suggest a framework for the consecutive steps leading to 
the release of mRNA at the final stages of nuclear export. More generally, they 
provide a paradigm for how binding of regulators can specifically inhibit DEAD-box 
proteins. 
 
 
 
 
 
 
 
  
 
 
  
 Zusammenfassung 
Die Entstehung des Zellkerns war eines der wichtigsten Ereignisse in der 
Entwicklung der eukaryotischen Zelle. Die daraus resultierende Unterteilung der Zelle 
in Zellkern und Zytoplasma erfordert jedoch den Transport von tausenden von 
Molekülen in und aus dem Zellkern. Als Schleuse hierfür dient der sogenannte 
Kernporenkomplex. Eines der Moleküle, welches aus dem Zellkern exportiert werden 
muss, ist die Boten-RNA (mRNA). mRNAs assozieren mit einer Vielzahl 
verschiedener Proteine im Zellkern und bilden sog. Boten-Ribonukleoprotein-Partikel 
(mRNP). mRNPs interagieren mit bestimmten Transportproteinen, welche die 
Bewegung durch den Kernporenkomplex und dadurch den Export aus dem Zellkern  
ermöglichen. Eines der Proteine welches mit mRNPs assoziert ist die DEAD-box 
Helikase Dbp5, welche in Mensch und Hefe essentiell am Kernexport von mRNAs 
beteiligt ist. Dbp5 bindet RNA und liegt konzentriert auf der cytoplasmatischen Seite 
des Kernporenkomplexes vor. Hier bindet es an das cytoplasmatischen Nukleoporin 
Nup214 und wird durch ein weiteres Protein lokal aktiviert. In meiner Doktorarbeit 
habe ich die Kristallstrukturen des menschlichen Dbp5 im Komplex mit RNA und im 
Komplex mit Nup214 bestimmt. Zusammen mit in vitro Experimenten konnte ich 
zeigen, dass RNA und Nup214 die gleiche Bindungstelle benutzen und sich deren 
gleichzeitige Bindung somit ausschliesst. Die für diese Interaktionen entscheidenden 
Aminosäuren sind konserviert und implizieren einen ähnlichen Erkennungs-
mechanismus in Mensch und Hefe. Diese Ergebnisse stellen die Grundlage für ein 
Modell, indem die letzten Schritte des Kernexportes, welche in der Freigabe der 
mRNA enden, zusammengefasst sind. Desweiteren liefern diese Ergebnisse wichtige 
Einblicke in den Regulierungsmechanismen von DEAD-box Helikasen. 
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1 Introduction 
One highlight of modern biology was the enunciation of the central dogma of 
molecular biology half a century ago by Francis Crick (Crick 1958; Crick 1970). This 
dogma is the framework of the flow of information from DNA to protein. DNA is the 
carrier of genetic information that is transcribed into messenger RNA (mRNA), which 
is then translated into protein. This flow of information applies to all kingdoms of life.  
The hallmark in the evolution of eukaryotic life was the development of the 
nucleus. The nucleus is separated from the cytoplasm by a semi permeable lipid 
bilayer, known as the nuclear envelope (NE). The NE consists of two membranes 
(inner and outer) that impede free diffusion of molecules in and out the nucleus. This 
compartmentalization required the (co-)development of nucleocytoplasmic transport. 
Since the genetic information is exclusively stored in the nucleus (except 
mitochondrial DNA) and proteins are only synthesized in the cytoplasm, mRNA that is 
transcribed in the nucleus has to be exported to the cytoplasm. The only exit from the 
nucleus (at interphase) for macromolecules like mRNA is the nuclear pore complex 
(NPC). 
1.1 The nuclear pore complex 
The nuclear pore complex is one of the biggest protein assemblies in cells and 
has been studied for several decades (recently reviewed in Suntharalingam and 
Wente 2003; Hetzer 2005; Antonin 2008; D'Angelo and Hetzer 2008; Lim 2008; Lim 
2008; Meier and Brkljacic 2009). The NPC was discovered in the 1950s and the 
overall architecture was described more than a decade later (Gall 1967). The 
development of new techniques, such as cryo-electron tomography (ET), field-
emission in-lens scanning electron microscopy (FEISEM), two photon 4pi fluorescent 
microscopy and atomic force microscopy, in the last few years has provided more 
detailed structural information (Stoffler 2003; Beck 2004; Maco 2006; Beck 2007; 
Huve 2008; Lim 2008). The NPC is a dynamic multiprotein complex made up of 
proteins called nucleoporins (Nups) and can be divided into three major structures: 
the NE embedded central core, the nuclear basket and the cytoplasmic fibrils (Figure 
1a and 1b). The central core is symmetric and spans both membranes (outer and 
inner) of the NE with a central channel of ~ 40 nm in diameter. A frequently observed 
central plug occupying this channel was the subject of a long debate and has been 
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recently demonstrated to be cargo in transit in a cryo-electron microscopy study 
(Beck 2007). 
Figure 1: General architecture of the nuclear pore complex (NPC).  
(a) cut away schematic illustration of the NPC. The NPC can be divided in three major 
structures: the nuclear envelope (NE) embedded core, the nuclear basket and the 
cytoplasmic filaments. (b) cryo-electron tomography structure of the Dictyostelium NPC 
adopted from (Beck 2004) in a similar cut away view as in panel a. The central cannel and 
the nuclear basket are further divided into substructures as indicated. The NPC has a 
maximum diameter of ~ 125 nm with a minimal luminal diameter of ~ 40 nm. 
 
The cytoplasmic filaments and the nuclear basket consist of asymmetrically 
distributed nucleoporins (with respect to the NE plane) and are thought to play 
functional roles (reviewed in Marelli 2001; Rout and Aitchison 2001). From EM 
studies the overall size was estimated to be ~ 55 - 72 MDa for the yeast NPC (Rout 
and Blobel 1993; Yang 1998) and 125 MDa for the Xenopus NPC (Hinshaw 1992; 
Akey and Radermacher 1993). More recent calculations from proteomic approaches 
revealed a smaller total mass of ~ 44 MDa for the yeast (Rout 2000) and ~ 60 MDa 
for the mammalian NPC (Cronshaw 2002). This difference could be explained by the 
fact that the first estimations based on electron microscopy (EM) studies also 
included transiently bound proteins. In the metazoan case it is so far not clear why 
the Xenopus and the mammalian NPCs have such different masses (i.e. whether it 
reflects a larger/smaller assembly or experimental reasons).  
Despite their enormous size, NPCs consist of a surprisingly small number of ~ 
30 - 40 different Nups (Reichelt 1990; Yang 1998; Rout 2000; Cronshaw 2002). With 
a molecular weight (MW) between 100 and 358 kDa nucleoporins are above the 
average molecular weight of proteins in the cell. EM studies revealed an octagonal 
rotational symmetry and approximations of the abundances of the different Nups 
based on SDS PAGE quantification indicated that some Nups are represented by 
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multiples of eight copies - up to 48 copies of some Nups might be present per NPC 
(Rout 2000; Cronshaw 2002) resulting in a total number of 500 - 1000 Nups per pore 
(D'Angelo and Hetzer 2008). Depending on the cell cycle, a haploid yeast nucleus 
has 65 - 182 (Winey 1997) and mammalian nuclei have ~ 2000 - 3000 NPCs (Gerace 
and Burke 1988).  
The NPC can be separated into subcomplexes that are thought to be defined 
units that are important for NPC assembly and disassembly during mitosis. The 
details are not fully understood (reviewed in Antonin 2008). Many interactions are not 
yet clear and under debate (e.g. Brohawn 2008 vs. Debler 2008). High-resolution 
structural data for some subcomplexes (Jeudy and Schwartz 2007; Melcak 2007; 
Boehmer 2008; Brohawn 2008; Debler 2008) and several domains (for e.g. Berke 
2004; Weirich 2004; Napetschnig 2007, see Figure 3) are available from 
crystallographic studies. Together with computational predictions, it has been 
proposed that only a few common folds are present in the architecture of the NPC: 
beta-propeller, alpha-helical and coiled-coil domains are repetitively found/predicted 
in nucleoporins (reviewed in Schwartz 2005; Alber 2007). Only three Nups (Pom121, 
Gp210 and Ndc1, reviewed in Peters 2009) contain transmembrane domains that are 
believed to anchor the NPC in the NE (Mansfeld 2006; Stavru 2006).  
Other common motifs found in Nups are the FG-repeats. These are peptide 
stretches of 4 to 48 repetitive phenylalanine-glycine motifs (GLFG, FxFG, PxFG or 
SxFG, where x is any residue) connected by linkers (5 - 50 residues). The motifs 
belong to the class of intrinsically disordered protein domains (Denning 2003). They 
are found in more than one third of the Nups, resulting in ~ 190 FG domains and ~ 
2700 FG motifs per NPC (reviewed in Peters 2009). FG repeats play important roles 
in the selective permeability of NPCs (Macara 2001; Ribbeck and Gorlich 2001; Rout 
2003; Peters 2005; Frey 2006). Ions, small metabolites, hydrophobic molecules and 
some molecules up to 30 - 40 kDa can diffuse through NPCs (Paine 1975). Large 
molecules up to a diameter of 39 nm and smaller molecules such as tRNAs or 
histones can be transported through the pore (Pante and Kann 2002), when 
associated with transport proteins that are able to interact with the FG repeats and 
escort the cargo through the NPC. Estimation of the traffic that occurs at a single 
NPC indicate that 1000 translocations per second per NPC and a total mass of one 
kg per day per eukaryotic cell are transported (Ribbeck and Gorlich 2001). It is 
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remarkable that the NPC is able to cope with these high numbers of transport events 
while maintaining selectivity. 
Several models that account for the selective barrier have been proposed. In 
the „virtual gate model‟ (Rout 2003) an energetic and not a physical barrier defines 
the permeability of the NPC. The FG Nups of the central channel generate an 
entropic barrier that prevents the passage of inert molecules. The entropy barrier 
increases with the size of the molecule and therefore the probability for large 
molecules to cross the NPC is low. In a second model, the „oily spaghetti‟ model 
(Macara 2001), the FG repeats form a physical barrier by obstructing the central 
channel. Translocation in this model is achieved by transient interactions of transport 
factors with the FG repeats. In this case a „binding and release mechanism‟ would 
allow a transport factor (+ cargo) to move through the pore. In the „selective phase 
model (Ribbeck and Gorlich 2001), the FG Nups in the channel form a network of 
weak hydrophobic interactions. In vitro, FGs of the yeast nucleoporin Nsp1 can form 
a 3D-hydrogel (Frey 2006; Frey and Gorlich 2007). In vivo, such a gel-like sieve 
could hinder diffusion of molecules that are larger than its pore size. Transport factors 
would transiently disrupt the mesh by interacting with the FGs. The „reduction of 
dimensionality model„ (Peters 2005) predicts that the FG repeats act like a filter. In 
this model, the FG repeats form a hydrophobic layer coating the wall of the pore and 
therefore forming a ~ 10 nm nanopore in the center. Only molecules that are small 
enough to move through this nanopore or molecules that interact with the FGs 
(directly or via transport receptors) can slide through this filter. Although the details 
vary, all four models are based on the properties of the FG repeats. It is possible that 
a combination of the different mechanisms explains the selectivity of the NPC. 
 
1.2 Nucleocytoplasmic transport 
The FG repeats of the NPC do not solely define permeability but are also 
required for active transport (Bayliss 2002; Bednenko 2003). Independent work from 
Wente and Weis has shown that the FG repeats do not provide directionality (Strawn 
2004; Zeitler and Weis 2004). Deletion and exchange of FG repeats of 
asymmetrically localized Nups have no effect on nucleocytoplasmic transport 
processes. How is the directional transport achieved? The transport between the two 
compartments is mediated by soluble transport factors that recognize specific cargos 
and are able to shuttle through NPCs. Most cargos associate with the largest family 
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of transport factors, the β-karyopherins, also known as importin β-like proteins 
(named after the first protein (importin β) identified). β-karyopherins belong to the 
family of HEAT (Huntington, elongation factor 3 (EF3), protein phosphatase 2A 
(PP2A), and the yeast PI3-kinase TOR1) repeat proteins. β-karyopherins involved in 
nuclear import are also called importins. Exportins mediate nuclear export in the 
reciprocal manner. In general transport factors can interact with their cargo either 
directly or via adaptor proteins. Binding to cargo and its release is regulated by the 
small GTPase Ran (RAs-related nuclear protein). The asymmetric distribution of 
RanGTP and RanGDP confers directionality in β-karyopherin dependent transport 
events. Ran is regulated by RanGTP-activating proteins (RanGAPs) in the 
cytoplasm. RanGDP is imported to the nucleus by the non-karyopherin transport 
factor NTF2 (nuclear transport factor 2). In the nucleus RanGDP is converted to 
RanGTP by the Ran guanine nucleotide exchange factor (RanGEF or RCC1). The 
interaction with the karyopherins is facilitated by another protein known as RanBP 
(Ran binding protein). Exportins bind RanGTP and the cargo in the nucleus and 
hydrolysis of GTP to GDP in the cytoplasm triggers release of both. Importins bind 
their cargo in the cytoplasm and are regulated in the reciprocal manner. 
1.2.1 Nuclear export of messenger RNA 
One of the cargos that need to be exported to the cytoplasm is messenger RNA 
(mRNA). mRNAs are transported as mRNPs (messenger ribonucleoprotein particles) 
and their export is independent of β-karyopherins and Ran (Clouse 2001). The 
mRNA export factor is a heterodimer consisting of TAP (NXF1 in metazoans and 
Mex67 in yeast) and p15 (NXT1 in metazoans and Mtr2 in yeast) recently reviewed in 
Cook 2007. The proteins p15 and Mtr2 are not conserved in sequence but are 
functionally and structurally homologous (Fribourg and Conti 2003). TAP is a 
multidomain protein with a N-terminal cargo (RNA binding domain (RBD) and leucine 
rich repeat (LRR) domain) and a C-terminal nucleoporin binding site (Braun 1999; 
Bachi 2000; Liker 2000). It has two binding sites for FG repeats (Fribourg 2001; 
Grant 2003) that are both required for efficient mRNA export (Braun 2001). The 
adaptor protein Aly/REF (Yra1 in yeast) binds the export factor and mRNA (Bruhn 
1997; Strasser and Hurt 2000; Stutz 2000; Strasser and Hurt 2001) and is probably 
recruited by the DEAD-box helicase UAP56 (Sub2 in yeast) (Luo 2001; Strasser and 
Hurt 2001). UAP56 is essential for poly(A)+-RNA in S. cerevisiae, D. melanogaster 
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and C. elegans (Gatfield 2001; Strasser and Hurt 2001). Another DEAD-box helicase 
that is involved in mRNA export is Dbp5 and is described in paragraph 1.3.1.1. 
 
1.3 Helicase family of proteins 
Helicases are ATPases that use the free energy of hydrolysis of adenosine 
triphosphate (ATP) to catalyze the separation of nucleic acid duplexes into single 
strands. These duplexes can consist of DNA-DNA, RNA-RNA, or DNA-RNA hybrids. 
Predictions for random sequence RNAs have revealed thermodynamic stable 
secondary structures with 50 % base pairing (Gralla and DeLisi 1974). This 
propensity to form stable structures is enhanced by the ability of RNA to form non 
Watson-Crick interactions. While some duplexes have defined conformations that 
fulfill cellular functions (e.g. tRNA, DNA double helix etc.), others are 
thermodynamically favored conformations with no functional relevance. Both types of 
duplexes need to be unwound at certain stages by helicases. In addition, some 
proteins that bind nucleic acids need to be removed (e.g. from mRNPs). Depending 
on their amino acid sequence, their substrates and unwinding polarity (5‟ - 3‟ or 3‟ - 5‟ 
or both), helicases are classified into five superfamilies (SF1 - SF5). Since the 
discovery of the first helicase more than 30 years ago, dozens of helicases have 
been identified in all kingdoms of life. Both DNA and RNA helicases belong to the 
same five superfamilies. DNA helicases are involved in processes such as DNA 
repair, recombination, replication and transcription. RNA helicases are involved in all 
aspects of RNA metabolism and many of them are essential. The superfamilies are 
further divided into subfamilies. SF1 and SF2 are the two largest superfamilies and 
are closely related. In yeast, 39 RNA helicases have been identified that belong to 
the SF2 family.  
1.3.1 DEAD-box helicases 
The largest SF2 subfamily is the so called DEAD-box family of RNA helicases. 
In yeast, 25 out of the 39 SF2 helicases belong to this subfamily. Most of them are 
involved in ribosome biogenesis or pre-mRNA splicing. Others play roles in 
translation, RNA export, RNA turnover and RNA quality control. The family of DEAD-
box helicases was first described two decades ago (Linder 1989). At this time, 
sequence alignments identified eight conserved motifs. One of these, motif II, 
composed of the amino acids aspartate, glutamate, alanine and aspartate (DEAD) 
Introduction 
23 
gave the family its name. An additional motif (Q motif) consisting of a highly 
conserved glutamine residue (Tanner 2003) and a conserved aromatic residue 
upstream of the Q-motif was identified later (Cordin 2004). All DEAD-box proteins 
consist of a helicase core that is responsible for both ATP-binding/hydrolysis and 
RNA binding, which is achieved in a sequence independent manner. This core spans 
350 - 400 residues and consists of two globular RecA-like domains that are 
connected by a linker (Caruthers and McKay 2002). Most DEAD-box helicases have 
N- and C-terminal flanking regions that are not conserved but are thought to play a 
role in specific interactions with binding partners and the localization within the cell 
(reviewed in Cordin 2006). The two RecA-like domains contain the 9 conserved 
motifs and are shown in Figure 2. Motif I (Walker A) and motif II (a variation of the 
Walker B motif) have been first described by John Walker (Walker 1982). They are 
not specific for RNA helicases and are found in other non helicase proteins (e.g. ABC 
transporters). Both motifs are responsible for NTP/ATP binding and hydrolysis. Motifs 
Ia, Ib, and IV, the partially conserved GG and the QxxR motif are involved in RNA 
binding. The Q motif is thought to be specific for the DEAD-box family of helicases 
and is involved in ATP binding. It has been suggested that the Q motif senses the 
nucleotide state of the protein and therefore regulates ATP binding and hydrolysis 
(Tanner 2003; Cordin 2004). Motifs V and VI are involved in the coordination and 
hydrolysis of ATP. The role of the motif III is somewhat ambiguous: it is thought to 
couple ATP hydrolysis with RNA unwinding. Some mutations in this motif have been 
shown to be ATPase deficient while other mutations have no effect on ATP 
hydrolysis but show loss of unwinding activity (Pause and Sonenberg 1992; Rocak 
2005). 
 
Figure 2: Schematic representation of the domain architecture of DEAD-box helicases. 
DEAD-box helicases consist of two RecA-like domains that form the minimal helicase core. 
The two domains are connected by a linker and include nine conserved motifs, shown here 
as different colored blocks with their consensus sequences. Most helicases have additional 
N- and C-terminal flanking regions of variable length or additional domains that are not 
conserved within the DEAD-box family. 
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From structural data it has become clear that despite their different functions 
and high specificity DEAD-box helicases bind RNA and ATP essentially in the same 
way (Andersen 2006; Bono 2006; Sengoku 2006). ATP is bound in between the two 
RecA-like domains. RNA is bound in a sequence independent manner by both 
domains. Although these proteins have been named for their activity (unwinding RNA 
helices/duplexes) actual unwinding activity has only been shown for a few helicases 
in vitro (e.g. Yang and Jankowsky 2006). Unlike some SF1 and most DNA helicases 
DEAD-box proteins are not processive (reviewed in Jankowsky and Fairman 2007). 
Compared to DNA helicases, the intrinsic ATPase activity of these proteins is rather 
low (reviewed in Cordin 2006). Most DEAD-box helicases show an RNA dependent 
stimulation of the helicase activity that is independent of the RNA sequence. Some 
helicases have additional domains that confer specificity and activity. One example is 
DbpA, a helicase that binds specifically to 23S rRNA (Fuller-Pace 1993) via an 
additional domain. Activators have been described for only a few helicases (e.g. 
Alcazar-Roman 2006; Weirich 2006). Unwinding of blunt-end duplexes has been 
demonstrated for a few helicases (Rogers 1999; Liu 2008) but single stranded 
regions increase the unwinding efficiency, possibly by facilitating loading onto 
duplexes. Several helicases have been implicated in multiple cellular functions, as in 
the case of DEAD-box helicase 5 (Dbp5). 
1.3.1.1 DEAD-box helicase 5 
Dbp5 (DDX19B in H. sapiens and also called ribonucleic acid-trafficking 
protein 8 (rat8) in yeast) belongs to the DEAD-box family of SF2 RNA helicases and 
is conserved across species. The 54 kDa human protein consists of an N-terminal 
flanking region (spanning 75 residues), the helicase core and a short C-terminal 
region (Figure 2 and Figure 6a). In yeast, the N-terminal flanking region (1 - 79) is 
dispensable (Snay-Hodge 1998) and its function is as yet unknown. Dbp5 has been 
shown to be essential for mRNA export in yeast (Snay-Hodge 1998; Tseng 1998) 
and human (Schmitt 1999). In yeast a temperature sensitive Dbp5 mutant results in 
the fast accumulation of poly(A)+-RNA in the nucleus at permissive temperature 
(Snay-Hodge 1998). Dbp5 localizes at the cytoplasmic side of the NPC but is 
predominantly cytoplasmic (Snay-Hodge 1998; Tseng 1998). The helicase can 
shuttle between the nucleus and the cytoplasm. It docks at the NPC via the 
interaction with Nup214 (also called CAN) in humans (Kraemer 1994; Schmitt 1999) 
or Nup159 in yeast (Schmitt 1999). Nup214 is a cytoplasmic nucleoporin with a 45 
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kDa N-terminal β-propeller domain, a coiled-coil domain and C-terminal FG-
repeats (Figure 3). 
Dbp5 is an RNA-dependent ATPase with low activity in vitro and it is 
activated at the cytoplasmic side of the NPC by Gle1 and its cofactor IP6 (Inositol 
hexakisphosphate) (Alcazar-Roman 2006; Weirich 2006). Mutations within the 
ATP binding motifs inhibit mRNA export and are lethal in vivo (Tseng 1998; 
Schmitt 1999). Dbp5 has been proposed to act in the final steps of mRNA export. 
It has been shown that Dbp5 can remove proteins from mRNA: in vivo studies in 
yeast indicate the removal of the transport factor Mex67 by the helicase (Lund and 
Guthrie 2005) and in vitro yeast Dbp5 displaces the RNA binding protein Nab2 in 
presence of ADP (Tran 2007). It has been suggested that the remodeling activities 
of the helicase (e.g. removal of the transport factor at the cytoplasmic side of the 
NPC) would bring directionality into mRNA export. Dbp5 has also been reported to 
bind cotranscriptionally in the nucleus with Balbani ring pre-mRNA in C. tentans 
(Zhao 2002) and might also interact with transcription factors (Estruch and Cole 
2003). Furthermore, it is thought to play roles in translation termination, where the 
helicase has been shown to be involved in the recruitment of release factors 
(Gross 2007). More recently Dbp5 has been connected with P body components 
(Scarcelli 2008) and cell division in S. cerevisiae (van den Bogaart 2009). 
Whether these interactions are direct or mediated by another protein is at present 
unknown.  
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Figure 3: Comparison of H. sapiens Nup214 and S. cerevisiae Nup159. 
(a) overall domain architecture of human Nup214 and yeast Nup159. Both proteins consist of 
a conserved N-terminal β-propeller domain (green), a coiled-coil domain (light grey) and FG-
repeats (grey). Both in (b) human (Napetschnig 2007) and (c) yeast (Weirich 2004) the N-
terminal domain mainly consists of anti parallel beta sheets connected with loops that form 7 
beta propellers positioned around a central axis. (d) The two proteins superpose well (overall 
r.m.s.d of ~ 1.2 Å). The major difference lies in the C-terminal region. Here the crystal 
structure of the human protein features an extension (marked red in panel a and d) that binds 
across the β-propeller face in an unstructured fashion.  
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2 Aims and Scope of the Thesis 
This PhD thesis examines the human DEAD-box helicase Dbp5 and its 
binding partner Nup214, both involved in nuclear export of messenger RNA. The 
work described in this thesis addresses the structural and biochemical details of the 
two proteins and tries to elucidate their role in nucleocytoplasmic transport. 
Elucidation of the molecular mechanisms of complex recognition and 
formation requires detailed understanding of the three dimensional structures of the 
proteins. Even though the structures of the N-terminal domain of human Nup214 and 
the yeast orthologue Nup159 had been solved, it was not possible to draw 
conclusions on the functional role of the nucleoporin and its effect on the helicase. In 
order to understand how Dbp5 specifically docks at the nuclear pore complex via the 
interaction with Nup214 and to understand how the helicase binds to mRNA, it was 
necessary to solve the crystal structures of the two complexes. 
The work focuses on two aspects: the Dbp5-AMPPNP-RNA complex and the 
Dbp5-Nup214 complex. In both parts the major aim was to determine the three-
dimensional crystal structures of the two complexes. The insights and the 
conclusions drawn from the two structures were used to further characterize the 
DEAD-box helicase biochemically. Mutational studies, binding and ATPase assays 
were performed in vitro to support the structural conclusions. 
The research of the presented thesis was carried out in the laboratory of Prof. 
Dr. Elena Conti at the European Molecular Biology Laboratories in Heidelberg from 
January 2006 to September 2007 and at the Max Planck Institute of Biochemistry in 
Martinsried from October 2007 until January 2009. 
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3 Materials and Methods 
3.1 Materials 
A detailed list of all suppliers is in appendix 6.6 and therefore only the names 
of the companies are specified in the text. 
3.1.1 Chemicals and reagents 
All common chemicals were purchased from Hampton, Fluka and Sigma-
Aldrich unless otherwise stated.  
3.1.2 Kits 
Kit Supplier 
JBS Protein Methylation Jena Bioscience 
Qiaquick Gel Extraction Qiagen 
Qiaquick Spin Miniprep Qiagen 
QuikChange Site-directed Mutagenesis Stratagene 
3.1.3 Enzymes 
All restriction enzymes including the appropriate buffers were purchased from 
New England Biolabs (NEB). For DNA amplification by PCR, Phusion polymerase 
from Finnzymes was used. Site directed mutagenesis was also performed with 
Phusion polymerase or with the polymerase supplied with the QuikChange site-
directed mutagenesis kit (Stratagene). T4 DNA ligase, with its corresponding buffer, 
was purchased from Promega. T4 DNA Polymerase for LIC cloning was purchased 
from Novagen. TEV and PreScission (Rhinovirus 3C) protease were expressed and 
purified in the lab. 
3.1.4 Vectors 
 Vector purchased from 
E. coli pETMCN gift from C. Romier, IGBMC, Strasbourg 
 LIC-system designed & cloned by F. Martin and J. Basquin 
 pGEX-4T GE Healthcare 
 pProEx-HTa Invitrogen 
 pETM-14  
(& derivatives) 
EMBL protein expression facility and G. Stier 
Yeast pYES 263 EUROSCARF 
 pYES 260  
insect cells pFASTBAC Invitrogen 
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3.1.5 DNA oligos 
DNA oligonucleotides were ordered from Sigma-Aldrich. PCR primers were 
purchased desalted and lyophilized and were diluted in H2O. All sequences are given 
in 5´- 3´ direction. 
Protein Primer 
yeast Dbp5 (82FWD)CTCTTAGAAATAAAAGTCCCGCGGCTGGGTTTAAGAGGTAACATGTCACG 
(83FWD)GCACTGTACAATGGAGAATTTGGGTCGGCGCCCTGAAAATAAAGATTCTC 
(482REV) GTCGGATCCCTACTAATCCTTTAACACTTTCTTAAC 
(457REV) TAAGGATCCCACGAGTCATTTCTACTACACCGAAG 
(293REV) GTCGGATCCCTATTCTAAAGTATTAGCATTTGGAACG 
site directed 
mutagenesis 
(E159AD160AFWD)GCTAACAAGAGTAAACCCAGCATCCGCATCTCCACAGGC 
(E159AD160AREV)GCCTGTGGAGATGCGGATGCTGGGTTTACTCTTGTTAGC 
(E202AK203AFWD)GTTCCCGATTCTTTTGCGGCAAACAAGCAAATTAATGCTC 
(E202AK203AREV)GAGCATTAATTTGCTTGTTTGCCGCAAAAGAATCGGGAAC 
(K205AQ206AFWD)CCCGATTCTTTTGAGAAAAACAAGCAAATTAATGCTCAAGTGATTG 
(K205AQ206AREV)CAATCACTTGAGCATTAATTTGCTTGTTTTTCTCAAAAGAATCGGG 
GCTATATGGTTTAATGACAATTGGATCTTCCATTATTTTTGTTGCA 
GCTATATGGTTTAATGACAATTGGATCTTCCATTATTTTTGTTGCA 
GCAGATAAGTTTGATGTTTTAACTGAGCTATATGGTTTAATGACAATTGGATCTTCC 
GCAGATAAGTTTGATGTTTTAACTGAGCTATATGGTTTAATGACAATTGGATCTTCC 
GACGACTTCAGAGAGGGTAGATCCAAAGTTTTGATTACTACTAATGTCCTGGCCCGT 
CCATCCAAAATTCAAGAAAGGGCGCTGCCATTATTATTAC 
(R224AR225AFWD)CGCCGGGCACTGTTCTTGACCTAATGGAAGAAAAATTGATGCAGC 
(R224ER225EREV)GCTGCATCAATTTTTCTTCCATTAGGTCAAGAACAGTGCCCGGCG 
(I255ER256EFWD)CAGCAGGGTCTAGGTGACCAGTGTGAAGAAGTTAAGAGATTTTTACCC 
(I255ER256EREV)GGGTAAAAATCTCTTAACTTCTTCACACTGGTCACCTAGACCCTGCTG 
yeast Gle1 (1FWD)TTCTTCTTCCCATGGCAAGATTTGTGTTCGATGAGGTTTTCAATTCAG 
(118FWD)TTCTTCTTCCCATGGGCACGAAGAAATTGGTAAATGAGTCGG 
(135FWD)TTCTTCTTCCCATGGCGACAGCACCCTTACTCGAGGCAATAGAAG 
(239FWD)TTCTTCTTCCCATGGCACAAAACTTGGTGCTTGCCAATCAGAAAG 
(252FWD)TTCTTCTTCCCATGGGTAAAGCAGTTACAAACTTTGATAAAATCTCC 
(273FWD)TTCTTCTTCCCATGGCATTTTGGCATTATAAAGACAAAATTGCTC 
(238FWD)TTCTTCTTCCCATGGCTGATGTGAATGTAAGGAATTTGCTC 
(FLREV)AAAAAAAAAGGATCCCTAAGGAGACATTTCCGGAAAGGACTCC 
(REV2)AAAAAAAAAGGATCCGCTTTTTTTATAGGCAGAACTATGTCTTGC 
human 
Dbp5 
(1FWD)GGAATTCCATATGACATCTCCAAAATCGGATCTGGNTCGCG 
(68FWD)GGAATTCCATATGAGCAACCTTGTTGATAACACAAACC 
(55FWD)GGAATTCCATATGGACAGAGCTGCCCAGTCCTTACTC 
(58FWD)GGAATTCCATATGGCCCAGTCCTTACTCAACAAGCTG 
(72FWD)GGAATTCCATATGGATAACACAAACCAAGTGGAAGTCC 
(84FWD)GGAATTCCATATGCCAAACTCCCCTCTGTACTCGGTG 
(300REV)CCCGTCGGATCCCTACTCACGCTTCAGTTTGATAACGTTTGGG 
(302REV)CCCGTCGGATCCCTACTCTTCCTCACGCTTCAGTTTGATAACG 
(306REV)CCCGTCGGATCCCTAGGTGTCCAGGGTCTCTTCCTCACGC 
(479REV)CCCGTCGGATCCCTAGTTGGCGATTTTCTCAATCTCGTCC 
site directed 
mutagenesis 
(D223RFWD)GGCACCCCTGGGACTGTGCTGAGGTGGTGCTCCAAGCTCAAGTTCATTG 
(D223AFWD)GGCACCCCTGGGACTGTGCTGGCCTGGTGCTCCAAGCTCAAGTTCATTG 
(D223RREV)CAATGAACTTGAGCTTGGAGCACCACCTCAGCACAGTCCCAGGGGTGCC 
(D223AREV)CAATGAACTTGAGCTTGGAGCACCAGGCCAGCACAGTCCCAGGGGTGCC 
(I258AFWD)CCACCAAGATCAGAGCGCCCGCATCCAGAGGATGCTGCCC 
(I258DFWD)GGGCAGCATCCTCTGGATGCGGGCGCTCTGATCTTGGTGG 
(I258AREV)CCACCAAGATCAGAGCGACCGCATCCAGAGGATGCTGCCC 
(I258DREV)GGGCAGCATCCTCTGGATGCGGTCGCTCTGATCTTGGTGG 
(R259AFWD)CCACCAAGATCAGAGCATCGCCATCCAGAGGATGCTGCCC 
(R259DFWD)GGGCAGCATCCTCTGGATGGCGATGCTCTGATCTTGGTGG 
(R259AREV)CCACCAAGATCAGAGCATCGACATCCAGAGGATGCTGCCC 
(R259DREV)GGGCAGCATCCTCTGGATGTCGATGCTCTGATCTTGGTGG 
(R262AFWD)GATCAGAGCATCCGCATCCAGGACATGCTGCCCAGGAACTGCC 
(R262DFWD)GATCAGAGCATCCGCATCCAGGCGATGCTGCCCAGGAACTGCC 
(R262AREV)GGCAGTTCCTGGGCAGCATGTCCTGGATGCGGATGCTCTGATC 
(R262DREV)GGCAGTTCCTGGGCAGCATCGCCTGGATGCGGATGCTCTGATC 
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human 
Nup214 
(1FWD)GGAATTCCATATGGGAGACGAGATGGATGCCATGATTCCCG 
(450REV)CCCGTCGGATCCCTAATTAATCATATAAAATGGACAAAGCACACCATCTGTTG 
(405REV)CCCGTCGGATCCCTAAGAAGCATCCAGTTTCTGTGGGGCTTGAGAGGAG 
site directed 
mutagenesis 
(R359AFWD)GCCTGTGACAGACAAGAGTGATGCCTCCTTGCCCATGGGAGTTGTCG 
(R359AREV)CGACAACTCCCATGGGCAAGGAGGCATCACTCTTGTCTGTCACAGGC 
(R359DFWD)GCCTGTGACAGACAAGAGTGATAGGTCCTTGCCCATGGGAGTTGTCG 
(R359DREV)CGACAACTCCCATGGGCAAGGACCTATCACTCTTGTCTGTCACAGGC 
(R348AFWD)GGCTACTGGAGGATTCTAGTGCAGCTGAATTGCCTGTGACAGAC 
(R348AREV)GTCTGTCACAGGCAATTCAGCTGCACTAGAATCCTCCAGTAGCC 
(R348DFWD)GGCTACTGGAGGATTCTAGTGACGCTGAATTGCCTGTGACAGAC 
(R348DREVGTCTGTCACAGGCAATTCAGCGTCACTAGAATCCTCCAGTAGCC 
(V353AFWD)CTAGTCGAGCTGAATTGCCTGCGACAGACAAGAGTGATG 
(V353AREV)CATCACTCTTGTCTGTCGCAGGCAATTCAGCTCGACTAG 
(V353DFWD)CTAGTCGAGCTGAATTGCCTGACACAGACAAGAGTGATG 
(V353DREV)CATCACTCTTGTCTGTGTCAGGCAATTCAGCTCGACTAG 
 
3.1.6 RNA oligos 
In all binding and crystallization experiments single stranded (ss) RNAs were 
used. 
 length (bases) purchased from 
ss poly-U 5, 6, 7, 8, 10, 12, 15 & 20 Dharmacon 
ss poly-A 10, 15, 20 Dharmacon 
5´-biotinylated ss poly-U 20 Dharmacon 
20γ polyuridylic acid potassium salt ~ 300 - 2000 Sigma-Aldrich  
 
3.1.7 Media and buffers 
Plates, buffers and media were prepared and autoclaved by EMBL‟s media 
kitchen or at MPIB. 
Media 
Luria-Bertani (LB) 
(Miller 1972) 
1 % (w/v) bacto trypton 
0.5 % (w/v) bacto yeast extract 
170 mM NaCl 
The medium was adjusted to pH 7.6 with NaOH 
LB agarose plates 1.5 % (w/v) bacto agar in LB 
antibiotics (50 μg/ml Ampicillin or 25 μg/ml Kanamycin) 
Terrific broth (TB) 1.2 % bacto trypton  
2.4 % bacto yeast extract  
0.4 % glycerol  
ddH2O to 900 ml  
0.017 M KH2PO4 
0.072 M K2HPO4 
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Auto inducing  
(Studier 2005) 
929 ml ZY + 20 ml 5052 + 50 ml NPS + 1 mM MgSO4 
   ZY 1 % N-Z-Amine (10 g /l) or Tryptone 
0.5 % Yeast-Extract (5 g/l) 
   5052 (50x stock) 25.0 % Glycerol 
2.5 % Glucose 
10 % α-lactose-monohydrate 
   NPS (20x stock) 
 
0.5 M (NH4)2SO4 
1.0 M KH2PO4 
1.0 M Na2HPO4  
pH 6.75 
Purification buffers 
Lysis buffer 50 mM Hepes pH 7.5 
500 mM NaCl  
1 mM DTT 
complete protease inhibitor cocktail (Roche) 
GSH elution buffer 
 
20 mM HEPES pH 7.5 
100 mM NaCl  
1 mM DTT 
10 mM MgCl2  
10 % Glycerol 
20 mM reduced GSH 
complete protease inhibitor cocktail (Roche) 
Ni-NTA elution buffer 20 mM HEPES pH 7.5 
100 mM NaCl  
1 mM DTT 
10 mM MgCl2  
500 mM Imidazole 
complete protease inhibitor cocktail (Roche) 
Ionexchange buffer 20 mM HEPES pH 7.5 
1000 mM NaCl  
1 mM DTT 
complete protease inhibitor cocktail (Roche) 
(supplemented with 10 mM MgCl2 and 10 % glycerol for 
the AMPPNP+RNA complex) 
Gel filtration buffer 20 mM HEPES pH 7.5 
100 mM NaCl  
1 mM DTT 
(supplemented with10 mM MgCl2 and 10 % glycerol for the 
AMPPNP-RNA complex) 
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Buffers for assays 
ATPase buffer 20 mM HEPES pH 6.5 
100 mM NaCl  
1 mM DTT 
10 mM MgCl2  
10 % Glycerol 
0.1 % Nonidet P40 
binding buffer 20 mM HEPES pH 7.5 
100 mM NaCl  
1 mM DTT 
10 mM MgCl2  
10 % Glycerol 
0.1 % Nonidet P40 
SAXS buffer 20 mM HEPES pH 7.5 
100 mM NaCl  
1 mM DTT 
10 mM MgCl2  
5 % Glycerol 
 
3.1.8 Cloning and expression strains 
 Strain / Cell type Genotypes 
E. coli XL1 blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F´ proAB 
lacIqZΔM15 Tn10 (Tetr)] 
BL21 DE3 E. coli B F– ompT hsdS(rB– mB–) dcm+ Tetr gal endA Hte 
BL21 DE3 Gold E. coli B F– ompT hsdS(rB– mB–) dcm+ Tetr gal λ(DE3) endA Hte 
insect cells SF9 wt 
S. cerevisiae BJ5459 Matα, ura3-52, trp1, lys2-801, leu2Δ1, his3Δ200, pep4::HIS3, 
prb1Δ1.6R, can1, GAL> 
 
3.1.9 Equipment 
Instrument Model Supplier 
Cell culture 
   Shakers 
 
KS-15  
Climo-Shaker ISF1X & W 
 
Edmund Bühler, Kühner 
Centrifuges Avanti J-20 XP 
Micro centrifuge 5417C & 5810 
Megafuge 1.0 
Sorvall RC 5C 
Beckman Coulter 
Eppendorf 
 
 
Sorvall 
  
Materials and Methods 
33 
Chromatography 
   FPLC 
 
 
   Columns 
 
 
 
   Chromatography media 
 
Aekta Explorer 
Aekta Purifier 
Aekta Prime 
Hiload Superdex 200 16/60 
Hiload Superdex 200 10/300 
Superdex 200 5/150 gl 
Hitrap Heparin, Hitrap Q 
Heparin Sepharose, GSH-
Sepharose 4B fast flow  
His-select gel  
magnetic streptavidin beads 
 
GE Healthcare 
 
 
 
 
 
 
 
 
Sigma Aldrich 
Dynal 
Crystallization 
   Plates 
 
   Pipetting robots 
 
96well MRC96T 
24well vdx 
Phoenix 
 
SwissCI 
Hampton Research 
Art Robbins Instruments 
Electrophoresis 
   Gel casting 
   Precast gels 
   Gel chamber 
   Power supply 
 
 
 
 
 
   Gel imaging 
 
Made by workshops  
NuPAGE 
 
PowerPac300  
PowerPack515T 
PowerEase  
GPS200/400 
LKB-EPS 500/400  
EPS301 
Safe imager 
Ebox3026 
 
EMBL & MPI 
Invitrogen 
 
Biorad  
Biometra  
Invitrogen  
GE Healthcare 
 
 
Invitrogen  
Peqlab 
Electroporation 
   Instrument 
 
   Cuvettes 
 
gene pulser  
micro pulser 
Gene pulser cuvette  
0,2 cm electrode gap 
 
Biorad 
 
 
 
French-press Emulsiflex Avestin 
Liquid scintillation counter Tri-carb 2100TR LSA Packard 
PCR Primus96 Peqlab 
pH meter Lab860 Schott 
Pipettes  Eppendorf 
Scales LA1200S 
TE1502S 
Sartorius 
Static light scattering TDA302 Viscotech 
Surface plasmon resonance 
Chips 
Instrument 
 
CM5 chip 
BIAcore 3000 
 
GE Healthcare 
Thermoblock/-shaker  
compact 
Memert 
Eppendorf 
UV/visible spectrometer BioPhotometer  
Nanodrop ND-1000 
Eppendorf  
Thermo Fisher 
Water bath Arius 611UF & 611DI Sartorius 
X-ray 
   Sealed tube 
   Plate scanner  
   Cryo loops  
   Caps and vials 
 
PX scanner 
Xcalibur Nova 
CryoLoop 20 micro 
Magnetic caps and vials  
 
Oxford Diffraction 
 
Hampton research 
Molecular Dimensions 
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3.1.10 Synchrotron facilities and X-ray sources 
All crystallographic data were collected at Swiss Light Source (SLS) at the 
Paul Scherrer Institute (PSI), Villigen, Switzerland at beam lines X06SA and X10SA. 
Crystals were tested in-house on PX-scanner and Excalibur before measuring at 
SLS. Small angle scattering data were collected at Advanced Light Source (ALS), 
Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, CA, USA at beam 
line SYBILS12.3.1. 
 
3.1.11 Software 
The following software was used to write this thesis, analyze data and 
generate figures and alignments. 
Adobe Illustrator (www.adobe.com) 
Adobe Photoshop (www.adobe.com) 
BIAcore evaluation software (GE Healthcare) 
Bioedit (Tom Hall, Ibis Biosciences) 
CCP4 (CCP4 1994) 
Coot (Emsley and Cowtan 2004) 
Credo (Petoukhov 2002) 
Crysol (Svergun 1995) 
Damaver (Svergun 1999) 
Dammin (Svergun 1999) 
DSSP (Kabsch and Sander 1983) 
Endnote (www.endnote.com) 
Gnom (Svergun 1992) 
Microsoft Office (www.microsoft.com) 
Origin (www.originlab.com) 
Primus (Konarev 2003) 
Pymol (DeLano ) 
XDS (Kabsch 1993) 
 
3.1.12 Servers 
The following servers were used to analyze the refined structures and to 
generate input files for data refinement in Refmac (CCP4 1994). 
3d-SS (http://cluster.physics.iisc.ernet.in/3dss/) 
Aquaprot (http://bioinfo.weizmann.ac.il/aquaprot/) 
Molprobity (http://molprobity.biochem.duke.edu/) 
Prodrg (http://davapc1.bioch.dundee.ac.uk/prodrg/) 
TLSMD (http://skuld.bmsc.washington.edu/~tlsmd/) 
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3.2 Methods 
3.2.1 Cloning 
3.2.1.1 PCR 
PCR reactions were set up in a total volume of 50 µl: 
0.5 µl Phusion Polymerase (1 U/µl) 
10 µl 5x reaction buffer 
1 µl DMSO (100 %) 
1 µl dNTP mix (dATP, dTTP, dCTP, dGTP, 10 mM each) 
1 µl forward primer (10 µM) 
1 µl reverse primer (10 µM) 
50 ng template DNA 
 
The following cycling conditions were used: 
30 s - 98°C initial denaturing step  
10 s - 98°C denaturing 
10 s - annealing 30 cycles* 
  x s - 72°C extension** 
5 min - 72°C final extension 
*Annealing temperature was varied depending on the melting temperature (Tm) of 
the primers. In some cases touch-down PCR was applied with a decrease of the 
annealing temperature of 0.5°C per cycle.  
**An extension time of 30 s per kb was used.  
3.2.1.2 Agarose gel electrophoresis 
DNA fragments generated by PCR or restriction digestion were separated by 
agarose gel electrophoresis, using a minigel system produced by the mechanical 
workshops, EMBL (Heidelberg; Germany). 1 % w/v agarose was melted in 1x TBE 
buffer (90 mM Tris-base, pH 8.3, 90 mM boric acid, 1 mM EDTA). After cooling to 
65ºC, ethidium bromide or SYBR safe (Invitrogen) was added (0.5 μg/ml final 
concentration), and gels were casted. Before loading, the samples were 
supplemented with 0.5 volumes DNA dye (20 % Ficoll, 1 mM EDTA, 0.1 % SDS, 0.05 
% Bromophenol Blue). DNA size marker (1 kb ladder, NEB) was loaded in a separate 
lane. Gel electrophoresis was performed at 7 V/cm in 1x TBE buffer. DNA fragments 
were visualized with UV light (ethidium bromide) or a blue light transilluminator 
(SYBR safe, Invitrogen) emitting blue light at a wavelength of ~ 470 nm.  
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3.2.1.3 Purification of DNA fragments 
DNA fragments from restriction digestions were purified from an agarose gel. 
DNA bands of interest were cut from gel and purified with the gel extraction kit 
(Qiagen) according to the manufacturer‟s instructions. DNA fragments generated by 
PCR were purified directly from the reaction mixture using the PCR purification kit 
(Qiagen) and following the manufactures manual. All DNA fragments were eluted in 
buffer containing 10 mM Tris-Cl, pH 8.5 
3.2.1.4 Restriction digest and ligation 
Plasmids and DNA fragments generated by PCR were digested with 
appropriate enzymes (NEB). Optimal reaction buffers were used as recommended by 
the manufacturer. Reactions were typically carried out in a total volume of 50 μl, 
using 1 μl of each enzyme (10 U/μl), 5 µl of the appropriate 10x buffer (NEB), and if 
required 0.5 μl BSA (10 mg/ml). Reaction time and temperature varied depending on 
the enzymes used. Cloned plasmids were all tested by restriction digest prior to DNA 
sequencing. Plasmids and PCR fragments were digested with the appropriate 
restriction enzymes and were ligated using T4 DNA ligase (Promega). Generally, 6 μl 
of the gel-purified digested PCR product and 20 ng linearised plasmid were ligated. 
Ligations were performed in a 20 μl reaction containing the linearised plasmid and 
the PCR product, 1 μl T4 DNA ligase (400 U/ml, Promega), and 2 μl 10x T4 DNA 
ligase buffer (100 mM MgCl2, 100 mM DTT, 10 mM ATP, 300 mM Tris-Cl, pH 7.8). 
Ligation reactions were performed for at least 1 h at room temperature. 
3.2.1.5 LIC cloning  
3.2.1.5.1 Principle 
Ligation independent cloning (LIC) is a fast and efficient way to integrate the 
desired ORF into a vector. Vectors and protocols were designed and produced by 
Jérôme Basquin and Florence Martin in our lab. The LIC system is using the 3' to 5' 
exonuclease activity of a T4 DNA polymerase to generate 12 - 15 bp overhangs on 
both the vector and the insert. The complementary overhangs of plasmid and insert 
anneal and are stable enough (without ligation) to be transformed into cells. The 
nicks in the plasmid get repaired by the E. coli replication machinery. Since this 
method is independent of restriction enzymes and their target sequences, this system 
provides a fast way to clone different constructs in different vectors. Here the 
principle and sequences are briefly described: 
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Linearization of vector with SacII: 
5`actagtgaaaacctgtatttccagggagcagccgc      ggccggtgctttgcaggatcc`3 
3`tgatcacttttggacataaaggtccctcgtcgg      cgccggccacgaaacgtcctagg`5 
  ------ E  N  L  Y  F  Q  G  A  ------------             ------ 
   SpeI         TEV Site  ^         SacII                  BamHI 
Treatment with T4 DNA Pol + dTTP: 
Digestion with T4 DNA polymerase with its 3' to 5' nuclease activity produces 
overhangs (underlined). The polymerase stops as soon as it reaches a thymine. 
5`actagtgaaaacctgtattt                     ggccggtgctttgcaggatcc`3 
3`tgatcacttttggacataaaggtccctcgtcgg                      tcctagg`5 
Insert processing: 
The LIC sequences are included in the primers.  
5`ccagggagcagcctcgATG(desired ORF)TAAcgaggccggtgctttgc`3 
3`ggtccctcgtcggagctac             attgctccggccacgaaacg`5 
                   M              * 
Digestion with T4 DNA polymerase (+ dATP) produces the overhangs (underlines). 
5`ccagggagcagcctcgATG(desired ORF)TAAcga`3 
3`             agctac             attgctccggccacgaaacg`5 
After annealing of the complementary overhangs (underlined) the final plasmid 
(including two nicks) can be used for transformation: 
5`tctaga(TAG)actagtgaaaacctgtatttccagggagcagcctcgATG(desiredORF)TAAcgaggccggtgctttgcaggatcc`3 
3`agatct     tgatcacttttggacataaaggtccctcgtcggagctac            attgctccggccacgaaacgtcctagg`5 
  ------     ------ E  N  L  Y  F  Q  G  A  A  S  M              *                   ------  
   XbaI       SpeI         TEV Site  ^                                                BamHI 
The integration of the LIC system into different vectors allows different tags and 
protease sites. 
3.2.1.5.2 Experimental procedure 
Insert processing: 
For processing of the PCR product, the following reaction was prepared: 
gel purified PCR product  600 ng 
T4 DNA Pol. buffer (10x)  2 µl 
dATP (25 mM)  2 µl 
DTT (100 mM)  1 µl 
T4 DNA Pol. LIC qualified (Novagen)  0.4 µl 
H2O  add to 20 µl 
The reaction mix was incubated for 30 min at room temperature. The enzyme was 
inactivated at 75°C for 20 min. 
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Vector processing: 
The vector needs to be linearised first by digestion (or by PCR). Therefore 2 µg of 
vector were digested with 60 u SacII (or 20 u ZraI for 3C LIC vectors). 
The cut vector was gel purified (0.8 % agarose gel) and processed as followed: 
linearized vector 450 ng 
T4 DNA Pol. buffer (10x) 3 µl 
dTTP (25 mM) 3 µl 
DTT (100 mM) 1.5 µl 
T4 DNA Pol. LIC qualified (Novagen) 0.6 µl 
H2O add to 30 µl 
 
The reaction mix was incubated for 30 min at room temperature. The enzyme was 
inactivated at 75°C for 20 min. 
 
Annealing reaction: 
For the annealing, 2 µl of processed insert and 1 µl of processed vector were mixed 
and incubated for 10 min at room temperature. Then 1 µl of EDTA (25 mM) was 
added and the mix was incubated 10 min at room temperature. 2 µl of the reaction 
were used for transformation into E. coli cells. 
3.2.1.6 Transformation 
Transformation-competent bacteria were thawed on ice. 2 μl of the ligation 
reaction or 0.2 μg of plasmid were added to 50 μl of the competent bacteria, and 
transformed using the electroporation method. Here an electrical pulse of 1.8 kV (0.1 
cm cuvettes) or 2.5 kV (0.2 cm cuvettes) was applied. After electroporation cells were 
slowly shaken on a thermomixer at 37°C for 30 min. The bacteria were then plated 
onto LB agar plates containing the appropriate antibiotic and were incubated over 
night at 37ºC. 
3.2.1.7 Site-directed mutagenesis 
For the generation of point mutants PCR mutagenesis was performed, using 
the QuikChange Site-Directed Mutagenesis Kit (Stratagene) or Phusion polymerase 
(Finnzymes). The mutagenesis strategy involves the amplification of the target 
plasmid with sense and antisense oligonucleotide primers that contain the desired 
mutation. The same protocol as for the normal PCR was used. After amplification 1 μl 
of Dpn I enzyme (20 U/μl) was added to the amplification reaction and incubated for 
5 h at 37ºC in order to digest the template DNA. 
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3.2.1.8 DNA sequencing 
All plasmids were validated by DNA sequencing performed by core facilities at 
EMBL Heidelberg or MPIB Martinsried.  
 
3.2.2 Expression and purification of recombinant proteins 
All proteins were expressed in baffled Erlenmeyer flasks with 10 % v/v media 
per flask. Traces of antifoam (Sigma-Aldrich) were used to prevent formation of foam. 
Cells were grown at an initial temperature of 37°C to different optical densities 
(OD600) depending on the media used (auto inducing: OD600 ~ 2 - 3, TB: OD600 ~ 3, 
LB: OD600 ~ 0.8). For (overnight) expression the temperature was decreased to 18°C. 
Cells grown in TB and LB were induced with 0.1 - 0.5 mM IPTG. All purification steps 
were carried out at 4°C or on ice. Cells were lysed in lysis buffer by 2 - 3 french-press 
cycles. 
3.2.2.1 Yeast Dbp5 
All yeast Dbp5 constructs were expressed at 18°C in E. coli BL21 Gold cells 
using LB or auto inducing media. Cells were lysed in lysis buffer (paragraph 3.1.7) 
using an emulsiflex french-press. Lysed cells were centrifuged for 45 min at 48000 x 
g. GST-tagged constructs were batch purified using GSH-Sepharose. The GST-tag 
was cleaved over night at 4°C with TEV protease. Untagged proteins were eluted 
from resin with gel filtration buffer (paragraph 3.1.7), and proteins were further 
purified by gel filtration chromatography (S200). 
3.2.2.2 Yeast Nup159 
All yeast Nup159 constructs were expressed in E. coli BL21 Gold cells using 
LB or auto inducing media. In the case of LB 0.1 - 0.5 mM IPTG was used for 
induction at 18°C. Cells were lysed in lysis buffer (paragraph 3.1.7) using an 
emulsiflex french-press. Lysed cells were centrifuged for 45 min at 48000 x g. 6xHis-
tagged constructs were batch purified using Ni-NTA resin. Protein was eluted in gel 
filtration buffer (paragraph 3.1.7) containing 500 mM Imidazole and tag was cleaved 
overnight using TEV protease at 4°C during dialysis against gel filtration buffer 
(paragraph 3.1.7). Protein was further purified by ion exchange chromatography 
(Hitrap Q) and a final gel filtration step (S200). 
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3.2.2.3 Yeast Dbp5-Nup159 complex 
Yeast Dbp5 and Nup159 were both expressed at high levels when 
cotransformed into E. coli BL21 cells. Cells were lysed using french-press. The 
complex was captured in a GSH-Sepharose affinity batch purification step followed 
by tag cleavage on the resin with TEV protease overnight (4°C) on a rolling shaker. 
Cleaved proteins were eluted from the resin with gel filtration buffer and were further 
purified by gel filtration chromatography (S200). The complex was also reconstituted 
from separately purified proteins and further purified by size exclusion 
chromatography (S200). 
3.2.2.4 Human Dbp5 
Human Dbp5 constructs were expressed at 18°C overnight as GST-fusions in 
E. coli BL21 cells using auto inducing media. GST-Dbp5 constructs were captured on 
GSH-resin followed by extensive washing in gel filtration and ion exchange buffer. 
The 1 M NaCl wash (ion exchange buffer) was implemented to remove bound nucleic 
acids from the protein. GST-Dbp5 was either eluted with GSH elution buffer or the 
GST-tag was cleaved overnight with TEV/PreScission protease. Tagged and 
untagged Dbp5 constructs were further purified using a Heparin column. Bound 
proteins were eluted in gel filtration with a linear salt gradient of (100 to 1000 mM 
NaCl) and subjected to a size exclusion chromatography step (S200). 
3.2.2.5 Human Nup214 
Nup214 βΔC was expressed in E. coli BL21 Gold cells as N-terminal 6xHis- or 
GST-fusion proteins. Initial capturing using the appropriate resin (Ni-NTA or GSH-
Sepharose) was followed by overnight tag cleavage using TEV protease. After tag 
cleavage untagged proteins were further purified by ion exchange chromatography 
(Hitrap Q) and size exclusion chromatography (S200).  
3.2.2.6 Human Dbp5-Nup214 complex 
For complex formation the two purified proteins were mixed at 4°C for one 
hour in gel filtration buffer. A slight excess of Dbp5 was typically used to saturate the 
nucleoporin. The formed complex was separated from an excess of unbound Dbp5 or 
Nup214 by size exclusion chromatography (S200).  
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3.2.3 Polyacrylamid gel electrophoresis 
Proteins were analyzed on SDS PAGE using 15 % gels (according to Laemmli 
1970). Separating gels were prepared according to the following recipe: 
2.7 ml H2O 
2 ml 1.5 M Tris, pH 8.7 
3.2 ml 30 % acrylamide/N,N‟-methylene-bisacrylamide solution (37.5:1) 
80 µl 10 % SDS 
36 µl 10 % ammonium persulfate (APS) 
12 µl 100 % N, N, N‟N‟-tetramethylethylene diamine (TEMED) 
The stacking gel had the following composition: 
2.63 ml H2O 
500 μl 1 M Tris-Cl, pH 6.8 
800 μl 30 % acrylamide/N,N‟-methylene-bisacrylamide solution (37.5:1) 
40 µl 10 % SDS 
24 µl 10 % APS 
8 µl 100 % TEMED 
 
3.2.4 Native gel electrophoresis  
Native gels were used to analyze the homogeneity of protein samples and for 
electromobility shift assays (EMSA). Gels were cast and run in a glass-plate and a 
gel apparatus made by the EMBL workshop. 10 % polyacrylamide 
(acrylamide:bisacrylamide 29:1) in 50 mM Tris-acetate pH 8.0 and 10 mM 
magnesium-acetate was used. To avoid heat (denaturing), gels were run on ice or at 
4°C with 80 V. 20 % glycerol was added to the samples as loading buffer. One lane 
was loaded with buffer supplemented with 20 % glycerol and traces of bromophenol 
blue as a control of migration. Gels were then stained for nucleic acids with toluidine 
(0.1 % toluidine in water). 
 
3.2.5 ATPase assays 
An initial reaction was performed to find the best pH condition for this assay, 
using different buffers with pH from 6.0 up to pH 8.0 in 0.5 pH steps.  
Final ATPase reactions were performed in the buffer of maximal ATPase activity of 
Dbp5 containing 50 mM MES pH 6.5, 100 mM NaCl, 10 mM MgCl2, 1 mM DTT, 10 % 
glycerol and 0.1 mg/ml BSA. 15 pmol of Dbp5, 2 mM ATP, 4 µg polyU RNA and 
traces of [γ-32P] ATP (10 ci/mmol purchased from Perkin Elmer). Reactions were 
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incubated 0, 30, 60, 90 min at 30°C and stopped by adding 400 µl of ice-cold 10 
% (w/v) acid-washed charcoal (Sigma-Aldrich) in 10mM EDTA as described. After 
30 minutes of centrifugation at 16,000 g, supernatants containing [γ-32P] Pi were 
counted by the Cerenkov method using a Packard liquid scintillation counter (Tri-
carb 2100TR LSA). 
 
3.2.6 Binding experiments 
3.2.6.1 GST pull-downs 
All GST-pull-down experiments were carried out at 4°C. About 2 µg of GST-
tagged recombinant Dbp5 proteins were immobilized on 20 µl of glutathione 
agarose beads (GE Healthcare) per binding reaction. After 2 hours incubation, 
beads were washed three times with 1 ml of binding buffer (paragraph 3.1.7). 
Equimolar amounts of Nup214 proteins were added in a final volume of 100 µl 
binding buffer per reaction. A two-fold excess of Nup214 proteins was used for 
pull-downs with mutant proteins. After two-hour incubation, beads were washed 
three times with 1 ml binding buffer. Bound proteins were eluted with SDS sample 
buffer and analyzed by SDS PAGE. 
3.2.6.2 RNA binding 
All RNA-binding experiments were performed at 4°C using 5‟-end-
biotinylated U20 ssRNA (Dharmacon). 2 µg of each Dbp5 construct was incubated 
in binding buffer in the presence or absence of 1 mM AMPPNP and 170 nM U20 
RNA. Samples were incubated overnight at 4°C. 50 µg magnetic streptavidin 
beads (Dynal) were added for 1h. Beads were washed three times with 0.5 ml 
binding buffer. Proteins mixtures before (input, 17 % of the total) and after co-
precipitation (precipitate, eluted in SDS loading buffer) were separated on a 15 % 
(w/v) acrylamide SDS-PAGE (as described in paragraph 3.2.3) and visualized 
using Coomassie stain. 
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3.2.6.3 Electromobility shift assays (EMSA) 
EMSA experiments were performed in order to analyze binding of Dbp5 to 
nucleic acids. EMSA were performed in buffer containing 50 mM HEPES pH 8.0, 
100 mM NaCl, 10 mM MgCl2, 1 mM DTT, 10 % glycerol supplemented or not with 
1 mM ATP, AMPNP, ADP and AMP. Proteins were incubated with ssRNAs (6 - 20 
nucleotides poly-U or poly-A, see paragraph 3.1.6) for 30 min on ice, before 
loaded on a native polyacrylamide gel. Gels were stained for nucleic acids using 
toluidine. After toluidine staining gels were destained in water and then stained for 
proteins using Coomassie.  
3.2.6.4 ATP binding 
Binding affinities of Dbp5 for ATP were measured using a spin column 
protocol. Here, the protein is incubated with the ligand. Bound and unbound 
ligands (in this case [γ-32P] ATP) are separated using small spin gel filtration 
columns. Quantification of the amount of bound ligand in the presence of 
increasing concentrations of proteins allows the calculation of the binding constant 
(KD). For KDs ≥ µM this method is limited by the amount (& solubility) of the 
proteins used. For the reaction the same buffer (pH 6.5) as for ATPase assay was 
used. For the gel filtration columns, a 5 % Sephadex G75 (GE Healthcare) 
suspension (incubated on rotating shaker for 2h at 4°C) in ATPase buffer was 
prepared. Minicolumns (Micro Bio-Spin, Bio-Rad) were loaded with 800 μl 
Sephadex G75 suspension and spun for 1 min at 750 x g (without drying the 
matrix). 5x10-5 - 5 nmols of protein were mixed with buffer in a total volume of 10 
µl on ice and then pre-incubated for 10 min at 37°C. 10 µl of ATP mix containing 
traces (~ 2 fmol) of [γ-32P] ATP (Perkin Elmer) buffer was added. Samples were 
incubated for 2 min at 37°C. The 20 µl samples were then added on the resin of 
the freshly prepared spin columns. Columns were spun for 2 min at 750 x g. The 
eluates were counted in a scintillation counter using the Cerenkov method (as 
described in 3.2.5). Data were analyzed with the following assumptions: 
(where  is the enzyme and  its ligand) 
    and    can be combined to  
 
(eq. 1)  
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when it is assumed that  (where  is the range of protein 
concentration). Since negligible amounts of labeled ATP (L) are incubated with the 
protein (E) this assumption is valid. can be estimated with the above equation 
with measured  and known concentration of the protein by plotting  against 
the concentration range . 
 
3.2.7 Surface plasmon resonance (SPR) spectroscopy 
Binding constants for the Dbp5-Nup214 complex were determined using 
SPR spectroscopy. All experiments were designed together with Claire Basquin 
(MPIB) who performed the experiments. 
3.2.7.1 Theory 
Surface Plasmon Resonance (SPR) is based on surface plasmons. These 
are fluctuations of electron density at the boundaries of two materials (metal and 
dielectric) and can be described by different models (quantum mechanics, Drude 
model, Drude 1900). Surface plasmons can be excited by both electrons and 
photons and are then called polaritons. These propagate along the metal surface 
and decay. The excitation of plasmons by visible light is denoted as SPR. Incident 
polarized light interacts with the free oscillating electrons in the metal surface. 
Resonance occurs at a critical angle of incident, resulting in a minimum of 
intensity of reflected light (figure 3a and b). The angle depends on the refractive 
index (RI) at, or close to the metal surface. Therefore SPR instruments can be 
used to detect small changes of RI equivalent to a change in mass (for e.g. the 
immobilization of a ligand or a binding event). SPR chips are typically coated with 
gold, since it is a metal that supports surface plasmons.  
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Figure 4: Surface Plasmon 
Resonance spectroscopy. (a) 
schematics of an SPR experiment. 
Polarized light is used to exited 
surface plasmons. The reflected 
light is recorded by a detector. 
Molecules A (red) is immobilized 
on the functionalized gold surface 
(e.g. covalently bound antibodies) 
of the SPR chip. This results in a 
minimum of intensity of reflected 
light (see panel b, minimum A). 
The analyte (molecule B in yellow) 
binds to molecule A and results in 
a minimum that is shifted by angle 
φ (see panel b, minimum B). (b) 
Example of excitation of surface 
plasmons. At a certain angle φ 
excitation occurs, resulting in a 
minimum of intensity of reflected 
light. A change on the surface 
(e.g. immobilization of a protein) causes a change in refractive index resulting in an angular 
shift from A to B. c) example of a sensorgram, molecule A is immobilized on the gold surface 
and the analyte (molecule B) is injected. Binding of the two molecules results in a change of 
the resonance signal.  
This technique is typically used to determine the binding affinity between two 
molecules. One of the molecules (ligand) is immobilized to a chemically modified 
matrix using well defined chemistry and the binding partner (analyte) is injected from 
the micro fluidic system. The binding signal observed is generally expressed in 
response units (RU) and reflects the association (on-rate) and dissociation (off-rate) 
of the reaction, from which the affinity constants can be calculated. Scatchard plots 
(SPR angle at equilibrium (Req) / concentration of analyte) can be used to evaluate 
data but can result in large errors especially in the low concentration range. 
Therefore a better approach is to use a non-linear regression using the Langmuir 
binding isotherm, 
 
(eq. 2)  
where  is the maximum binding capacity,  the concentration of the analyte 
and the dissociation constant  . Various binding models can be used to evaluate 
data (Karlsson and Falt 1997). In our case a simple bimolecular binding model could 
be used: 
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    and  
(with  and describing association and dissociation constants)  
3.2.7.2 Experimental procedure and data analysis 
SPR spectroscopy was performed at 25°C using a BIAcore 3000 (GE 
Healthcare). Anti-GST antibody (GE Healthcare) was immobilized on a CM5 chip 
using an amine coupling procedure (according to GE healthcare instructions) with a 
30 µg/ml antibody at 5 µl/min in 10 mM Na-acetate at pH 5.0. Approximately 10000 
response units (RU) were immobilized on the chip. The anti-GST chips were then 
derivatized with 100 to 150 RUs with GST-tagged Dbp5 constructs in running buffer 
(20 mM HEPES, pH 7.5, 100 mM NaCl, 5 mM DTT, 10 mM MgCl2 supplemented or 
not with 1 mM AMPPNP or ADP). An anti-GST ﬂow cell was used as the control. 
Untagged Nup214 constructs were injected across the chip at a flow rate of 30 
µl/min. The BIAcore 3000 evaluation software was used for analysis of the 
experimental data. The saturation binding values were ﬁtted according to a one-site 
Langmuir binding model using Origin software (http://www.originlab.com/ ).  
 
3.2.8 Static light scattering 
To determine the molecular weight (and the oligomerization state) of proteins 
and protein complexes and the monodispersity of samples static light scattering was 
applied. 
3.2.8.1 Theory 
A typical static light scattering experiment consists of a size exclusion 
chromatography column coupled to a static light scattering devise with a triple 
detector array. The detector array consists of a laser light scattering (LS), a UV 
absorbance (UV) and a refractive index (RI) detector. With this experimental setup 
the homogeneity, monodispersity, oligomerization state and the molecular weight of 
proteins can be accurately determined. The basic light scattering equation is  
 
(eq. 3)  
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Where  is the excess intensity of light scattered at angle  (Rayleigh ratio) and 
 the optical parameter (Debye constant) , c the concentration in 
mg/ml, λ0 is the wavelength of the light in vacuum, M is the weight-average MW,  the 
wavelength of the incident light,  is the mean square of the radius of gyration, 
A2 is the second virial coefficient, n is the refractive index,  is the refractive 
increment and NA is Avogadro‟s number. For low concentrations A2 is negligible. For 
scattering molecules smaller than the wavelength of the incident light term  is 
~1. This is a good approximation for proteins with , which corresponds to 
globular proteins  with MW < 5x107 Da. Therefore this equation can be simplified to 
 
(eq. 4)  
With  the intensity of the light-scattering signal is 
 
(eq. 5)  
refractive index signal is described by 
  (  is an instrument calibration constant) (eq. 6)  
The UV absorbance is  
  (  is an instrument calibration constant and  the extinction coefficient)  (eq. 7)  
From this we can derive 
 
(eq. 8)  
Where  and  are the molecular weight and the extinction coefficient of the protein. 
For most complexes  is not known, but can be calculated from the amino acid 
composition. From this combination of three detectors accurate MWs can be 
measured and therefore stochiometries of protein-protein or protein-nucleic acid 
complexes can be determined. In our experimental setup the UV detection has only a 
monitoring function. The accurate determination of the concentration (RI detector) 
and the light scattering signal can be used to calculate the molecular weight. 
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3.2.8.2 Experimental procedures 
All static light scattering experiments were performed at 25°C and in gel 
filtration buffer. A Superdex 200 column (5/150) coupled to a static light scattering 
devise (TDA302, Viscotech) with a triple detector array was used. Measurements 
were performed at a single angle (90°). 10 µl of protein sample at 2 mg/ml were 
injected. 
 
3.2.9 Storage of purified proteins 
For short term storage protein samples were stored on ice or at 4°C in gel 
filtration buffer. For long term storage purified protein samples (10 - 50 µl aliquots in 
thin wall PCR tubes at concentrations between 1 - 50 mg/ml) were flash frozen in 
liquid nitrogen and kept at - 80°C. Large protein quantities were directly (slowly) 
pipetted into liquid nitrogen (as described in Bergfors 1999), stored at - 80°C and for 
further use slowly thawed on ice, concentrated and subjected to size exclusion 
chromatography (S200).  
 
3.2.10 Measurement of protein concentration 
Protein concentration was determined using the Bradford assay (Bradford, 
1976) or a spectrophotometer (Nanodrop). Dye reagent for Bradford assay was 
purchased from Bio-Rad. Bovine serum albumin (BSA) was used as a standard. 
 
3.2.11 X-ray crystallography 
Many textbooks (Blundell and Johnson 1976; Drenth 1999; Rhodes 2000; 
McPherson 2001) describe the theory and methods in detail and therefore I only 
describe the experimental procedures. 
 
3.2.11.1 Crystallization 
Initial screening was performed in 96well sitting drop plates using commercial 
and homemade screens. 100 nl protein was mixed with 100 nl of the mother liquor 
using a Phoenix pipetting robot. Two different temperatures (4°C and 18°C) were 
screened. Initial hits were then optimized and refined in 96well sitting drop or 24well 
hanging drop plates.  
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3.2.11.1.1 Human Dbp5-AMPPNP-RNA complex 
Dbp5 ΔN was concentrated to 18 mg/ml and incubated with 1 mM AMPPNP 
and a 1.2 molar excess of U10 ssRNA for one hour at 4°C. Initial crystals grew in 
several conditions containing different PEGs. Optimized crystals were obtained using 
a reservoir solution consisting of 100 mM Tris pH 7.0, 20 % PEG 2000 mono-methyl-
ether, 3 % PEG 3350 and 30 mM NaF. The crystals grew as needles and were 
cryoprotected by the addition of 15 % glycerol. Crystals were flash frozen in liquid 
nitrogen. The best data set extends to 2.2 Å resolution (statistics in Table1).  
3.2.11.1.2 Human Dbp5-Nup214 Complex 
Initial crystals of the Dbp5 ΔNΔC-Nup214 βΔC complex grew within 1 - 2 days 
in conditions with high concentrations of Na-Citrate, Na-Malonate, Na-Acetate or Na-
Oxalate. Optimized crystals grew as plates by mixing equal volumes of protein 
complex at 50 mg/ml and a reservoir solution containing 50 mM MES pH 6.0 and 
900 mM Na-Citrate. Crystals were cryoprotected in paraffin oil prior to data collection.  
 
3.2.11.2 Data collection and processing 
Crystals were mounted in cryo-loops (Hampton research, USA). All data were 
collected at 100°K at the Swiss Light Source (SLS) at beamlines X06SA and X10SA 
with an oscillation range of 1° and exposure times of 1 sec/frame. Diffraction images 
were recorded on mar225 CCD or mar225 mosaic CCD detector (mar research). 
Other experimental settings are listed in Table1. In order to collect complete 
datasets, collecting strategies using MOSFLM (Leslie 1992) and LABELIT (Sauter 
2004) were applied. Raw data were indexed, integrated and processed with XDS 
(Kabsch 1993) and scaled/merged with XSCALE (Kabsch 1993).  
 
3.2.11.3 Structure solution and model building 
All structures were solved by molecular replacement using Phaser (McCoy 
2004). Phases were improved using density modification with Pirate (CCP4 1994). 
Molecular replacement solutions were subjected to initial rigid body refinement with 
Refmac (CCP4 1994). Models were manually built using Coot (Emsley and Cowtan 
2004) and refined with Refmac (CCP4 1994). Input files for TLS 
(Translation/Libration/Screw) refinement were generated using the TLSMD (TLS 
motion determination) server (Painter and Merritt 2006). TLS is a mathematical 
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model describing the local positional displacement from a mean position for atoms 
that are part of a rigid body. This deviation from a spherical electron density at the 
atomic position is similar to the individual atomic anisotropic thermal parameters and 
is caused by thermal vibration of the molecule/atoms and static disorder in the crystal 
lattice. In contrast to full anisotropic refinement, where the displacement for each 
atom is described by 6 parameters, TLS groups are described by more sophisticated 
models of displacement that add only 20 parameters of refinement per TLS group. 
Therefore TLS refinement, where typically only a few TLS groups are refined 
individually, does not require such high resolution (< 1.2 Å) data in order to satisfy the 
parameter/observation ratio. TLS refinement describes the model more accurately 
and typically results in improvement of R-factors by a few percent. 
Figures were prepared with Pymol (DeLano). Structural superpositions were 
performed with the secondary structure matching function of Coot (Emsley and 
Cowtan 2004) or the 3D-SS server (Sumathi 2006). Secondary structures were 
assigned using DSSP (Kabsch and Sander 1983) and were implemented in the pdbs 
for correct representation in Pymol (DeLano ) using the DSSP2PDB script (James 
Stroud). 
3.2.11.3.1 Human Dbp5-AMPPNP-RNA complex 
The Dbp5 ΔN-AMPPNP-U10RNA structure was solved using human eIF4A3 
from the EJC structure (PDB entry 2J0S; sequence identity 39 %) as a search model. 
The crystals contain two molecules per asymmetric unit. The model was refined 
using tight non crystallographic symmetry (NCS) restraints, which were released in 
the final stages of refinement to account for variation between the two molecules.  
3.2.11.3.2 Human Dbp5-Nup214 complex 
The Dbp5 ΔNΔC-Nup214 βΔC structure was solved by molecular replacement 
using the N-terminal domain of Dbp5 from the refined Dbp5 ΔN-AMPPNP-U10RNA 
structure and the 1.65 Å human Nup214 structure (PDB entry 2OIT) as consecutive 
search models in Phaser (Emsley and Cowtan 2004). The statistics of the refined 
structures are in Table1.  
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3.2.12    Small angle X-ray scattering  
To determine conformations of Dbp5 in presence of nucleotides and to 
investigate flexibility of some regions of Dbp5 and Nup214 (as described in 
paragraph 4.4) I collected solution small angle X-ray scattering (SAXS) data. 
3.2.12.1 Theory 
SAXS is a technique based on the elastic scattering of X-rays of 
macromolecules in solution. Scattering is recorded (scattering intensity as a function 
of the scattering angle) at low angles (0.1 - 10°) and can be used to derive structural 
information like global shape and size of macromolecules. In addition parameters 
such as molecular weight (MW), radius of gyration (Rg) and the maximum 
intramolecular distance (Dmax) can be determined. Rg and forward scattering 
intensity I(0) can be obtained from the Guinier formula (  for 
small momentum transfer q ( ), where 2θ is the total scattering angle and 
 the X-ray wavelength) and in the Guinier plot (plotting ln I(q) versus q2). Rg is a 
model free characterization of the molecular dimensions and I(0) can be related to 
the molecular weight with the relation κc , where κ is a 
proportionality constant that can be determined from a measurement of a standard 
(protein of known molecular weight and concentration), c is the concentration of the 
macromolecule, Δρ is the average electron density contrast of the molecule, and MW 
is the molecular weight. The scattering profile can be expressed as a distribution 
function p(r) of intramolecular atomic distances (Dmax being the maximum 
intramolecular distance). p(r) can be obtained from an indirect Fourier transform of 
the scattering profile. In the ideal case (no aggregation, no heterogeneity of 
conformations etc. reviewed in Putnam 2007) it is possible to use the 1D-scattering 
profile for ab initio reconstructions of low-resolution 3D electron density. Typically a 
bead based approach is used for the reconstruction using program such as Gasbor 
(Svergun 2001). 
3.2.12.2 Data collection, processing and analysis 
All samples were subjected to an additional size exclusion chromatography 
step to remove aggregates. Samples were taken from the individual fractions of each 
gel filtration peak in order to get different concentrations of the sample. For higher 
concentrations the remaining fractions were pooled and concentrated to their final 
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concentration using spin concentrators. Samples were flash frozen in thin walled 
PCR tubes at concentrations from 1 - 10 mg/ml. Protein concentrations were verified 
by Bradford assay and a spectrophotometer (Nanodrop) before freezing. Samples 
were gently thawed on ice and spun in a table top centrifuge at maximum speed for 
10 min prior to data collection.  
SAXS data were collected at Advanced Light Source (ALS), Ernest Orlando 
Lawrence Berkeley National Laboratory at SIBYLS beamline BL12.3.1. Data were 
measured on a mar165 detector. 15 µl samples in a sample cell were illuminated at 
10 keV (λ = 1.1159 Å) for data collection (q range = 0.010 A-1 - 0.250 A-1) with a 
detector distance of 1.5 m. Scattering profiles in SAXS buffer (20 mM HEPES pH 7.5, 
100 mM NaCl, 5 % glycerol, and 1 mM DTT supplemented or not with 1 mM ADP) 
were collected from samples with concentrations between 1 and 10 mg/ml.  
Guinier plot analysis was used to determine the particle radius of gyration (Rg) 
in Primus (Konarev 2003). Gnom (Svergun 1992) was used to evaluate the electron 
pair distribution function, p(r) function and to calculate the maximum dimension of 
particles (Dmax). Theoretical scattering was computed with Crysol (Svergun 1995). 
Ab initio dummy residue models were calculated with Gasbor (Svergun 2001) and 
averaged with Damaver (Volkov and Svergun 2003). Missing loops and domains 
were added to the known crystal structures using Credo (Petoukhov 2002). Modeling 
of conformations of Dbp5 was performed by Friedrich Förster (MPIB). N- and C-
terminal RecA-like domains of the Dbp5 ΔN-AMPPNP-RNA structure were used as a 
starting model. The two domains were treated as two rigid bodies connected with a 
flexible linker and were optimized against a scoring function that includes the 
experimental scattering profiles (as described in Forster 2008). 
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4 Results  
During the first year of my PhD work I tried to crystallize the S. cerevisiae Dbp5-
Nup159 complex. Despite good expression, solubility and homogeneity of the purified 
complex, crystallization experiments were not successful. I cloned, expressed and 
purified several constructs of both proteins and tested multiple combinations of those. 
In all cases a soluble and stable 1:1 complex was formed but never crystallized. 
Crystallization of the helicase alone and in presence of different ligands (ATP, 
AMPPNP, ADP, AMP and the combination with RNA) was also not successful. After 
testing several crystallization methods (sitting and hanging drop vapor diffusion and 
microbatch) and other methods that can promote crystallization, like reductive 
methylation of surface residues (Walter 2006; Kim 2008) and mutation of surface 
residues (Derewenda 2004), I started working on the human proteins. An overview of 
some of the attempts and results of the yeast proteins is shown in appendix 6.4. 
 
4.1 Human Dbp5 in complex with single stranded RNA 
4.1.1 Purification, crystallization and data collection 
A vector encoding the full length (fl) human Dbp5 gene was available in our 
lab. Dbp5 had been cloned as an N-terminal glutathione S transferase (GST) and as 
an N-terminal 6xHis-fusion in pETMC vectors. Test-expressions in several E. coli 
expression strains revealed the highest protein yield in E. coli BL21 Gold cells. Even 
without a 6xHis-tag the protein had the tendency to stick to Ni-NTA (nickel-
nitrilotriacetic acid) Sepharose and therefore I only used GST as a purification tag. 
The GST-fused protein was purified to homogeneity with an initial batch affinity 
purification step using glutathione Sepharose, followed by overnight cleavage of the 
tag by TEV protease as described in paragraph 3.2.2.4. For binding and pull-down 
experiments the tagged protein was eluted in buffer supplemented with 20 mM 
reduced glutathione without TEV cleavage. GST-tagged and untagged proteins were 
further purified by affinity chromatography using a heparin Sepharose matrix. Heparin 
is a highly sulphated glucosaminoglycan that mimics the polyanionic structure of 
nucleic acids and is therefore commonly used to purify DNA- and RNA-binding 
proteins. The fraction of the protein that bound to the heparin matrix was eluted with 
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a linear NaCl gradient (Figure 5a) and was then further purified to homogeneity by 
size exclusion chromatography (Figure 5b).  
 
Figure 5: 15 % SDS gels of the 53 kDa human fl Dbp5.  
(a) Elution from heparin sepharose and (b) gel filtration peak (S200) 
In the first purifications I observed that a considerable amount of Dbp5 did not 
bind to the heparin sepharose. I collected this fraction and also purified it by size 
exclusion chromatography (S200), but despite apparently equal homogeneity on 
SDS gels this protein fraction never crystallized. With hindsight the heparin step is 
most likely selecting for properly folded and active proteins that are not bound to 
nucleic acids. To remove possible E. coli RNA contaminations, I introduced a high 
salt wash (1 M NaCl) in the first affinity step. This however reduced the amount of 
unbound Dbp5 in the heparin purification step. 
The purified protein was first subjected to crystallization without any ligand. 
Several sparse matrix screens were tested but no crystals were obtained. Structural 
data for two other DEAD-box helicases in complex with RNA (Andersen 2006; Bono 
2006; Sengoku 2006) suggested that the two RecA-like domains of Dbp5 might have 
a certain degree of flexibility without RNA bound and might be difficult to crystallize. 
Upon RNA binding the two RecA-like domains form a specific closed, more rigid 
conformation. I performed initial electro-mobility shift assays (EMSA, data not shown) 
and later pull-down experiments using biotinylated RNA (Figure 6b, lanes 2-5) to 
show that Dbp5 binds to single stranded (ss) RNA. In order to form the closed 
conformation and to promote crystallization a 20mer poly-A single stranded RNA 
(20A ssRNA) and the non-hydrolysable ATP analogue AMPPNP were added to the 
protein in a 1.2 molar excess. After incubation for 1h on ice the sample was used for 
crystallization. Initial crystals all shared a similar needle shaped habitus and grew 
within 5 days in a few conditions containing different sized poly-ethylenglycol (PEG) 
polymers (Figure 7a). Optimization of the PEG concentrations yielded marginally 
bigger crystals that were however still too small for data collection. Comparison of 
successful crystallization conditions of RNA helicases led to a more rational 
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optimization: several helicases (e.g. eIF4AIII) had been crystallized in conditions 
containing sodium cacodylate as buffer. Exchange of buffers further improved the 
crystal size (Figure 7b). Despite the small size of the needles (~ 150 x 10 x 10 µM), 
datasets up to 3.5 Å resolution were collected at the Swiss Light Source (SLS) 
synchrotron. Data were processed using XDS (Kabsch 1993) and the structure could 
be solved in spacegroup P21212 using eIF4AIII from the exon junction complex (EJC) 
as a search model in molecular replacement (MR) with the program Phaser (McCoy 
2004) as described in methods 3.2.11.3. 
In order to get higher resolution data I continued optimization of the 
crystallization conditions. As the length of the RNA substrate is likely to influence 
crystallization (a too long RNA might interfere with crystal packing), I tested several 
oligoribonucleotides in order to find a minimal RNA. Preliminary electromobility shift 
assays (as described in 3.2.6.3) were performed (data not shown) with different 
ssRNA (20, 15, 10, 8, 7, 6 and 5mers of poly U or poly A). 5 - 8mer ssRNAs were not 
visible on the native gel and therefore not used for crystallization. The structures of 
DEAD-box helicases Vasa and eIF4AIII have visible electron density for six 
nucleotides, although longer ssRNAs were used for crystallization in both cases 
(Andersen 2006; Bono 2006; Sengoku 2006). This is consistent with RNAse 
protection assays of eIF4AIII that resulted in 6 - 7 protected nucleotides (Ballut 2005). 
Fl Dbp5 crystallized in the presence of 10, 15 or 20mer RNAs (+ AMPPNP), but 
surprisingly the 10mer poly-U RNA changed the crystal habitus from needles to 
slightly larger plate-like crystals (Figure 7c). Therefore a 10mer ssRNA was used in 
all crystallization experiments. 
These crystals diffracted to 3.0 Å resolution at SLS and the structure was 
solved by molecular replacement using Phaser (CCP4 1994) in the same spacegroup 
(P21212) using eIF4AIII as a search model. Manual model building was performed 
with the program Coot (Emsley and Cowtan 2004). Even without complete refinement 
(Rfree = 31.5 %) it became apparent that a major part of the N-terminus (~ first 75 
residues) had no visible electron density. Based on the partially refined model I 
cloned an N-terminally truncated construct (Dbp5 ΔN, residues 68 - 479, Figure 6a) 
since removing flexible parts of proteins is known to often improve the (diffraction) 
qualities of crystals. Dbp5 ΔN behaved like the fl protein during expression and 
purification. In RNA binding experiments (Figure 6b) I tested the minimal RNA-
binding constructs and showed that the N-terminal truncated construct (Dbp5 ΔN) in 
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presence of AMPPNP binds to ssRNA (lane 4) to a similar extent as the GST-tagged 
(lane 3) and untagged fl Dbp5 (lane 2). The N-terminal RecA-like domain alone is not 
sufficient to bind RNA (lane 5). These pull-down experiments also confirmed that 
AMPPNP (compare lanes 2 and 11) and not ADP (lane 13) is needed for RNA 
binding. In addition I tested the effect of Nup214 on RNA binding that is discussed in 
paragraph 4.3. 
Figure 6: The human Dbp5- 
AMPPNP-RNA complex.  
(a) Schematic representation of 
the domain organization of Dbp5 
with the domain boundaries of 
the protein constructs used in 
this thesis. The RecA-like 
domains are colored blue. The 
N-terminal region is shown in 
orange. (b) Protein 
precipitations with biotinylated 
ssRNA identify the RNA-binding 
region of human Dbp5 for 
structural studies. Purified 
proteins were mixed with 5‟ end 
biotinylated 20-mer ssRNA and 
incubated with or without 
AMPPNP or ADP, as indicated. 
Protein mixtures before (input) 
and after co-precipitation 
(precipitate) were separated on 
a 15 % (w/v) acrylamide SDS-
PAGE and visualized using Coomassie stain. The molecular weight standards are shown in 
lane 1. Dbp5 constructs are described in panel a. Nup214 βΔC corresponds to residues 1 - 
405 (human sequence).  
The N-terminal truncated protein (Dbp5 ΔN) crystallized in presence of 
AMPPNP and 10mer poly-U (U10) ssRNA. The needle shaped crystals (Figure 7d) 
diffracted to 2.2 Å (see Figure 8 and Table 1). Data could be indexed and processed 
in the orthorhombic spacegroup P21212, and a single MR solution (llg of 90, z-score 
of 7.5) was found in Phaser (McCoy 2004) using the partially refined fl model. One 
molecule per asymmetric unit was found corresponding to a solvent content of 37 %. 
Electron density maps were noisy and refinement showed no improvement of R-
factors of ~ 40 %. I reprocessed the data that could also be indexed in the lower 
symmetry monoclinic spacegroup P2 and a beta angle of 90.022° (see Table 1). A 
clear MR solution (llg of 330, z-score of 17) was found in spacegroup P21, with 2 
molecules per asymmetric unit corresponding to a solvent content of 41 %. 
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Superposition of the two molecules reveals that they relate to each other by rotation 
along a and c axes, and a small translational shift of 4 Å along the b axes. The model 
was manually built in Coot (Emsley and Cowtan 2004) and refined in Refmac (CCP4 
1994) using individual isotropic B-factor refinement and tight NCS (non-
crystallographic symmetry) restrains, which were released in the final rounds of 
refinement. The final model was refined to 2.2 Å with an Rfree = 22.7 % and Rwork = 
17.1 % resolution using TLS refinement (Table1). 
 
 
Figure 7: Crystals of human Dbp5 in complex with AMPPNP and RNA.  
(a) initial crystals grew in a few PEG containing conditions (e.g. 100 mM HEPES pH 7.5, 10 
% PEG 8000) using a 20mer poly-U RNA, (b) optimized crystals grew in 100 mM Na-
Cacodylate pH 7.5, 26 % PEG 400 using a 20mer poly-U RNA, c) crystals grown in the same 
buffer as in panel b but in presence of a 10mer poly-U RNA d) final needle shaped crystals of 
Dbp5 ΔN-AMPPNP-RNA complex grew in 100 mM Tris pH 7.0, 20 % PEG 2000 mono-
methyl-ether, 3 % PEG 3350 and 30 mM NaF in presence of a 10mer poly-U ssRNA. 
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Figure 8:  
Diffraction image of a Dbp5 ΔN-AMPPNP-RNA 
complex crystal. 
Data was recorded at beamline PXI (SLS, Villigen, 
Switzerland). Crystals diffracted to a maximum 
resolution of 2.2 Å. 
 
 
 
 
 
4.1.2 Structure of human Dbp5 in complex with AMPPNP and RNA 
There are two molecules in the asymmetric unit (molecule A and B) that are 
essentially identical (root mean square deviation (r.m.s.d.) of 0.2 Å over all amino-
acid residues). Molecule A includes Dbp5 residues 75 - 466 and molecule B residues 
75 - 467. Both molecules show no or very poor density for a disordered loop 
(residues 201 - 208). This loop is also disordered in other helicase structures (e.g. 
eIF4A, Schutz 2008). No density was observed for the C-terminal 12 - 13 residues. 
Each molecule includes six bases of poly-U RNA, one molecule AMPPNP and one 
magnesium ion (Figure 6c). The model of the Dbp5 ΔN-AMPPNP-RNA complex has 
good stereochemistry (Table 1 and Figure 9). 
Figure 9: Ramachandran 
plot of Dbp5 ΔN in complex 
with AMPPNP and RNA. 
Plotted are the Φ - Ψ torsion 
angles of the protein 
backbone. The four basic 
Ramachandran plots are 
shown  (a) general case (18 
non-glycine non-proline 
amino acids) (b) glycine (c) 
proline and (d) pre-proline 
(referring to residues 
preceding a proline). 99.6 % 
(776/779) of all residues are 
in favored (98 %, light blue) 
regions, 100 % are in 
allowed (>99.8 %, blue) 
regions. There are no 
outliers.  
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Table 1: Data collection and refinement statistics (molecular replacement). 
 Dbp5-AMPPNP-RNA Dbp5-Nup214 
Data collection    
Space group P21 P21212 I222 
Cell dimensions    
    a, b, c (Å) 41.60, 79.66, 124.54 91.3, 148.5, 42.1 117.41, 134.71, 152.85   
    α, β, γ( ) 90.0, 90.022, 90.0 90.0, 90.0, 90.0 90.0, 90.0, 90.0 
Resolution (Å) 41.5 - 2.2 (2.3 - 2.2) 43.6 - 3.0 (3.2 - 3.0) 47.7 - 2.8 (3.0 - 2.8)  
Rmeas 10.6 (27.3) 12.7 (72.4) 13.8 (36.4) 
I / σI 10.89 (4.54) 11.22 (2.27) 11.59 (3.31) 
Completeness (%) 99.5 (99.3) 98.5 (99.3) 100 (100) 
Redundancy 4.11 (4.11) 3.5 (3.5) 14.13 (13.6) 
 
Refinement 
   
Resolution (Å) 41.5 - 2.2  43.6 - 3.0 47.7 - 2.8  
No. reflections 39149 41938 30169 
Rwork / Rfree 16.8 / 22.5 26.0*/31.4* 21.8 / 26.0 
Molecules/AU 
Solvent content 
No. Atoms 
2 
41 % 
1 
54 % 
1 
70 % 
    Protein 6190  4824 
    Ligand/ion 326   
    Water 299  85 
B-factors    
    Protein 18.7  40.5 
    Ligand/ion 14.3 (ATP), 33.6 (RNA)  - 
    Water 35.1  28.9 
R.m.s. deviations    
    Bond lengths (Å) 0.009  0.012 
    Bond angles ( ) 1.4  1.4 
Values in parentheses are for highest-resolution shell. R factors are as indicated: 
,   
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4.1.2.1 Structural organization of Dbp5 
Dbp5 can be divided into four parts (see Figure 6a and Figure 10): The N-
terminal RecA-like domain (residues 75 - 296), the C-terminal RecA-like domain 
(residues 306 - 466), the connecting linker (residues 297 - 305) and a N-terminal 
flanking region (residues 75 - 92). Both RecA-like domains have a similar α-β 
topology with a central parallel β-sheet with loops on the N- and C-terminal ends of 
the strands. These loops contain the characteristic DEAD-box helicase motifs and 
converge to bind AMPPNP or RNA (see alignment Figure 17). The two RecA-like 
domains are in a closed conformation, binding AMPPNP and the magnesium ion in 
their cleft (Figure 10). The two β-sheets (7 strands in the N-terminal and 6 strands in 
the C-terminal RecA-like domain) are surrounded by 9 and 7 α-helices, respectively 
(see secondary structures in alignment, Figure 17). The short N-terminal flanking 
region preceding the N-terminal domain forms a small helix that is involved in 
AMPPNP binding. A more detailed description of this N-terminal region is given in 
paragraph 4.1.2.3.  
 
Figure 10: Structure of Dbp5 in complex with RNA and AMPPNP. 
Dbp5 ΔN (light blue) bound to AMPPNP (yellow) and single-stranded RNA (black). The 
magnesium ion at the ATP-binding site is shown in magenta. Six ordered nucleotides of a 
single-stranded poly-U RNA are present in the 2.2 Å resolution structure. The N- and C-
terminal residues of Dbp5 visible in the electron density are indicated. An N-terminal helix 
(orange) preceding the N-terminal domain is involved in binding of AMPPNP. 
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Dbp5 has a similar structure (Figure 11) as that observed in the RNA-
AMPPNP-bound complexes of Vasa and of eIF4AIII (Andersen 2006; Bono 2006; 
Sengoku 2006). According to the structural superposition of Dbp5 with eIF4AIII 
using 3d-SS (Sumathi 2006), about 90 % of the amino-acid residues superpose in 
their α-carbon positions with an r.m.s.d. of less than 1.2 Å. A major conformational 
variation is observed in the N-terminal region and is further described in Figure 
34. Minor differences are in loops located on the surface of the molecules. Overall 
in the RNA-bound form the DEAD-box helicases Vasa, eIF4AIII and Dbp5 (and 
most likely other members of this protein family) assume a closed conformation. 
 
 
Figure 11: Superposition of three DEAD-box helicases. 
Stereo-view of Dbp5 in light blue superposed with the two DEAD-box helicases eIF4AIII 
in yellow (Bono 2006, pdb code 2J0S) and Vasa in magenta (Sengoku 2006, pdb code 
2DB3) shown as ribbons. The three proteins superpose well except for conformational 
differences in surface loops and the N-terminal region preceding the N-terminal RecA-like 
domain.  
 
4.1.2.2 Dbp5 binds RNA in a sequence independent manner 
Dbp5 binds RNA by both RecA-like domains opposite the linker (Figure 6c, 
Figure 12a) region. The relatively high resolution of the structure allows to unravel 
the molecular details of the Dbp5-RNA interaction. Six nucleotides of single-
stranded RNA bind with the 3‟ end at the N-terminal domain of Dbp5 and with the 
5‟ end at the C-terminal domain (Figure 6c, Figure 12b). Both domains contribute 
to the binding site and although more contacts are from by the N-terminal domain 
(Figure 6c and Figure 12); this domain is not enough to bind RNA alone in vitro 
(Figure 6b, lane 5).  
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The interaction is mainly mediated via the ribose-phosphate backbone of 
the RNA and hence binding occurs in a sequence-independent manner. Only two 
contacts (involving Leu226 and Phe230) are observed that contact the base of U6. A 
mesh of interactions involving four 2`-hydroxyl groups of the ribose explains the 
exclusive binding of Dbp5 to RNA and not DNA (Figure 12b). Normal base 
stacking of nucleotides 1 - 4 is disrupted by a sharp bend of the RNA between 
nucleotides 4 and 5 as also observed in the eIF4AIII and Vasa structure 
(Andersen 2006; Bono 2006; Sengoku 2006).  
Compared to eIF4AIII, the overall properties of the RNA-binding pocket are 
conserved. More than 50 % of the residues are identical (Figure 12b). Binding of 
RNA is mediated by the conserved DEAD-box motifs: motifs Ia and Ib in the N-
terminal domain and motifs IV and V in the C-terminal domain bind along the 
oligoribonucleotide chain (Figure 12b and Figure 17). Two other loops containing 
the so-called GG and QxxR motifs also contact RNA. This interaction is also 
observed in Vasa and eIF4AIII, although these motifs are only partially conserved 
in the Dbp5 sequence (Figure 17 and alignment in appendix). Interestingly, a 
different binding mode is observed in the 3.0 Å fl Dbp5-AMPPNP-RNA structure 
(Figure 13a). Here, nucleotides 1 - 4 show the same base stacking as in the   
Dbp5ΔN-AMPPNP-RNA structure. A sharp bend is also induced between 
nucleotides 4 and 5 but the gap is filled by the base of nucleotide 6, which turns ~ 
180° and stacks in between the two bases (Figure 13a). Since there is limited 
space due to crystal contacts (Figure 13b), this unusual RNA conformation might 
be induced by crystal packing and might have no biological relevance in vivo. 
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Figure 12: Binding of RNA.  
(a) Stereo-view of the RNA binding pocket. Electron density (2FO-FC) is contoured at 1 σ 
around the RNA. The N-terminal RecA-like domain is shown in blue and the C-terminal 
RecA-like domain in grey (b) Schematic representation of RNA binding. RNA is bound in a 
sequence independent manner with the 5‟-end to the N-terminal domain (residues boxed 
blue) and the 3‟-end to the C-terminal domain (residues boxed grey) of Dbp5. Interactions 
are mainly based on backbone contacts. The hydroxyl group of the ribose is involved in 
several contacts (in purple), explaining why Dbp5 binds RNA, but not DNA. Marked are the 
conserved motifs and for comparison the corresponding residues of eIF4AIII of the EJC in 
yellow.  
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Figure 13: RNA binding of fl Dbp5 in the crystal structure of space group P21212 at 3.0 
Å resolution. (a) Stereo-view of an unusual conformation of RNA bound to Dbp5. Electron 
density (2FO-FC) is contoured at 1.0 σ around the RNA. Base 6 turns 180° and stacks in the 
gap between bases 4 and 5. (b) Dbp5 (blue, labeled 1) is shown in the same orientation as in 
panel a, with bound RNA (black) and its symmetry related molecules (grey, numbered 2 - 4). 
In the crystal molecule 4 contacts molecule 1 close to its RNA binding side and thereby limits 
the space for the 3`end of the emerging RNA molecule. 
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4.1.2.3 AMPPNP is coordinated in a highly conserved binding pocket 
AMPPNP is bound in between the two RecA-like domains. Conserved 
residues of the loops formed by motifs Q, I, II, and III in the N-terminal domain and 
motifs V and VI in the C-terminal domain converge to bind the nucleotide (AMPPNP, 
Figure 14, Figure 17). In addition to the two folded domains, a short N-terminal region 
preceding the first RecA-like domain (residues 75 - 92) stretches back towards the C-
terminal domain and contributes to the ATP-binding site (Figure 6c). The adenine ring 
of the nucleotide is sandwiched between Phe112 of the N-terminal RecA-like domain 
and Phe433 of the C-terminal domain, which is surrounded by Val77 and Leu88 of this 
N-terminal region (Figure 15). A similar arrangement is observed in the structures of 
Vasa and eIF4AIII of the EJC (Andersen 2006; Bono 2006; Sengoku 2006), where 
the hydrophobic environment of the adenine ring is formed by apolar residues of the 
C-terminal domain and N-terminal region (Vasa Val583 and Phe225), or by apolar 
residues of the C-terminal domain and an additional protein (eIF4AIII Tyr371 and 
Mago Ile146 in the EJC). Val77 and Arg114 are most likely the reason why Dbp5 
exclusively binds ATP and not GTP. The apolar residue would interfere with the 
amino group of the purine ring and the ketogroup and its enol tautomere of GTP 
would be repulsed by the backbone carbonyl-group of Arg114. 
The majority of the residues binding AMPPNP are contributed by the N-
terminal domain (Figure 14). The residues necessary for binding of the magnesium 
ion and hydrolysis of ATP are contributed by both RecA-like domains. Several DEAD-
box helicases have been crystallized in complex with ADP. Several structures of only 
the N-terminal domain bound to AMPPNP or ADP have been deposited in the protein 
data bank (e.g. pdb codes: 2PIX, 3DKP, 3FE2, 3B7G). Comparison of the binding 
pocket reveals that in absence of the C-terminal domain ADP is coordinated by the 
same residues binding AMPPNP in the structure reported here. 
Altogether an almost identical AMPPNP binding mode of Dbp5, Vasa and 
eIF4AIII is observed, although these proteins have very distinct functions in mRNA 
metabolism (Figure 14, Figure 15). This is further discussed in paragraph 5.3 
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Figure 14: Schematics of AMPPNP binding.  
Interacting residues are boxed in blue (N-terminal RecA-like domain) and in grey (C-terminal 
RecA-like domain). Conserved DEAD-box helicase motifs are marked on top of the residues 
(see alignment Figure 17). Backbone contacts are represented by boxed residues without 
side-chains. Water molecules that contribute to the coordination and/or hydrolysis of ATP are 
shown in black and the magnesium ion in magenta.  
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So far the binding constants of DEAD-box helicases for ATP or ADP have not 
been reported in the literature. I measured binding data based on radiolabel ATP and 
spin column experiments (see methods 3.2.6.4) but due to experimental limitations 
(discussed in 3.2.6.4) I could not determine absolute binding constants. Nevertheless 
the results from these experiments suggest that the KD for ATP is much higher than 5 
µM and though extrapolations have a large error, KDs are likely in the high 
micromolar to millimolar range. Comparison with other helicases suggest that the N-
terminal domain of Dbp5 (and other DEAD-box helicases) alone might bind ATP/ADP 
with low affinity. This would explain results from binding experiments discussed in 
4.2.2. 
 
Figure 15: Stereo view of AMPPNP binding.  
AMPPNP is shown in yellow, Dbp5 residues in blue and the magnesium ion in magenta. 
Coordinated waters are not shown for clarity. 
 
4.1.2.4  Hydrolysis of ATP 
The non-hydrolysable ATP analogue AMPPNP is sandwiched between the 
two RecA-like domains as described in the preceding paragraphs. The helicase is 
trapped in an active conformation where the magnesium ion, several waters and the 
residues important for hydrolysis are in a productive state. The overall coordination of 
the nucleotide and the position of catalytic waters and the magnesium ion is similar to 
that observed for GTP in small GTPases such as H-Ras p21 (Pai 1990). Dbp5 (and 
other DEAD-box helicases) might use a similar mechanism for ATP hydrolysis 
(Figure 16). The reaction is most likely initiated by the abstraction of a proton from a 
catalytic water (probably the one coordinated by motif III, see Figure 14) by the γ-
phosphate of ATP. The resulting nucleophilic hydroxide (probably stabilized by the 
surrounding His425, Lys144 and motif III) would then attack the protonated γ-
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phosphate. A pentacovalent intermediate would be formed that would result in 
cleavage of the γ-phosphate group and the final products ADP and inorganic 
phosphate. 
A water molecule responsible for the nucleophilic attack has been described in 
the structure of Vasa (Sengoku 2006). I observe two well ordered waters (b-factors of 
9 and 16) that are both contacting the γ-phosphate of AMPPNP and are both in 
position for a nucleophilic attack (Figure 14). Both waters are also present in the 
structures of Vasa (2DB3) and eIF4AIII (2J0S). It is not obvious, which one acts as 
the catalytic water. A second water, that has not been described in the Vasa structure 
(Sengoku 2006) could be the candidate: it is less than 2.9 Å (compared to 3.2 Å for 
the other water) away from the γ-phosphorous atom and it is coordinated by residues 
(Glu243 of motif II (that likely polarizes the nucleophile), the conserved His425 and 
Ala275 of motif III) that have been shown to be important for the ATPase activity of 
DEAD-box proteins. Mutations of the equivalents residues (Glu243 and His425) of 
eIF4A reduced the ATPase activity and impaired unwinding (Pause and Sonenberg 
1992; Pause 1993). Mutations in motif III (SAT to AAA) had no effect on the ATPase 
activity or RNA binding but showed defects in RNA unwinding (Pause and Sonenberg 
1992). The contact of motif III to the putative catalytic water is mediated by the main-
chain amide group of Ala275 and therefore not affected in this mutation. Overall the 
role of motif III is somewhat ambiguous since this motif seems to couples ATP 
hydrolysis with RNA unwinding.  
Another factor necessary for ATP hydrolysis is the bound magnesium ion 
(Figure 10, Figure 14 and Figure 15). The magnesium is coordinated in an octahedral 
geometry by four water molecules and one oxygen each of the β- and γ-phosphate of 
AMPPNP (Figure 14). The role of the metal ion in catalysis has been discussed for 
GTPases and ATPases (e.g. H-ras p21, Pai 1990). Several functions of the 
magnesium ion in nucleotide hydrolysis are possible: shielding the negative charge of 
the attacked γ-phosphate, increasing the acidic strength of the leaving group (β-
phosphate) or stabilization of the transition state.  
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Figure 16: Possible ATP hydrolysis mechanism. A probable mechanism involves 4 steps: 
I) Hydrolysis of ATP is likely initiated by the abstraction of a proton from a water by the γ-
phosphate of ATP. II) the resulting hydroxide ion attacks the γ-phosphate III) a pentavalent 
intermediate is formed that results in IV) cleavage of the γ-phosphate group. 
 
Figure 17: Conservation of structural and functional features of Dbp5.  
The structure-based sequence alignment includes orthologues from H. sapiens (Hs), S. 
cerevisiae (Sc), S. pombe (Sp) and D. melanogaster (Dm). The secondary structure 
elements are shown below the sequences (h for α-helices, b for β-strands and dots for 
extended or loop regions). Boxed in red are residues I mutated for in vitro studies. The Dbp5 
sequence alignment includes a functionally different DEAD-box helicase (human eIF4AIII). 
Conserved sequence motifs shared by all DEAD-box helicases are boxed and defined below 
the sequences (motifs Q, I, Ia, GG, Ib, II, III, IV, QxxR, V and VI). Residues that are 
conserved specifically in Dbp5 orthologues are shaded in light blue. Highlighted above the 
sequences are the residues of human Dbp5 contacting AMPPNP (A, yellow) and RNA (R, 
white) in the Dbp5 ΔN-AMPPNP-RNA complex, or the nucleoporin (N, green) in the 
Dbp5 ΔNΔC-Nup214 βΔC complex. Residues 77 - 92 of human Dbp5 adopt different 
conformations in the two Dbp5 structures, forming a helix in the Dbp5 ΔN-AMPPNP-RNA 
complex (here indicated) and a β-strand in the Dbp5 ΔNΔC-Nup214 βΔC complex.  
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4.2 Human Dbp5 in complex with Nup214 
Dbp5 not only binds to RNA but also interacts with the N-terminal region of the 
human nucleoporin Nup214 (Schmitt 1999; Napetschnig 2007) and in yeast with its 
orthologue Nup159 (Schmitt 1999; Weirich 2004). The structures of the N-terminal 
domains of Nup214 and Nup159 have been recently solved (Weirich 2004; 
Napetschnig 2007) and contain a conserved β-propeller domain (Figure 3 and Figure 
20). In order to investigate how Dbp5 specifically docks to Nup214 (at the NPC) and 
how the nucleoporin influences the helicase, I solved the structure of the human 
Dbp5-Nup214 complex and performed several biochemical assays as discussed 
below 
4.2.1 Purification 
The complex of the N-terminal RecA-like domain of human Dbp5 (Dbp5 
ΔNΔC, see Figure 6a) and the β-propeller domain of Nup214 (Nup214 βΔC) was 
reconstituted after purifying the two proteins separately. Dbp5 ΔNΔC was expressed 
as a GST-fusion and purified as the fl protein as described in paragraph 4.1.1. 
Untagged (for crystallization) and GST-tagged Dbp5 ΔNΔC (for surface plasmon 
resonance (SPR) and pull-down experiments) were purified to homogeneity as 
discussed before (paragraph 4.1.1). Tagged and untagged Dbp5 ΔNΔC eluted from 
the final size exclusion chromatography column (S200) in distinct peaks as shown for 
the untagged protein in Figure 18. In general Dbp5 ΔNΔC behaved like the fl protein 
during expression and purification with the exception that it precipitated slowly but 
continuously at 4°C. In contrast, the constructs consisting of both RecA-like domains 
and all Dbp5 constructs in presence of Nup214 were stable. 
 
Figure 18: Purification of Dbp5 ΔNΔC. 
(a) Size exclusion chromatogram (S200). Dbp5 ΔNΔC elutes as a distinct peak (b) 15 % SDS 
PAGE of selected fractions of the peak of the size exclusion chromatography shown in a. 
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Two protein constructs of Nup214, both consisting of the N-terminal β-
propeller domain, Nup214 βΔC (residues 1 - 405) and Nup214 β (residues 1 - 450) 
were expressed in BL21 Gold cells as N-terminal 6xHis- or GST-fusions and purified 
using the appropriate resin (Ni-NTA or GSH-Sepharose), followed by overnight tag 
cleavage using TEV protease. Untagged proteins were further purified by ion-
exchange (Hitrap Q) and size exclusion chromatography (S200) as described in 
methods 3.2.2.5.  
For complex formation the two proteins were mixed for one hour on ice and 
further purified to homogeneity by size exclusion chromatography (Figure 19). The 
complex elutes in a distinct peak (peak II), well separated from the excess of 
Dbp5 ΔNΔC (peak III). Since homogeneity on SDS gels does not necessary equal 
monodispersity, which is prerequisite for crystallization, I determined the 
monodispersity and the molecular weight using static light scattering (sls). All sls 
experiments were performed by Jörg Tittor and Claire Basquin at MPIB. In these 
experiments (Figure 20), a single peak was observed the size exclusion 
chromatogram and was used to determine the concentration and the molecular 
weight as described in methods 3.2.7. The experimental MW is 71.124 KDa and 
corresponds to a 1:1 complex of Dbp5 ΔNΔC and Nup214 βΔC and is in good 
agreement with the calculated MW of 71.35 KDa. The sample is highly monodisperse 
with a MW/Mn ratio of 1.0008. We investigated all proteins before they were 
subjected to crystallization. We tested the Dbp5 ΔNΔC-Nup214βΔC complex (shown 
in Figure 20) before and after concentration of the sample up to 100 mg/ml and after 
6, 24, and 48 h after the final size exclusion chromatography and observed no 
aggregation. Interestingly after 6 days (stored at 4°C) we determined a MW of 131 
kDa with high monodispersity (MW/Mn = 1.008). This approximately corresponds to a 
dimer of the complex but was not further investigated. 
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Figure 19: Purification of Dbp5 ΔN-Nup214 βΔC-complex. 
(a) Size exclusion chromatogram (S200) (b) 15 % SDS PAGE of selected fractions of gel 
filtration peaks shown in a. Peak I contains impurities of GST-Dbp5 ΔNΔC, peak II the 1:1 
complex of Dbp5 ΔN-Nup214 βΔC and peak III the excess of Dbp5 ΔNΔC. 
Figure 20: 
Chromatogram from 
static light scattering 
experiments. 
(a) Chromatogram of 
the Dbp5 ΔNΔC- 
Nup214 βΔC complex. 
The three detectors 
(UV, refractive index 
and light scattering, as 
described in methods 
3.2.7) are shown as 
indicated. The first 
peak contains the 
purified complex, the 
second peak does not 
contain any proteins 
(no UV detection) and 
most likely results from 
an excess of glycerol 
from the sample. (b) 
Close-up of the first 
peak shown in panel a. 
This peak was used to determine the concentration and the experimental MW (71.124 KDa).  
  
4.2.2 The N-terminal RecA-like domain of Dbp5 is sufficient to bind to Nup214  
There are seemingly conflicting reports in the literature on the requirements of 
Dbp5 for nucleoporin interaction. It has been shown that fl human Dbp5 binds the N-
terminal region of Nup214 (residues 1 - 586) and that this interaction is destabilized 
in the presence of ATP nucleotides (Schmitt 1999). In addition it has been shown that 
a portion of yeast Dbp5 lacking the C-terminal RecA-like domain (Dbp5 ΔC) is 
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sufficient for Nup159 binding, and that this interaction is not affected by the presence 
of ATP nucleotides (Weirich 2004). To further analyze the minimal binding regions to 
generate a core complex suitable for crystallization I performed pull-down 
experiments with different constructs. GST-fused Dbp5 constructs were immobilized 
on GSH-resin and Nup214 constructs were then added. In these pull-down 
experiments with the human proteins, I find that even without the N-terminal region 
(Dbp5 residues 1 - 67), the N-terminal RecA-like domain alone is sufficient for 
Nup214 binding (Dbp5 ΔNΔC (residues 68 - 302), Figure 22a, lane 5).  
 
Figure 21: Conservation of structural and functional features of N-terminal domain of 
Nup214. The structure-based sequence alignment includes orthologues from H. sapiens 
(Hs), S. cerevisiae (Sc), S. pombe (Sp) and D. melanogaster (Dm). The secondary structure 
elements are shown below the sequences (h for α-helices, b for β-strands and dots for 
extended or loop regions). Boxed in red are residues I mutated for in vitro studies. The β-
strands are numbered with 1 to 7 (to indicate the blades of the β-propeller they belong to) 
and with A to D (to indicate the consecutive β-strands within each blade). Blades 6 and 7 
contain an additional strand (E). Residues conserved in Nup214 orthologues are shaded in 
light green. Residues of human Nup214 contacting Dbp5 (D, blue) are highlighted above the 
sequence. 
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The structure of human Nup214 features a C-terminal extension (residues 405 
- 450) that binds in an extended unstructured conformation across the β-propeller 
face (Napetschnig 2007). In pull-downs with full-length GST-Dbp5, I observed binding 
to the human Nup214 both in the presence and in the absence of this C-terminal 
extension (Figure 22a, Nup214 βΔC in lane 3 and Nup214 β in lane 4, respectively). 
Thus, the β-propeller core of human Nup214 is sufficient for Dbp5 binding. Moreover 
crystallization trials of the complex featuring this extension were not successful. This 
supports the idea that this part of the molecule is rather flexible and interferes with 
crystallization. Together with the fact that Napetschnig et al. observed no binding of 
this C-terminal tail in gel filtration and in binding experiments (Napetschnig 2007), it is 
likely that binding of this tail across the β-propeller face is a crystallization artifact.  
Having the qualitative binding information from pull-down experiments I tested, 
with the help of Claire Basquin, the relative binding affinities of the different 
constructs quantitatively by surface plasmon resonance (BIAcore, GE Healthcare). 
Initially I designed the experiment using GST-Nup214 constructs in order to directly 
compare binding of different Dbp5 constructs to the same immobilized Nup214 
molecule. However, under these experimental conditions Nup214 did not bind to 
Dbp5. Most likely the binding site is not accessible when immobilized on the surface. 
I therefore used GST-tagged Dbp5 constructs. Under the given conditions (methods 
3.2.7.2) Dbp5 fl binds with a similar affinity of about 20 nM to either Nup214 β or 
Nup214 βΔC (Figure 22b, red and orange sensorgrams). These data indicated that 
the C-terminal extension of Nup214 does not influence Dbp5 binding and is not 
required. The dissociation constant is also similar when only the N-terminal RecA-like 
domain of Dbp5 is immobilized (Figure 22b, green sensorgrams), indicating that this 
domain alone is sufficient to bind to Nup214. The N-terminal domain includes all the 
binding determinants that are present in the fl protein. The C-terminal domain of 
Dbp5 does not contribute to binding of the nucleoporin. Data were fitted according to 
a bimolecular binding model using the non-linear Langmuir binding isotherm as 
shown in Figure 23. 
To investigate the effect of nucleotides on the Dbp5-Nup214 complex we 
performed the same SPR experiments in presence of 500 µM AMPPNP or ADP. In 
the presence of these nucleotides, binding of Nup214 to fl Dbp5 is reduced by two 
orders of magnitude, to a KD larger than 1 μM (AMPPNP, Figure 22b, blue 
sensorgrams) and larger than 0.6 μM (ADP. Figure 22b, purple sensorgrams). These 
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data show that the binding between Nup214 and fl Dbp5 is reduced when in the 
presence of nucleotides, even though the interaction with Nup214 is mediated by the 
N-terminal RecA-like domain alone. Interestingly we observed similar though slightly 
lower KDs for the Dbp5 ΔNΔC-Nup214 βΔC interaction in presence of ADP and 
AMPPNP (data not shown). This suggests that the conformation of the N-terminal 
domain (Dbp5 ΔNΔC) alone and the interaction with Nup214 is also altered in 
presence of nucleotides. This indicates that N-terminal Dbp5 domain is sufficient to 
bind to nucleotides to some extend and affects the Dbp5-Nup214 interaction. 
 
 
Figure 22: The human Dbp5-Nup214 complex. 
(a) Protein precipitations by GST pull-down assays qualitatively identify the binding regions 
of Nup214 and Dbp5 for structural studies. Glutathione agarose beads were pre-coated with 
GST or GST-Dbp5 proteins as indicated, and incubated with the purified β-propeller domain 
of Nup214 either with the C-terminal extension (residues 1 - 450, Nup214 β) or without it 
(residues 1 - 405, Nup214 βΔC). One fifth of the input and one eighth of the bound fractions 
were analyzed by SDS-page. Nup214 βΔC precipitates with full-length Dbp5 at least as 
efficiently as Nup214 β (lanes 3 and 4). A Dbp5 construct containing the first RecA-like 
domain and lacking both the N-terminal region and the second RecA-like domain 
(Dbp5 ΔNΔC, residues 68 - 302) binds Nup214 βΔC to a similar extent as full-length Dbp5 
(compare lanes 5 and 3). (b) BIAcore analyses of the interaction between Dbp5 and Nup214. 
Sensorgrams were obtained from the injection of Nup214 over GST-Dbp5 immobilized on 
chip surfaces coated with anti-GST antibody. The horizontal axis of the sensorgram indicates 
the time (seconds) and the vertical axis indicates the response units (RU). In the 
experiments, the flow cells were derivatized with about 100 - 150 RU of the respective GST-
Dbp5 proteins. Nup214 proteins were injected at different concentrations (indicated). Each 
dissociation constant (KD) was obtained from at least two separate experiments and derived 
using a bimolecular interaction model.  
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Figure 23: Fit of SPR binding data.  
This example shows the fit of binding data of GST-Dbp5 ΔNΔC (immobilized) with Nup214 
βΔC (analyte) according to a non-linear regression using the Langmuir binding isotherm. 
Plotted is  (SPR angle at equilibrium in RU) against the concentrations (in nM) of 
Nup214 βΔC used. With  the  can be calculated.  describes the 
quality of the fit (with  = 1.0 describing a perfect fit). 
 
4.2.3 Crystallization and data collection 
The core complex between Dbp5 ΔNΔC and Nup214 βΔC was crystallized in a 
sitting drop vapor diffusion experiment. Plate-like crystals were optimized (Figure 
24b), cryoprotected with parafine oil, flash frozen in liquid nitrogen and diffracted to 
2.8 Å (Figure 25 and Table1) as described in 3.2.11.1.2. 
 
Figure 24: 
Crystals of the 
Dbp5 ΔNΔC-
Nup214 βΔC  
complex. 
Initial crystals 
grew in 50 mM 
MES pH 6.0 and 
1.1 M Na citrate 
and several 
other condition containing high concentrations of sodium salts of organic acids like citric, 
malonic, acetic and oxalic acid. (b) Crystals were optimized in 50 mM MES pH 6.0 and 
900 mM Na citrate and cryoprotected in parafine oil.  
 
 
Model: one site binding 
Equation:  
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Figure 25: Diffraction image of a Dbp5 ΔNΔC-
Nup214 βΔC complex crystal. 
Data were recorded at beamline PXII (SLS, Villigen, 
Switzerland). Crystals diffracted to a maximum 
resolution of 2.8 Å. 
 
 
 
 
4.2.4 Structure of human Dbp5 in complex with Nup214 
The structure was solved by molecular replacement as described in 
methods 3.2.11.3.2. The 1.65 Å crystal structure of Nup214 (Napetschnig 2007) 
and the N-terminal domain of Dbp5 (from the Dbp5-AMPPNP-RNA structure) were 
used as consecutive search models. The model was refined to 2.8 Å resolution to 
an Rfree of 26.0 % and Rwork of 21.8 % and good stereo chemistry (Table1 and 
Figure 26). One molecule of the Dbp5-Nup214 complex is present in the structure, 
where the N-terminal RecA-like domain of Dbp5 (Dbp5 ΔNΔC) binds to the side of 
the β-propeller face of nucleoporin (Nup214 βΔC, Figure 27). The overall fold of 
the N-terminal RecA-like domain of Dbp5 is essentially the same as observed in 
the Dbp5-AMPPNP-RNA structure. The major difference lies in the N-terminal 
region of Dbp5 (Figure 6, residues 77 - 92, orange). While in the AMPPNP-RNA-
bound structure this region forms a helix that contributes to ATP binding (Figure 
6), in the Nup214-bound structure (where AMPPNP is not present) the same 
region wraps around the opposite side of Dbp5, forming an additional β-strand in 
the core domain. Other structural differences are smaller and localized at the 
regions containing motifs Ib and GG, and at the helix between motifs II and III. 
These regions contact Nup214 (Figure 17) and have different conformations 
compare to the RNA-AMPPNP bound structure.  
The β-propeller domain of Nup214 adopts the typical ring-like structure 
assembled of seven blades arranged around a central axis (Figure 3 and Figure 
27). Each blade is formed by β-strands connected by loops of variable length. 
Long loops extend on one side of the ring (top side), while the other side (bottom 
side) features shorter extensions (Figure 27, left side). Dbp5 binds to the top side 
and the contact is mainly mediated by these loops from Nup214 protruding from 
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blades 1, 6 and 7 and loops and one helix of Dbp5 (Figure 27). The β-propeller 
domain of Nup214 is in a very similar conformation as observed in the apo 
structure solved in the lab of Hoelz and Blobel (Napetschnig 2007). Structural 
differences are mainly in the region responsible for Dbp5 binding. Here loops have 
slightly different conformations as compared to the unbound structure, while the 
core of the molecule is essentially unchanged (r.m.s.d. of 0.7 Å between all α-
carbon atoms).  
 
 
Figure 26:  
Ramachandran plot of 
Dbp5 ΔNΔC in complex 
with Nup214 βΔC.  
Plotted are the Φ - Ψ torsion 
angles of the protein 
backbone. The four basic 
Ramachandran plots are 
shown (a) general case (18 
non-glycine non-proline 
amino acids) (b) glycine (c) 
proline and (d) pre-proline 
(referring to residues 
preceding a proline). 98.5 % 
(588/597) of all residues are 
in favored (98 %, light blue) 
regions and 100 % are in 
allowed (>99.8 %, blue) 
regions. There are no 
outliers. 
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Figure 27: Structure of the human Dbp5-Nup214 complex. 
View of the Dbp5 ΔNΔC-Nup214 βΔC complex in two orientations: On the left, the structure is 
shown with the N-terminal RecA like domain of Dbp5 in the same orientation as in the 
Dbp5 ΔN-AMPPNP-RNA structure in Figure 6. On the right, the complex is rotated by 90° 
around a vertical axis and with a 20° rotation around a horizontal axis to better view the β-
propeller ring, where the blades are numbered 1 to 7. The N- and C-terminal residues of 
Dbp5 and Nup214 in the structure are indicated. The N-terminus of Dbp5 (residues 77 - 92) 
forms an additional β-strand (shown in orange). The N-terminus of Nup214 (residues 9 - 22, 
shown in magenta) folds back from blade 1 to complete the neighboring blades 7 and 6 of 
the β-propeller.  
 
4.2.5 Evolutionary conservation of the Dbp5-Nup214 interaction 
Analysis of the Dbp5-Nup214 binding interface by sequence alignments and 
the program AquaProt (Reichmann 2008) reveals an evolutionary conserved 
interaction (see alignments  Figure 17 and Figure 21). The loop between blade 6 and 
7 of Nup214 that is involved in Dbp5 binding is the most conserved part of the β-
propeller domain. Other residues involved in the interaction with Dbp5 are also 
conserved (see residues marked with blue D in alignment, Figure 21). The character 
of the binding interface is predominantly hydrophilic. In particular, there are two direct 
salt bridges: Nup214Arg348 and Dbp5Asp223, and Nup214Asp359 and Dbp5Arg259 and Arg262 
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(Figure 28a). These residues are conserved across species (corresponding yeast 
residues: Nup159Arg321 and yDbp5Asp221; Nup159 Asp333 and yDbp5Arg256 and Arg259). 
I mutated those residues in human Dbp5 and Nup214 and performed pull-down 
experiments (as described in methods 3.2.6.1) in order to investigate their role in 
complex formation. The mutants were expressed and purified as the wild type (wt) 
proteins. During expression and purification all mutants showed a similar behavior as 
the wt proteins, with the exception of Nup214R348D that was not expressed under the 
given conditions. In the pull-down experiments the single point mutation of Dbp5D223R, 
of Dbp5R259D or Dbp5R262A is sufficient to abrogate the interaction with the nucleoporin 
(Figure 28b, lanes 3, 5, 6). The reverse charge mutation of Nup214D359R also inhibits 
complex formation (Figure 28b, lane8).  
Only three amino-acid residues of Dbp5 involved in Nup214 binding are 
hydrophobic. The main contact is Dbp5Ile258 that interacts with Nup214Val353 (Figure 
28a). Previous work from Weis and coworkers (Weirich 2004) showed that a mutation 
of the corresponding residue of yeast nucleoporin, Nup159Ile326E together with 
Nup159Val323E, cause Dbp5 mislocalization and block mRNA export. Since human 
Nup214 already features a glutamic acid (Nup214Glu350) at the corresponding position 
of Nup159Val323 (Figure 21, Figure 28), the drastic effect of the double mutant in yeast 
might be due solely to the impairment of the interaction between Nup159Ile326 and 
Dbp5Ile355. This is supported by the fact that mutation of human Dbp5I258A is sufficient 
to disrupt the interaction with Nup214 βΔC by in vitro pull-down experiments (Figure 
28d, lane 4). Several other mutants of Dbp5 have been reported to affect mRNA 
export in in vivo experiments (Snay-Hodge 1998; Schmitt 1999). A summary of the 
mutants is shown in Appendix 6.3). Most mutations that showed severe effects in 
mRNA export carry mutations either in the conserved DEAD-box motifs or in the core 
of the protein and are therefore likely to impair ATP/RNA binding or to disturb the 
overall fold and stability of the protein. 
I also tested the Dbp5 mutants for their ability to bind to RNA (Figure 28c and 
d). A detailed description is given in paragraph 4.3. 
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Figure 28: The Dbp5-Nup214 interaction is mediated by conserved residues. 
(a) Close-up of the region of interaction between the N-terminal RecA-like domain of Dbp5 
(in blue) and Nup214 (in green) in the Dbp5 ΔNΔC-Nup214 βΔC structure. The residues 
involved in hydrophobic and electrostatic interactions are highlighted. (b) Protein 
precipitations by GST-pull-downs with Dbp5 and Nup214 mutant proteins. The pull-down 
assays were carried out as described in Figure 22a. Mutations of Dbp5D223R, Dbp5I258A, 
Dbp5R259D or Dbp5R262A impair the interaction with Nup214. Nup214V353A shows reduced 
binding to Dbp5, whereas Nup214D359R impairs the interaction. (c) Close-up of the region of 
interaction between the N-terminal RecA-like domain of Dbp5 (in light blue) and RNA (in 
black) in the Dbp5 ΔN-AMPPNP-RNA structure (shown in a similar view as for the Nup214-
interaction close-up in panel a). For clarity, the C-terminal domain and AMPPNP have been 
omitted in this figure. Binding of RNA at nucleotides 5 and 6 occurs via Dbp5 residues 
involved in binding Nup214. (d) Protein precipitations with biotinylated ssRNA and mutant 
Dbp5 proteins. The pull-down assays were carried out as described in Fig. 1b. Binding to 
RNA is impaired in the Dbp5D223R mutant and reduced in the Dbp5R259D mutant. In contrast, 
neither of the substitutions I258A or R262A impairs RNA binding, although slower binding 
compared to the WT protein was observed. 
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4.3 Dbp5 binds to either RNA/ATP or Nup214 in a mutually exclusive manner  
Comparison and superposition of the two described structures reveal that the 
N-terminal domain of Dbp5 uses part of the binding site for Nup214 to form the 
binding site for RNA (Figure 28a and c). In particular, Asp223 in motif Ib contacts 
ribonucleotides 5 and 6 (Figure 28c and Figure 17). Mutation of Dbp5D223R not only 
impairs Nup214 binding as discussed before (Figure 28b, lane 3), but also impairs 
RNA binding in a biotin pull-down experiment (Figure 28d, lane 3). The other half of 
the Nup214-binding site, which is formed by the helix between motifs II and III, 
contacts RNA only marginally. Consistently, Dbp5 mutants with an I258A or an 
R262A substitution are still able to bind RNA (Figure 28 d, lanes 4 and 6), while they 
are unable to bind Nup214 (Figure 28b, lanes 4 and 6). Although Dbp5I258A and 
Dbp5R262A still bind to RNA, I observed that compared to the wt protein they bind 
RNA much slower. After one hour (as described for the wt proteins in 3.2.6.2) barely 
any binding was detected for those mutants. In order to show that Dbp5D223R is really 
not capable of binding RNA the incubation time with RNA for all mutants in the pull-
downs (using biotinylated RNAs) was increased to 12 h.  
The observation from the structural analysis that Nup214 and RNA occupy 
overlapping binding sites on Dbp5 and the observation from pull-down experiments 
with biotinylated RNA, where only Dbp5 and not a Dbp5-Nup214 complex was 
precipitated (Figure 6, lanes 6 - 10, 12 and 15), suggests that binding of RNA and 
Nup214 is mutually exclusive. This prediction can be recapitulated in competition 
experiments. While Dbp5 is efficiently precipitated by biotinylated RNA immobilized 
on streptavidin beads in the presence of AMPPNP, the precipitation decreases when 
adding increasing amounts of Nup214 (Figure 29a). Conversely, binding of Nup214 
to GST-Dbp5 decreases when adding increasing amounts of RNA (in the presence of 
AMPPNP, Figure 29b). The same result is observed in EMSAs, where bound 
(shifted) RNAs are efficiently competed out by increasing amounts of Nup214 (Figure 
30, lanes 4 - 6 compared to lane 1).  
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Figure 29: Mutually exclusive binding of Dbp5 to RNA - AMPPNP and to Nup214.  
(a) Effect of Nup214 on the RNA-binding properties of Dbp5. The pull-down assay with 
biotinylated ssRNA shows that the efficiency of Dbp5 binding to RNA decreases 
progressively with increasing concentrations of Nup214. (b) Effect of RNA on the Nup214-
binding properties of Dbp5. The pull-down assay with GST-tagged Dbp5 shows that the 
efficiency of Dbp5 binding to Nup214 decreases progressively with increasing concentrations 
of RNA. Dbp5 and Nup214 proteins where incubated at 1.7 µM, and then mixed or not with 1 
mM AMPPNP or 1 mM ADP and increasing amounts of RNA. The RNA concentration in lane 
10 equals that in lane 8.  
 
 
Figure 30: Electromobility shift assay (EMSA) of Dbp5 and 20U ssRNA. 
Effect of Nup214 on the RNA-binding properties of Dbp5. Dbp5 shifts RNA only in the 
presence of AMPPNP (lane 1) and not without (lane 3). Increasing amount of Nup214 (lanes 
4 - 6) decrease the level of bound RNA. Nup214 alone does not shift RNA (lane 7). Nup214 
(lane 7, green asterisk) and the Dbp5-Nup214 complex (lane 8, red asterisk) are faintly 
stained by toluidine. Dbp5 alone does not migrate into the gel (lane 3, blue asterisk). These 
faint proteins bands were approved by Coomassie staining. 
These results are supported by ATPase experiments. I qualitatively tested the 
ATPase activity of Dbp5 in presence of Nup214 (as described in methods 3.2.5). I 
first tested the pH dependency for this reaction to find the condition with the highest 
activity (pH 6.5, Figure 31). This condition was used for further experiments, where 
increasing amounts of Nup214 were used. The amount of ATP hydrolyzed by Dbp5 
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constantly decreases with increasing amounts of Nup214. (Figure 32). This is 
further supported by ATPase assays using the previously described mutants of 
Dbp5 and Nup214 (Figure 33). Dbp5I258A, Dbp5R259D and Dbp5R262D have a lower 
ATPase activity as compared to the wt Dbp5 (Figure 33a). This is most likely due 
to the previously described slower RNA binding properties of these mutants. 
Nevertheless the effect of Nup214 on the ATPase activity of Dbp5 mutants unable 
to bind to the nucleoporin is negligible (Figure 33b), their ATPase activities are not 
affected in presence of the nucleoporin.  
 
 
Figure 31: 
Relative pH dependency of the 
ATPase activity of Dbp5.  
Plotted are the counts against the 
time. Fl Dbp5 has the highest 
ATPase activity at pH 6.5 (red 
line). No ATPase activity is 
observed when RNA (bottom blue) 
or Dbp5 is omitted (orange) 
 
 
 
Figure 32: 
Effect of Nup214 on the ATPase 
activity of Dbp5. 
The ATPase assay shows that the 
ATPase activity of Dbp5 
progressively decreases with 
increasing amounts of Nup214. 
Plotted is the relative amount of 
ATP hydrolyzed (%) vs. the time 
(min). The values are the mean of 3 
independent reactions with a linear 
fit. Error bars represent the 
standard deviation.  
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Figure 33: Relative ATPase activity of Dbp5 WT and mutants.  
a) Comparison of Dbp5 WT and mutants Dbp5 I258A, Dbp5R259A and Dbp5R262A. All mutants 
have lower ATPase activity than the WT, which can be explained by slower RNA binding 
properties of the mutants (observed in biotin pull-downs). (b) Comparison of Dbp5 WT 
and mutants in present of Nup214. As already shown in Figure 32 Dbp5 WT has a lower 
ATPase activity in presence of Nup214. Mutants unable to bind to Nup214 are not 
affected. For clarity only Dbp5I258A (purple and light purple) is plotted, but the other Dbp5 
mutants showed the same behavior. 
 
A second observation from the structures is that in the closed conformation 
of Dbp5 bound to RNA and AMPPNP, the C-terminal domain of Dbp5 would clash 
sterically with an incoming Nup214 (Figure 34, compare panels a and b). 
Interestingly, in the presence of ADP alone (pdb code 3EWS) recently deposited 
by the Structural Genomics Consortium SGC, the conformation of Dbp5 is more 
open than the AMPPNP-RNA bound form. In the ADP-bound structure the N-
terminal region of Dbp5 forms a helix that is sandwiched between the N- and C-
terminal domains (Figure 34c, in orange) and would partially clash with an 
incoming Nup214. This is further described in the paragraph 5.2. 
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Figure 34: Comparison of Dbp5 structures. 
(a) The Dbp5 ΔNΔC-Nup214 βΔC structure is shown in a similar orientation as in Figure 22c. 
Nup214 βΔC is in green. The N-terminal RecA-like domain of Dbp5 is in light blue, with the 
N-terminal region in orange. In red are regions of the Dbp5 N-terminal domain engaged in 
the interaction with the nucleoporin and with nucleic acid (see panel b). (b) The Dbp5 ΔN- 
AMPPNP-RNA structure is shown with the N-terminal domain in the same orientation and 
color scheme as in panel a. The C-terminal domain is shown in a lighter shade. (c) The 
structure of Dbp5-ADP from the Structural Genomics Consortium SGC (pdb code 3EWS) is 
shown with the N-terminal domain in the same orientations as in panels a and b. In the 
structure, there are 20 additional residues ordered at the N-terminus (ΔN‟). The N-terminal 
region (residues 53 - 67) forms a helix sandwiched between the two RecA-like domains. 
 
4.4 Small Angle X-ray Scattering 
In order to investigate the relative conformations of the two RecA-like domains 
of Dbp5 in the presence of nucleotides and Nup214 I performed SAXS experiments. I 
tried to address the question if a single conformation is induced by ATP or ADP 
alone, since Dbp5 has been shown to remove Nab2 from RNA only when in 
presence of ADP (Tran 2007). I also wanted to see the conformation of the N-
terminal flanking region of Dbp5 (1 - 68) in solution, which lacks electron density in 
the crystal structure. I therefore measured data for the fl and the N-terminally 
truncated helicase in presence and absence of nucleotides. No aggregation or 
intramolecular interactions was observed for any of the samples (experimental (red) 
scattering profiles in Figure 35 and Figure 36c), prerequisite for data analysis. 
Nevertheless I could not reconstruct 3D-electron density for the helicase in presence 
of ATP, ADP or Nup214. Resulting bead models were typically much bigger than 
expected. From SAXS and sls experiments I knew the molecular weight, which 
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excluded the possibility of a different oligomerization state. Altogether this 
suggests major flexibility or heterogeneity of conformations. Reconstructions 
based on simple bead models (used in e.g. Gasbor) typically fail when proteins 
have major flexible regions. I therefore tried to model conformations of the 
helicase treating the two RecA-like domains as rigid bodies. With the help of 
Friedrich Förster (MPIB), who performed the computational work, we tried to 
model different conformations of the helicase, based on the crystal structure. 
Dbp5 was treated as a molecule that consists of two rigid bodies (the two RecA-
like domains) that are connected with a flexible linker. 1000 independent 
optimizations of single models against a scoring function including the 
experimental scattering profiles were carried out (as described in Forster 2008). 
Each optimization probed ~ 100 different conformations and therefore a total 
number of ~ 100000 different models were tested. Comparison of the 
experimental scattering curves with calculated ones (using Crysol, Svergun 1995) 
show that the experimental scattering profiles cannot be fitted to and explained by 
a single conformation (Figure 35). Neither a closed conformation (as observed in 
the Dbp5-AMPPNP-RNA structure), nor a (modeled) open conformation explain 
the conformation of Dbp5 in presence of ADP (compare Figure 35 a and b). 
Comparison of relative radii of gyration (RG) derived from experimental data using 
Guinier plots (data not shown) reveal that Dbp5 without nucleotides (apo form) 
has the largest RG of 35 Å. In presence of ADP RG is 32.5 Å (vs. 31 Å calculated 
from pdb 3EWS). The closed conformation (as observed in the Dbp5-AMPPNP-
RNA structure) has the smallest RG of 28 Å (calculated from 3FHT). The 
observation that the experimental scattering profiles miss essential features 
suggests that an ensemble of different conformations exists in solution. This 
would explain the „smoothness‟ of the experimental profiles, since the 
experimental SAXS profile would be the average of multiple conformations.  
One of the major disadvantages of SAXS is the fact that the information 
content of SAXS profiles is very limited. Our measured profiles contain 
approximately 10 independent data points according to the Wittaker-Shannon 
theorem (Svergun and Koch 2003, reviewed in Putnam 2007). Therefore 
simultaneous fitting of an ensemble of models (e.g. 10 different conformations) 
hits the limit of the data-parameter ratio. Finding rigid body coordinates and the 
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relative abundances of those different conformations is simply underdetermined, 
and therefore reliability of those conformations would be very poor. 
 
 
Figure 35: Comparison of experimental and calculated small angle X-ray scattering 
profiles of Dbp5. Experimental scattering profiles are shown in red and calculated profiles 
(blue) from atomic structures using Crysol (Svergun 1995) as shown in blue as surface 
representation with (a) a closed conformation as observed in the AMPPNP and RNA bound 
structure and (b) a more open conformation (modeled as two rigid bodies connected by a 
flexible linker). The experimental scattering profiles cannot be fitted with the calculated ones. 
The experimental profiles miss essential features compared to the calculated ones and 
profiles are overall smoothened.  
 
I also recorded SAXS data for the β-propeller domain of Nup214 alone. For 
this experiment a construct including the C-terminal tail was used in order to see if 
this part of the molecule is ordered (like in the crystal structure) or unstructured in 
solution. Reconstructions with the programs Credo (Petoukhov 2002) and Gasbor 
(Svergun 1992) both result in electron density that fits the shape of the β 
propeller. The reconstruction is shown in (Figure 36b). I observe additional density 
outside the core (Figure 36b) , which could be explained by a flexible C-terminal 
tail. However fitting of the crystal structure in the SAXS density is not conclusive 
since the β-propeller is a flat, ring like molecule and can therefore be positioned 
into the density in two different orientations and all rotations. A comparison of the 
calculated scattering profile using the crystal structure of Nup214 (Napetschnig 
2007) with the experimental one (Figure 36c) shows that they are in good 
agreement. The differences observed could be explained by a certain degree of 
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flexibility of surface loops and the C-terminal tail. All in all the SAXS data for both 
proteins and the complex do not provide unambiguous and conclusive data. 
Reconstructions are either not possible due to flexibility or fitting of the data is 
impaired by the overall globular shape and the similar size of the proteins 
(domains).  
 
 
Figure 36: SAXS reconstruction of Nup214 β-propeller domain.  
a) Surface representation of Nup214 β crystal structure (Napetschnig 2007) , (b) bead model 
reconstruction of Nup214 β using the program Credo (Petoukhov 2002). Additional density is 
observed and marked with red circles. c) Comparison of calculated (blue) and experimental 
(red) scattering profiles of Nup214 β.  
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5 Conclusions and Outlook 
5.1 Mutually exclusive binding - a paradigm of DEAD-box helicase regulation 
Structural and biochemical analysis of the human DEAD-box helicase Dbp5 
reported in this thesis show that binding of RNA-AMPPNP and Nup214 are mutually 
exclusive. Nup214 binds the N-terminal domain of Dbp5 and occupies the binding 
pockets for RNA nucleotides on the surface of this domain. The C-terminal domain of 
Dbp5 does not provide binding sites for Nup214. However, the C-terminal domain 
would sterically hinder the access of Nup214 to the N-terminal domain when the 
molecule is in the closed, nucleotide-bound conformation. In cells, Dbp5 is 
concentrated at the cytoplasmic side of the nuclear pore complex by interaction with 
Nup214 (Nup159 in yeast). Nup214 not only localizes Dbp5, but also traps it in an 
inactive/inhibited conformation. In this conformation both ATPase activity and RNA 
binding of Dbp5 are impaired. It is conceivable that the C-terminal RecA-like domain 
is a target of another yet unknown regulator, acting in a similar way like Nup214. 
Notably, the binding sites for RNA and Nup214 on Dbp5 partially overlap. This 
prevents the concomitant binding of RNA and Nup214 but could allow Dbp5 to switch 
between RNA-bound and Nup-bound state. The incoming molecule (Nup214 or RNA) 
would be able to dock to Dbp5 at the sites left empty by the other and possibly 
accelerate its release. The overall hydrophilic character of the Dbp5-Nup214 
interface probably facilitates this switch between states, since major conformational 
changes (e.g. to bury a hydrophobic surface) are not necessary for both proteins in 
their apo and bound form. This raises the question of whether Nup214 removes RNA 
and ATP from Dbp5 or whether RNA and ATP dissociate Dbp5 from Nup214 during 
mRNA export. Both possibilities are discussed in paragraph 5.4.  
DEAD-box helicases are highly conserved in sequence and structure (further 
discussed in 5.3) and binding of RNA is therefore most likely similar for most DEAD-
box helicases. Hence, the interaction of Dbp5 and Nup214 suggest a paradigm of 
regulation that is likely to apply to other helicases and their regulators. This concept, 
where a regulator can act by decreasing the activity towards RNA and ATP, presents 
an efficient and probably universal way to inhibit this class of helicases. 
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5.2 DEAD-box helicase 5 is modulated in a nucleotide dependent fashion 
In its active state, upon concomitant RNA and ATP binding, Dbp5 assumes a 
closed conformation similar to that observed in the structures of Vasa (Sengoku 
2006) and eIF4AIII in the EJC (Andersen 2006; Bono 2006). ATP is bound in the 
cleft of the two RecA-like domains and RNA is bound by both domains opposite to 
the linker region, thus forming a compact globular conformation. 
Another crystal structure of the human Dbp5-AMPPPNP-RNA complex has 
been determined independently (Collins 2009, pdb code 3G0H at 2.7 Å resolution) 
and is essentially identical. The superposition of both RNA-bound structures 
reveals an r.m.s.d of 0.73 Å over all Cα-atoms. In the same paper, the authors 
describe the crystal structure of human Dbp5 in complex with ADP (Collins 2009, 
3EWS at 2.7 Å resolution). Hydrolysis of ATP to ADP triggers the transition to a 
more open conformation (see Figure 34c). In the ADP-bound structure, an 
additional helix is bound in between the two RecA-like domains. The authors 
speculate that this is a functionally important feature that regulates the helicase 
activity. In yeast, the N-terminal region including this helix has been shown to be 
dispensable for cell viability and mRNA export (Snay-Hodge 1998). It is possible 
that despite high conservation yeast and human Dbp5 are different in this respect. 
The SAXS analysis of human Dbp5 in presence of 1 mM ADP does not support a 
single conformation, but the two RecA-like domains adopt a more closed 
conformation in solution as compared to the apo form. Collins et al. used high 
concentrations of ADP (20 mM) to crystallize the complex. Altogether the 
conformation observed in the crystal structure could be favored by crystal contacts 
and the protein is likely to be more dynamic in solution. 
In the inhibited conformation, Nup214 is bound to the N-terminal RecA-like 
domain of the helicase. Dbp5 presumably adopts an open conformation since in 
the closed state the C-terminal domain would clash with the nucleoporin (compare 
Figure 34 panel a and b). Another crystal structure of the human Dbp5-Nup214 
complex was published (Napetschnig 2009) and appears similar, although the 
coordinates are so far not accessible and therefore a superposition and direct 
comparison has not been possible. Napetschnig et al. crystallized the N-terminal 
β-propeller domain of Nup214 in complex with a Dbp5 construct consisting of both 
RecA-like domains. In this 3.2 Å resolution structure (pdb code 3FMO) the authors 
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did not observe electron density for the C-terminal domain of Dbp5, suggesting 
that it is flexible. 
Yet another crystal structure of the S. pombe Dbp5 (3FH0, coordinates not 
accessible) together with NMR structures (2KBE and 2KBF, coordinates not 
accessible) of the two individual RecA-like domains of S. cerevisiae Dbp5 were 
published later (Fan 2009). Although the structural statistics of the NMR data are 
rather poor (~ 65 % in favored Ramachandran regions), the data suggest that the 
N-terminal flanking region is unstructured in solution and the N-terminal region 
(residues 71 - 121) is highly dynamic. The authors conclusions are in agreement 
with our data, where the fl human Dbp5 lacks ordered electron density for the first 
74 residues and where the N-terminal region (75 - 92) of the molecule adopts 
different conformations, depending on the nucleotide state. Furthermore the 
authors have shown that the N-terminal RecA-like domain is sufficient for ADP 
and ATP binding.  
Thus, it appears that Dbp5 transition from an open to a closed conformation 
occurs in an RNA and nucleotide dependent manner. The presence of RNA and 
ATP induce the closed conformation. Binding of ADP might induce a single 
conformation where the two RecA-like domains are separated by a helix, or form 
more open and dynamic conformations. In the nucleotide-free (apo) form the 
helicase adopts flexible conformations where the two RecA-like domains are best 
described as two rigid bodies connected by a flexible linker. The ADP bound state 
is compatible with Nup214 binding (Napetschnig et al. crystallized the Dbp5-
Nup214 complex in presence of ADP), although the nucleotide state affects the 
affinity for the nucleoporin. Compared to the nucleotide-free state binding to 
Nup214 in presence of AMPPNP is reduced by a factor of 50 and in presence of 
ADP by a factor of 30. Since the nucleotide binding site is the most conserved part 
of DEAD-box helicases this nucleotide dependent modulation likely applies to 
other DEAD-box proteins. 
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5.3 DEAD-box helicases have a functionally and evolutionary conserved core 
Comparison with other DEAD-box helicase structures shows that these 
proteins have conserved structural features: they consist of two globular RecA-like 
domains that bind ATP in their cleft with highly conserved residues. The two 
domains bind concomitantly to ssRNA in a sequence-independent manner. 
Including my work structural data for three DEAD-box helicases in complex with 
an ATP analogue and ssRNA are available (Vasa, Sengoku 2006; eIF4AIII, 
Andersen 2006; Bono 2006; Dbp5, Collins 2009) and show that ATP 
binding/hydrolysis is achieved by a similar mechanism involving equivalent amino 
acids, coordinated waters and metal ions. Most residues binding RNA are also 
conserved within this family (alignment in appendix 6.5).  
The high conservation of DEAD-box proteins on a sequence, structural and 
mechanistical level raises the question how they are able to specifically act on 
different substrates at different stages? Most DEAD-box helicases bind RNA in a 
sequence independent manner and therefore specificity is unlikely to be conferred 
by the RNA substrate, although some helicases have other domains outside the 
helicase core that do provide specificity. One example is DbpA that binds 
specifically to a hairpin of the 23S rRNA via its additional C-terminal domain 
(Fuller-Pace 1993). So far N- and C-terminal flanking regions, that are found in 
many DEAD-box helicase are poorly understood but could play roles in specificity 
by localizing helicases to specific compartments within the cell. Specificity might 
arise from direct and indirect interactions with regulators that activate or inhibit, 
transport and localize helicases, but so far only few interactions have been shown 
in vitro (e.g. eIF4A-eIF4G complex, Schutz 2008). Some of those interactions 
might only be transient and possible in the context of certain multiprotein 
complexes (e.g. in the case of the EJC, Andersen 2006; Bono 2006). The 
reconstitution of native complexes such as mRNPs in vitro seems to be an 
important but difficult task for the future in order to understand how helicases act 
on substrates and how they are regulated. 
Studies to date have focused on the activation of Dbp5 and of DEAD-box 
proteins in general. The activity of Dbp5 is stimulated by the protein Gle1 and its 
cofactor IP6 (Alcazar-Roman 2006; Weirich 2006). Gle1 binds the nucleoporin 
CG1 in humans or Nup42 in yeast and is believed to be in close proximity to 
human Nup214 and yeast Nup159 in the architecture of the nuclear pore complex 
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(Miller 2004). The molecular details of how Gle1 acts on the ATP-bound form of 
Dbp5 are currently unknown. Structural studies of the DEAD-box proteins eIF4A 
and eIF4AIII have given some insights into the molecular mechanism for their 
specific activation by eIF4G and Barentsz, respectively. The next aim is to get 
insights into the activation of Dbp5 at a molecular level, which could present a 
general paradigm of how this class of proteins is regulated. In addition to this, 
most mechanistic details of how ATP hydrolysis is coupled to unwinding are not 
yet understood. The use of different ATP transition state analogues like 
beriliumfluoride-ADP and aluminiumfluoride-ADP could provide some mechanistic 
insights.  
Comparison of crystal structures of various DEAD-box helicases reveal a 
common feature: independent of the ligand or regulator bound, the globular 
structures of the two individual RecA-like domains remain similar (Figure 37). 
DEAD-box helicases are highly conserved on a sequence level and probably 
evolved from the same ancestor. Together with the overall conservation of 
structural features this suggests that a stable core and an efficient mechanism for 
ATP binding/hydrolysis and RNA binding remained unchanged, while variations of 
the surface properties and modular addition of domains outside the core made 
different functions within the cell possible. 
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Figure 37: Overview of crystal structures of different DEAD-box helicases. 
In this schematic, structures of different helicases have been superposed and are shown in the 
same orientation. The N-terminal RecA-like domains are shown in dark grey (labeled N), the C-
terminal RecA-like domains (if present) in lighter grey. RNA is shown as a black line, regulators 
that are bound are shown in red, green or blue. (a) DEAD-box helicases bound to a non-
hydrolysable ATP analogue and RNA assume a closed conformation where the ATP analogue is 
bound in the cleft of the two RecA-like domains (e.g. Vasa, Sengoku 2006) (b) DEAD-box 
helicase eIF4AIII  in the exon junction complex (Andersen 2006; Bono 2006) is locked on the 
RNA by interactions with Barentsz (green) and Mago+Y14 (blue) (c) eIF4AIII assumes an open 
conformation when only bound to Barentsz (Bono 2006). Here, the C-terminal RecA-like domain 
rotates more than 180 degrees. The same conformation is observed in the absence of Barentsz 
(Andersen 2006) (d) only a few DEAD-box helicases have been crystallized in the apo form, 
where both domains are present (e.g. eIF4A, Caruthers 2000). The two domains have a very 
flexible conformation in respect to each other, preventing crystallization in most cases. The 
conformation of eIF4 shown here is most likely stabilized by crystal contacts and resembles one 
out of many possible conformations. (e) in the eIF4A+eIF4G complex (also known as eIF4F, 
Schutz 2008), the helicase is in an activated conformation. eIF4G binds opposite the RNA 
binding side and brings the two domains in close proximity. (f) several helicases have been 
crystallized with ADP (e.g. pdb code 2PL3), but in general only the N-terminal RecA-like domain 
was used or ordered. In the case of human Dbp5, both domains are present separated by a helix 
(shown in orange). The helicase assumes a more closed conformation compared to the apo 
conformation, which is probably stabilized due to crystal contacts. (g) In the Dbp5-Nup214 
complex (pdb code 3FHC, 3FMO), the helicase is in an inhibited conformation where both ATP 
hydrolysis and RNA binding are impaired. 
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5.4 Nuclear export of messenger RNA - an updated model 
Messenger RNA is transcribed in the nucleus and needs to be exported to the 
cytoplasm where translation occurs. Transport through the NPC is mediated by the 
nuclear transport factor TAP-p15 in metazoans and Mex67-Mtr2 in yeast. The N-
terminal half of TAP binds the mRNP, while the C-terminal half binds the FG repeats 
of nucleoporins (reviewed in Cook 2007) . Export competent mRNPs include many 
proteins, some of which bridge the mRNA to the transport factor, others are removed 
prior to or during export and some that are not dissociated until translation. The 
current model for mRNA export envisages that Dbp5 could bind to mRNA in the 
nucleus (Cole and Scarcelli 2006; Stewart 2007; Iglesias and Stutz 2008), where 
Dbp5 is found in both S. cerevisiae (Estruch and Cole 2003) and C. tentans (Zhao 
2002). Upon reaching the cytoplasmic side of the NPC, docking of mRNP-bound 
Dbp5 to Nup214 would position it close to its activator Gle1. The subsequent 
activation of Dbp5 would therefore occur specifically at the cytoplasmic side of the 
NPC and result in ATP hydrolysis, dissociation of Dbp5 and other mRNP-bound 
factors such as yeast Mex67 (Lund and Guthrie 2005) or Nab2 (Tran 2007), thus 
releasing the mRNP to the cytoplasm. 
However, the data reported are not compatible with this model since Dbp5 
binding to the mRNP and to Nup214 are mutually exclusive. The association of an 
mRNP-bound Dbp5 to Nup214 would result in the dissociation of RNA and ATP and 
the simultaneous activation of Dbp5 by Gle1 would therefore not be possible at this 
step. A way to reconcile this model with the results from my structural analysis would 
be if Gle1 binding/activation occurs prior to Nup214 binding (Figure 38), or in a 
second scenario, that binding to the emerging mRNP and binding to Gle1 and 
subsequent activation occurs after Nup214 binding (Figure 39): In the first case, the 
helicase would have to bind to the mRNP in the nucleus. As the mRNP-bound Dbp5 
would move through the NPC, it would encounter Gle1. Gle1 would stimulate ATP 
hydrolysis, promoting the remodeling activity of Dbp5, resulting in displacement of the 
mRNP-bound proteins and thus releasing the (remodeled) mRNP. Dbp5 in its apo 
(open) form would then be captured by Nup214, possibly by docking initially to the 
ADP-bound form and accelerating ADP displacement.  
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Figure 38: mRNA export and release model 1.  
The nuclear pore complex (NPC) is shown schematically with the nuclear basket, the central 
scaffold and the cytoplasmic fibrils. Dbp5 is shown in light blue, with the two RecA domains 
in a closed conformation (bound to ATP and RNA), in a slightly more open conformation 
(when bound to ADP) and in a completely open conformation (when unbound or bound to 
Nup214). The cytoplasmic nucleoporin Nup214 is shown in green, with the globular Dbp5-
binding domain and the FG-repeat domain. The FG repeats of nucleoporins are shown as 
zigzagged lines in green (Nup214), grey (hCG1) and in black (other Nups). The cytoplasmic 
nucleoporin hCG1 is in grey and is shown bound to Dbp5-activating protein Gle1. The mRNP 
is shown with various proteins bound to it (adaptors, DEAD-box proteins etc.). In the nucleus, 
the export competent mRNP is shown bound to the transport factor TAP-p15 (in dark gray). 
TAP-p15 binds the FG-repeats of nucleoporins via the C-terminal domain, and adaptors to 
bridge to RNA via the N-terminal domain. When Dbp5 bound to the mRNP approaches Gle1 
it is activated (red asterisk) and displaces the export factor by local unwinding and thereby 
prevents backsliding of the mRNP. The export factor shuttles back to the nucleus and free 
Dbp5 is captured by Nup214 to prevent removal of other proteins. 
 
In the second scenario (Figure 39), association of Dbp5 with RNA in the 
nucleus might not be required for the mRNP to become export competent. In this 
model, the emerging mRNP would encounter Dbp5 attached to Nup214 in an 
open form. Dbp5 would bind to ATP and the mRNP, resulting in dissociation from 
Nup214. The juxtaposition of Gle1 (Gle1 binds to CG1 (Nup42 in yeast) that is 
thought be in close proximity to Nup214 (Nup159 in yeast) in the architecture of 
the NPC) would then activate Dbp5 locally and result in remodeling of the mRNP,  
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removal of the transport factor and release of the RNA. Unbound Dbp5 would then 
either diffuse to the cytoplasm or be sequestered by Nup214 (possibly by docking 
initially to the ADP-bound form and accelerating ADP displacement), which would 
then position the helicase for the next emerging mRNP. This model predicts that 
fractions of Dbp5 bound to the mRNP in the nucleus would not necessarily be 
dissociated from the mRNP upon nuclear export. Whether this is a mechanism by 
which Dbp5 might be retained from the nucleus to cytoplasmic mRNPs until it 
reaches the translation machinery (Gross 2007) or P body components (Scarcelli 
2008) remains to be shown.  
Both models raise the question of how Dbp5 dissociates from the nucleoporin. 
In in vitro assays we have determined the binding affinities for the Dbp5-Nup214 
complex. The two proteins form a strong interaction with KDs in the nanomolar 
range. One way to disrupt the complex would be an unknown (protein-)factor that 
helps to dissociate this complex. A second way would be a nucleotide-dependent 
regulation, since different nucleotide states of the helicase influence the binding 
affinity for the nucleoporin. In the presence of AMPPNP or ADP, binding of the 
nucleoporin is reduced. Dbp5 bound to Nup214 would bind ATP, possibly by its N-
terminal domain alone and thus reduce the affinity for the nucleoporin. 
Cooperative binding of RNA and ATP would then result in dissociation from 
Nup214. Recent NMR titration experiments (Fan 2009) determined binding 
affinities of the S. cerevisiae N-terminal domain of Dbp5 for ATP (KD ~ 1.5 mM) 
and ADP (KD ~ 0.5 mM). It is surprising that the helicase has a higher affinity for 
ADP than ATP. Repeating these experiments with the human helicase in 
presence of the nucleoporin could provide more details. In the presence of 
Nup214, Dbp5 could have a preference for ATP. In this case the nucleoporin 
would help to preload the helicase with ATP, while inhibiting its ATPase activity. 
This would result in reduced affinity of the Dbp5-Nup214 complex and 
concurrently prepare the helicase to dissociate. 
Another open question in both models is how Dbp5 discriminates between 
proteins that must be dissociated and proteins that need to be retained on the 
cytoplasmic mRNP. As RNA binding by Dbp5 is independent of the nucleic acid 
sequence, and since DEAD-box helicases are not processive and therefore their 
activity does not propagate over long distances, discrimination is likely to arise 
from proximity effects. This would be the case if Dbp5 and the proteins that need 
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to be removed from the mRNP interact directly or via adaptors. However these 
interactions with possibly targets such as Mex67 and Nab2 have not been shown 
in vitro so far. The positioning of Dbp5-Gle1 in the vicinity of specific mRNP-bound 
proteins to be remodeled could confer selective mRNP remodeling without the 
necessity of direct interactions. Binding of the TAP-p15 transport factor to the 
nucleoporin FG repeats might position it near Dbp5 and Gle1, which are 
associated with the only two cytoplasmic nucleoporins Nup214 (yeast Nup159) 
and CG1 (yeast Nup42) that contain FG repeats (Terry and Wente 2007). The 
local activation of Dbp5 in the proximity of TAP-p15 would thus lead to the 
dissociation of the transport factor from the mRNP providing directionality in the 
export of mRNAs. 
Many steps in the final mRNA export and release mechanism remain 
unclear. In the case of Dbp5 one unresolved question is whether the cytoplasmic 
and the nuclear fractions of the helicase are separate pools with independent 
functions or if the same molecule travels all the way from transcription to 
translation on the same mRNA. It is also currently unknown how the helicase is 
imported to the nucleus, since a bipartite nuclear localization sequence (NLS) is 
not present in the sequence. Ultimately, in vivo studies in cells are likely to 
uncover more details of the interactions of Dbp5 in the cell. Single molecule 
studies and the use of fluorescence correlation spectroscopy could show, which 
proteins interact at which time and space. One example is the transport factor 
Mex67, which is thought to be removed from the transcript by the helicase. How 
and if these proteins interact has not been shown so far. It remains to be shown if 
the two proteins are already in close proximity in the nucleus (on the transcript) or 
only later at the nuclear pore. More details of the final steps of mRNA export are 
needed to understand how transcripts are directionally transported and finally 
released. 
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Figure 39: mRNA export and release model 2.  
The nuclear pore complex (NPC) is shown schematically with the nuclear basket, the central 
scaffold and the cytoplasmic fibrils. Dbp5 is shown in light blue, with the two RecA domains 
in a closed conformation (bound to ATP and RNA) and in a completely open conformation 
(when unbound or bound to Nup214). The cytoplasmic nucleoporin Nup214 is shown in 
green, with the globular Dbp5-binding domain and the FG-repeat domain. The FG repeats of 
nucleoporins are shown as zigzagged lines in green (Nup214), grey (hCG1) and in black 
(other Nups). The cytoplasmic nucleoporin hCG1 is in grey and is shown bound to the Dbp5-
activating protein Gle1. The mRNP is shown with proteins bound to it (adaptors, DEAD-box 
proteins etc.). In the nucleus, the export competent mRNP is shown bound to the transport 
factor TAP-p15 (in dark gray). TAP-p15 binds the FG-repeats of nucleoporins via the C-
terminal domain, and adaptors to bridge to RNA via the N-terminal domain. When the mRNP 
translocates through the pore and reaches the cytoplasmic Nup214, Dbp5 bound to the 
nucleoporin is released and binds ATP and the mRNP. The helicase travels further with the 
mRNP until it approaches Gle1 bound to hCG1. Dbp5 is activated (red asterisk) and 
displaces the export factor by local unwinding and thereby prevents backsliding of the 
mRNP. The export factor shuttles back to the nucleus. Free Dbp5 is either further travelling 
to the cytoplasm - possibly by rebinding the mRNP or is sequestered by Nup214, waiting for 
the next translocating mRNP. 
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6 Appendix 
6.1 Abbreviations 
Å Ångström (=10-10 m) 
ADP adenosine diphosphate 
ALS Advanced Light Source 
AMP adenosine monophosphate 
AMPPNP 5´-adenylyl-imido-triphosphate 
ATP  adenosine triphosphate 
bp base pairs 
BSA bovine serum albumin 
C. tentans Chironomus tentans 
dATP 2'-Deoxyadenosine 5'-triphosphate 
Dbp5 DEAD-box helicase 5 
dCTP 2'-Deoxycytidine 5'-triphosphate 
dd double destilled 
DDX19B DEAD-box polypeptide 19B 
dGTP 2'-Deoxyguanosine 5'-triphosphate 
DMSO dimethyl sulfoxide 
DNA  deoxyribonucleic acid 
dNTP  deoxynucleotide triphosphate 
dNTP deoxyribonucleotide 
DTT dithiothreitol 
dTTP 2'-Deoxythymidine 5'-triphosphate 
E. coli  Escherichia coli 
e.g. for example (exempli gratia) 
EDTA ethylenediaminetetraacetic acid 
EJC exon junction complex 
EM  electron microscopy 
EMBL European Molecular Biology Laboratories 
EMSA electro mobility shift assay 
fl full length 
FPLC fast protein liquid chromatography 
GSH glutathione 
GST glutathione S-transferase 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
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H. sapiens Homo sapiens 
IP6 inositol hexakisphosphate 
IPTG  isopropyl β-D-1-thiogalactopyranoside 
KD dissociation constant 
LB  Luria-Bertani 
LIC ligation independent cloning 
LRR leucine rich region 
M  molar 
min minute 
MPIB Max Planck Institute of Biochemistry 
MR molecular replacement 
mRNA messenger RNA 
mRNP messenger ribonucleoprotein particle 
MW  molecular weight 
MWCO  molecular weight cutoff 
NE nuclear envelope 
NEB New England Biolabs 
NLS nuclear localization sequence 
NPC nuclear pore complex 
Nup nucleoporin 
PAGE  polyacrylamide gel electrophoresis 
PCR  polymerase chain reaction 
PDB  Protein Data Bank 
PEG  polyethylene glycol 
PSI Paul Scherrer institute 
r.m.s.d root mean square deviation 
RBD RNA binding domain 
RG radius of gyration 
RI refractive index 
RNA  ribonucleic acid 
RU response units  
S. cerevisiae Saccharomyces cerevisiae  
S200 Superdex 200 
SDS  sodium dodecyl sulphate 
sls static light scattering 
SLS Swiss Light Source 
SPR surface plasmon resonance 
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ss single stranded 
TBE Tris base, boric acid and EDTA containing buffer 
TEV tobacco etch virus 
TLS translation/libration/screw   
TLSMD translation/libration/screw motion determination 
Tm melting temperature 
UV ultraviolet 
v volume 
w  weight 
Wt wild type 
 
Nucleotides 
one letter code nucleobase 
A adenine 
C cytosine 
G guanine 
T thymine 
U uracil 
 
Amino acids 
One letter code Three letter code  Amino acid 
A  Ala  alanine 
C  Cys  cystein 
D  Asp  aspartic acid 
E  Glu  glutamic acid 
F  Phe  phenylalanine 
G  Gly  glycine 
H  His  histidine 
I  Ile  isoleucine 
K  Lys lysine 
L  Leu  leucine 
M  Met methionine 
N  Asn  asparagine 
P  Pro  proline 
Q  Gln  glutamine 
R  Arg  arginine 
S  Ser  serine 
T  Thr  threonine 
V  Val  valine 
W  Trp  tryptophan 
Y  Tyr  tyrosine 
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6.2 Purification overview 
 
Figure 40: Purification scheme of Dbp5 and Nup214 constructs. 
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6.3 Summary of Dbp5 & Nup214/159 mutants 
Table 2: summary of mutants and their phenotypes. 
Mutant Phenotype structural explanation 
Human Dbp5 
Dbp5
D223R
 no binding to Nup214 direct salt bridge with Nup214
R348
 
 no binding to RNA D223 involved in RNA binding 
Dbp5
R262A
 binds RNA but not Nup214 not involved in RNA binding but direct salt 
bridge with Nup214 
Dbp5
R259D
 reduced RNA binding 
no binding to Nup214 
partly involved in RNA binding 
direct salt bridge with Nup214 
Dbp5
I258A
 binds RNA but not Nup214 not involved in RNA binding but 
hydrophobic interaction with Nup214
V353
 
Dbp5
E243Q
 ATPase deficient in vitro, 
block of mRNA export in vivo 
conserved DEAD-box motif, E243 binds γ-
phosphate of ATP 
Dbp5
E243Q+V386N
 ATPase deficient in vitro, 
block of mRNA export in vivo 
conserved DEAD-box motif 
Dbp5
R429Q
 reduced ATPase activity in vitro, 
in vivo partial inhibition of mRNA 
export when injected at high 
concentrations into Xenopus 
oocytes  
R429 involved in ATP coordination 
Dbp5
M270P+L271R
 no binding of Nup214 in vitro not involved in binding of Nup214, prob. 
disrupts the central sheet of the Nterm. 
domain. 
Dbp5
M270P+L271R+ E243Q
 no binding of Nup214 in vitro not involved in binding of Nup214, 
disrupts the central sheet of the Nterm. 
domain. 
Dbp5
S138R
 no binding of Nup214 in vitro not involved in binding of Nup214, S138 
located in the core 
Dbp5
S138R+E243Q
 restores  Nup214 binding by 50 
% 
- 
Human Nup214 
Nup214
V353A
 weak binding to Dbp5 hydrophobic contact to Dbp5
I258
 
Nup214
D359R
 no binding to Dbp5 direct salt bridge to Dbp5
R259 
and Dbp5
R262
 
Yeast Dbp5   
Dbp5
L267P
 growth defects at permissive 
temperature 
located in the protein core, corresponds to 
human Dbp5
M270
 
Dbp5
I285N
 growth defects at permissive 
temperature 
located in the protein core, corresponds to 
human Dbp5
V388
 
Dbp5
P170H
 growth defects at permissive 
temperature (cold sensitive), 
modest nuclear accumulation of 
poly(A)
+
-RNA 
located in the protein core 
Yeast Nup159 
Nup159
V323E,I326E
 Dbp5 mislocalization and mRNA 
export blocked in vivo 
Effect most likely only due to mutation of 
V323E - hydrophobic contact to Dbp5
I326
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6.4 Summary of other attempts 
This is a brief overview of other attempts. 
Attempt Experiment observation reference 
crystallization of yeast Dbp5 in 
complex with RNA 
sitting and hanging drop 
vapor diffusion 
good expression and 
purification 
no crystals,  
no binding of RNA 
 
crystallization of yeast Dbp5 in 
complex with Nup214 
several constructs tested in 
sitting and hanging drop 
vapor diffusion, microbatch 
good expression and 
purification 
no crystals 
 
surface engineering of yeast 
Dbp5 
Several mutation of surface 
lysines 
good expression and 
purification 
lower solubility 
no crystals 
Derewenda 
2004 
methylation of surface lysines chemical reductive 
methylation of surface 
lysines of dbp5, nup159 
and the complex 
aggregation and 
heterogeneity of 
samples. 
no crystals 
 
 
expression of yeast Gle1 several constructs with 
different Nterm.- and 
Cterm. tags tried in E. coli. 
all constructs that were 
expressed were 
insoluble 
 
 few constructs tried in S. 
cerevisiae 
no expression  
 full-length Gle1 in insect 
cells 
good expression but 
insoluble 
 
crystallization of human Dbp5 
in complex with different ATP 
transition state analogues 
co-crystallization of 
Dbp5+RNA together with 
ADP-BeFx and ADP-AlF3 
up to 2.2 Å resolution 
diffracting needle 
shaped crystals  
 
 
Before I started working on this project, a S. cerevisiae Dbp5-Nup159 complex 
was crystallized by Judith Ebert in our lab. A few crystals grew after several month in 
one condition (Hampton cryo screen: 170 mM Na-acetate, 85 mM Tris pH 8.5, 15 % 
glycerol, 25.5 % PEG4000), with only one of them diffracting to 4.5 Å resolution. The 
structure was solved by Esben Lorentzen by molecular replacement using a modeled 
Dbp5 structure based on the UAP56 helicase (27 % sequence identity) structures 
(pdb codes: 1T5J, 1T6N, 1XTK, 1XTI). A solution was found with the program Phaser 
(McCoy 2004) with two molecules per asymmetric unit cell. Although a construct of 
Dbp5 containing both RecA-like domains in complex with the N-terminal domain of 
Nup159 was used, only one N-terminal RecA-like domain of Dbp5 and 2 molecules of 
Nup159 were found. The C-terminal domain and the second molecule of the helicase 
had no visible electron density. Not only the relative low resolution of the data, but 
high mosaicity, high R factors and partial completeness of the dataset made 
refinement and model building impossible. Despite Judith‟s and later my work these 
crystals were never reproduced.  
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6.5  Alignment of known S. cerevisiae DEAD-box helicases 
                    10        20        30        40        50        60        70        80        90       100       110       120       130       140       150                        
            ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
DBP5   1    ------------------------------------------------------------------------------------------------------------------------------------------------------ 1     
PRP5   1    METIDSKQNINRESLLEERRKKLAKWKQKKAQFDAQKEHQTSRNDIVTNSLEGKQTTEKFTERQERVKEELRKRKNEFRKSDEPVSVKPSKKKSKRSKVKKKISFDFSDDDDSEIGVSFRSKEHIQKAPEHDNEKDPLDEFMTSLKEEKM 150   
DRS1   1    ------------------------MVVGTKKYSNLDFVPTISDSEDDVPILDSSDDEKVEAKKTTKKRKGKNNKKKVSEGDNLDEDVHEDLDAGFKFDLDADDTTSNFQGWNFLAEGESNKDDAEAFVKKDVDLDKIIRRKGGLVKMAHI 126   
DED1   1    -----------------------------------------------------------------------------------MAELSEQVQNLSINDNNENG------YVPPHLR--GKPRSARNNSSNYNNNNGGYNGGRGGGSFFSN 59    
DBP6   1    -----------------------------------------------------------------------------------MFASRFDPSQLTAPAASAPEGIVGTTPPAIVPLKRQATESDNEEYGSHQDSDESSNSSSEEDEDRMQ 67    
DBP2   1    -----------------------------------------------------------------------------------MTYGGRDQQYNKTNYKSRGG----------DFR--GGRNSDRN--SYNDRPQGGNYRG--------- 44    
DBP1   1    -----------------------------------------------------------------------------------MADLPQKVSNLSINNKENGGGGGKSSYVPPHLRSRGKPSFERSTPKQEDKVTGGDFFRRAGRQTGNN 67    
DBP3   1    -----------------------------------------------------------------------------------MTKEEIADKKRKVVDEEVIE----------------KKKSKKHKKDKKDKKEKKDKKHKKHK----- 46    
PRP28  1    -----------------------------------------------------------------------------------MARPIDVSQLIAGINKKKGLDENTSGKISKPRFLNKQERSKQERLKENEESLTPTQSDSAKVEIKKV 67    
MAK5   1    -------------------------------------------------------------------------------------MGKKRAPQKGKTVTKPQEIIVDESKLNWKPVDIPDTLDDFGGFYGLEEIDGVDVKVVDGKVTFVT 65    
DBP7   1    ----------------------------------------------------------------------------------------------------------------MSDEDSMLLNFTTNEDTAGSSYKQAAKVTGGRWKDRRR 38    
DBP10  1    ----------------------------------------------------------------------------------------------------------------------MAGVQKRKRDLEDQDDNGSEEDDIAFDIANEI 32    
MRH4   1    ---------------------------------------------------------------------------------------------------------------------------------MSLFFKPVISPQWSFPVLLKI 21    
MS116  1    ------------------------------------------------------------------------------------------------------------------------------------MLTSILIKGRTPVLASRN 18    
RRP3   1    ------------------------------------------------------------------------------------------------------------------------------------------------------ 1     
DBP4   1    ------------------------------------------------------------------------------------------------------------------------------------------------------ 1     
HAS1   1    ------------------------------------------------------------------------------------------------------------------------------------------------------ 1     
DHH1   1    ------------------------------------------------------------------------------------------------------------------------------------------------------ 1     
SUB2   1    ------------------------------------------------------------------------------------------------------------------------------------------------------ 1     
IF4A   1    ------------------------------------------------------------------------------------------------------------------------------------------------------ 1     
FAL1   1    ------------------------------------------------------------------------------------------------------------------------------------------------------ 1     
IF4A   1    ------------------------------------------------------------------------------------------------------------------------------------------------------ 1     
DBP9   1    ------------------------------------------------------------------------------------------------------------------------------------------------------ 1     
SPB4   1    ------------------------------------------------------------------------------------------------------------------------------------------------------ 1     
DBP8   1    ------------------------------------------------------------------------------------------------------------------------------------------------------ 1     
                    160       170       180       190       200       210       220       230       240       250       260       270       280       290       300               
            ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
DBP5   1    -------------MSDTKRDPADLLASLKIDNEKEDTSEVSTKETVKSQPEKTADSIKPAEKLVPKVEEKKTKQEDSNLISSEYEVKVKLADIQADPNSPLYSAKSFDELG--LAPELLKGIYAMKFQKPSKIQERALP---LLLHNPP- 131   
PRP5   151  SNSKGMYDRGDILDVEDQLFELGGTDDEDVEDNTDNSNIAKIAKLKAKKRVKQIYYSPEELEPFQKNFYIESETVSSMSEMEVEELRLSLDNIKIKGTGCPKPVTKWSQLG-LSTDTMVLITEKLHFGSLTPIQSQALP---AIMSG--- 293   
DRS1   127  DSKQEEETEKEKVEKENDSDDEELAMDGFGMGAPMNNGDENQSEEEEEEEEKEEEEEEEEEQEEMTLEKGGKDDEIDEEDDSEEAKADFYAPETEGDEAKKQMYENFNSLS--LSRPVLKGLASLGYVKPSPIQSATIP---IALLG--- 268   
DED1   60   NRRGGYG---NGGFFGGNN-GGSRSNGRSGGRWIDGKHVPAPRNEKAEIAIFGVPEDPNFQSSGINFDNY------------------DDIPVDASGKDVPEPITEFTSP--PLDGLLLENIKLARFTKPTPVQKYSVP---IVANG--- 179   
DBP6   68   VDYGASEEDSSEVEEEESKPSTHSTVLSRFKQTVSLQERLGASDIAESKEDEGIEDEAASTHQLKQIPQPEFVKNPMNLNTNSLQFKSTGWLNTEKIYYDNSLIKPFSDYANELEAKLLQNICKNFSTNTFPIQSIILDSILPVLNFTLN 217   
DBP2   44   ----GFG--------------GRSNYNQPQELIKPNWDEELPKLPTFEKNFYVEHESVRDRSDSEIAQFR------------------KENEMTISGHDIPKPITTFDEA--GFPDYVLNEVKAEGFDKPTGIQCQGWP---MALSG--- 150   
DBP1   68   GGFFGFSKERNGGTSANYNRGGSSNYKSSGNRWVNGKHIPGPKNAKLEAELFGVHDDPDYHSSGIKFDNY------------------DNIPVDASGKDVPEPILDFSSP--PLDELLMENIKLASFTKPTPVQKYSIP---IVTKG--- 191   
DBP3   46   ---------------------KEKKGEKEVEVPEKESEKKPEPTSAVASEFYVQSEALTSLPQSDIDEYFK----------------ENEIAVEDSLDLALRPLLSFDYL--SLDSSIQAEIS--KFPKPTPIQAVAWP---YLLSG--- 149   
PRP28  68   NSRDDSFFNETNDKKRNPSKQNGSKFHFSWNESEDTLSGYDPIVSTRAIDLLWKGKTPKNAAESSYMGKHWTEKSLHEMNERDWRILKEDYAIVTKGGTVENPLRNWEELNIIPRDLLRVIIQELRFPSPTPIQRITIPNVCNMKQY--- 214   
MAK5   66   KKDSKVLKDSNKEKVGDDQESVENESGSDSESELLEFKNLDDIKEGELSAASYSSSDEDEQGNIESSKLTDPSEDVDEDVDEDVLKENVFNKDINIDDISPVNLPEWTNLAP-LSMTILQSLQNLNFLRPTEIQKKSIP---VIMQG--- 208   
DBP7   39   MKMKLEGKTVSRKRKANTTGDEGIIPGRGENSIKKLHKESSYSSEEQEKYKGRNAHNTQGRTLPADSQFVSSLFTSNREITTAVNTNIHDENVAINPSNAPLKGDQFASLG-VSSLLVSHLEQKMRIKKPTSIQKQAIP--QIIGNAGK- 184   
DBP10  33   ALNDSESDANDSDSEVEADYGPNDVQDVIEYSSDEEEGVNNKKKAENKDIKKKKNSKKEIAAFPMLEMSDDENNASGKTQTGDDEDDVNEYFSTNNLEKTKHKKGSFPSFG--LSKIVLNNIKRKGFRQPTPIQRKTIP---LILQS--- 174   
MRH4   22   GVRSYAGGPRTKHKGNSPLASVPTGSSNKNRKQKAKGKKGNKKNDPDQAFNFGEYGGLKKDVEMNMDSTNKLIQKISN--------------FDQLLILPPVRDAVKEIISKESLKLQDSRKKTSENIIPSPIQTVAIKRISKNLMDP-- 155   
MS116  19   LLAALSNCNHITWAVSRRLYNDGNRDQRNFGRNQRNNNSNRYRNSRFNSRPRTRSREDDDEVHFDKTTFSKLIHVP------------------KEDNSKEVTLDSLLEEG-VLDKEIHKAITRMEFPGLTPVQQKTIK---PILSSED- 145   
RRP3   1    --------MSKIVKRKEKKANDELTSLAEKIRAKALENQKKLIEAEKEGGSESDSEEDATAEKKKVLKSKSKSTVSTQNENT----------------NEDESFESFSELN--LVPELIQACKNLNYSKPTPIQSKAIP---PALEG--- 118   
DBP4   1    -----------------------------------MAK-KNRLNTTQRKTLRQKEDEYIENLKTKIDEYDPK----------------------------ITKAKFFKDLP--ISDPTLKGLRESSFIKLTEIQADSIP---VSLQG--- 78    
HAS1   1    -----------------------------------MATPSNKRSRDSESTEEPVVDEKSTSKQNNAAPEGEQ----------------------------TTCVEKFEELK--LSQPTLKAIEKMGFTTMTSVQARTIP---PLLAG--- 79    
DHH1   1    ------------------------------------------MGSINNNFNTNNNSNTDLDRDWKTALNIPKKDT-----------------RPQTDDVLNTKGNTFEDFY--LKRELLMGIFEAGFEKPSPIQEEAIP---VAITG--- 83    
SUB2   1    -------------------------------------------MSHEGEEDLLEYSDNEQEIQIDASKAAEAGETGAATSATEGDNNNNTAAGDKKGSYVGIHSTGFKDFL--LKPELSRAIIDCGFEHPSEVQQHTIP---QSIHG--- 99    
IF4A   1    ---------------------------------------------------MSEGITDIEESQIQTN--------------------------------YDKVVYKFDDME--LDENLLRGVFGYGFEEPSAIQQRAIM---PIIEG--- 59    
FAL1   1    ---------------------------------------------------MSFDREEDQKLKFKTSK-------------------------------KLKVSSTFESMN--LKDDLLRGIYSYGFEAPSSIQSRAIT---QIISG--- 60    
IF4A   1    ---------------------------------------------------MSEGITDIEESQIQTN--------------------------------YDKVVYKFDDME--LDENLLRGVFGYGFEEPSAIQQRAIM---PIIEG--- 59    
DBP9   1    ----------------------------------------------------MSYEKKSVEG------------------------------------AYIDDSTTFEAFH--LDSRLLQAIKNIGFQYPTLIQSHAIP---LALQQK-- 55    
SPB4   1    ----------------------------------------------------------------------------------------------------MSKSLEWDNLGFSLLPWIRTGLDVMGFETMTPVQASTIP----MLAGN-- 44    
DBP8   1    -------------------------------------------------------------------------------------------------------MADFKSLG--LSKWLTESLRAMKITQPTAIQKACIP---KILEG--- 39    
                 Q motif     
                    310       320       330       340       350       360       370       380       390       400       410       420       430       440       450               
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            ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
DBP5   131  ----------RNMIAQSQSGTGKTAAFSLTMLTRVN---------------PEDASPQAICLAPSRELARQTLEVVQEMG-----KFT------KITSQ--LIVPDSFEKNKQ--INAQVIVGTPGTVLDLMRRKLMQ-----LQKIKIF 236   
PRP5   293  ----------RDVIGISKTGSGKTISYLLPLLRQVKAQRP---------LSKHETGPMGLILAPTRELALQIHEEVTKFT-----EADTSIRSVCCTGG--SEMKKQITDLKRG---TEIVVATPGRFIDILTLNDGK--LLSTKRITFV 412   
DRS1   268  ----------KDIIAGAVTGSGKTAAFMIPIIERLL-YKP-----------AKIASTRVIVLLPTRELAIQVADVGKQIA-----RFVSGITFGLAVGG--LNLRQQEQMLKSR---PDIVIATPGRFIDHIRNSAS----FNVDSVEIL 382   
DED1   179  ----------RDLMACAQTGSGKTGGFLFPVLSESFKTGPSPQPESQGSFYQRKAYPTAVIMAPTRELATQIFDEAKKFT------YRSWVKACVVYGG--SPIGNQLREIERG---CDLLVATPGRLNDLLERGKIS-----LANVKYL 303   
DBP6   218  VSKRNFTRRIGDILVNAATGSGKTLAYSIPIVQTLFKR--------------QINRLRCIIIVPTKLLINQVYTTLTKLTQG-----TSLIVSIAKLEN---SLKDEHKKLSNL--EPDILITTPGRLVDHLNMKSIN-----LKNLKFL 338   
DBP2   150  ----------RDMVGIAATGSGKTLSYCLPGIVHIN----------AQPLLAPGDGPIVLVLAPTRELAVQIQTECSKFG------HSSRIRNTCVYGG--VPKSQQIRDLSRG---SEIVIATPGRLIDMLEIGKTN-----LKRVTYL 264   
DBP1   191  ----------RDLMACAQTGSGKTGGFLFPLFTELFRSGPSPVPEKAQSFYSRKGYPSALVLAPTRELATQIFEEARKFT------YRSWVRPCVVYGG--APIGNQMREVDRG---CDLLVATPGRLNDLLERGKVS-----LANIKYL 315   
DBP3   149  ----------KDVVGVAETGSGKTFAFGVPAISHLMND-------------QKKRGIQVLVISPTRELASQIYDNLIVLT------DKVGMQCCCVYGG--VPKDEQRIQLKK----SQVVVATPGRLLDLLQEGSVD-----LSQVNYL 259   
PRP28  214  ----------RDFLGVASTGSGKTLAFVIPILIKMSRSPP------RPPSLKIIDGPKALILAPTRELVQQIQKETQKVTKIWSKESNYDCKVISIVGG--HSLEEISFSLSEG---CDILVATPGRLIDSLENHLLV-----MKQVETL 338   
MAK5   208  ----------VDVMGKASTGSGKTLAYGIPIVEKLISNFS-----------QKNKKPISLIFTPTRELAHQVTDHLKKICEP--VLAKSQYSILSLTGG--LSIQKQQRLLKYD-NSGQIVIATPGRFLELLEKDNTLI-KR-FSKVNTL 330   
DBP7   184  ----------NDFFIHAQTGSGKTLSYLLPIISTILNMDT---------HVDRTSGAFALVIAPTRELASQIYHVCSTLVS-----CCHYLVPCLLIGG--ERKKSEKARLRKG---CNFIIGTPGRVLDHLQNTKVIK-EQLSQSLRYI 304   
DBP10  174  ----------RDIVGMARTGSGKTAAFILPMVEKLKSHSG-------------KIGARAVILSPSRELAMQTFNVFKDFAR------GTELRSVLLTGG--DSLEEQFGMMMTN---PDVIIATPGRFLHLKVEMNLD-----LKSVEYV 285   
MRH4   155  --------KLQIHAIAAETGSGKTMAYLIPLIDYLKRQELETP--ELWETLRKNVLIRSIILVPTHELVDQVYETVSKTK--------TLLGLNSFKWDKATSYRDLLENIKNR---IDILVTTPGKLLNLFSIRMITRPDKVLSKVGFV 284   
MS116  145  ----------HDVIARAKTGTGKTFAFLIPIFQHLINTKF-----------DSQYMVKAVIVAPTRDLALQIEAEVKKIHDMN--YGLKKYACVSLVGG--TDFRAAMNKMNKLR--PNIVIATPGRLIDVLEKYSNK----FFRFVDYK 264   
RRP3   118  ----------HDIIGLAQTGSGKTAAFAIPILNRLW-HDQ-----------EPYYA---CILAPTRELAQQIKETFDSLG-----SLMG-VRSTCIVGG--MNMMDQARDLMRK---PHIIIATPGRLMDHLENTKG----FSLRKLKFL 228   
DBP4   78   ----------HDVLAAAKTGSGKTLAFLVPVIEKLYREKW-----------TEFDGLGALIISPTRELAMQIYEVLTKIG-----SHTS-FSAGLVIGG--KDVKFELERISR----INILIGTPGRILQHLDQAVG----LNTSNLQML 191   
HAS1   79   ----------RDVLGAAKTGSGKTLAFLIPAIELLHSLKF-----------KPRNGTGIIVITPTRELALQIFGVARELM-----EFHS-QTFGIVIGG--ANRRQEAEKLMKG---VNMLIATPGRLLDHLQNTKG----FVFKNLKAL 193   
DHH1   83   ----------RDILARAKNGTGKTAAFVIPTLEKVK---------------PKLNKIQALIMVPTRELALQTSQVVRTLG-----KHC-GISCMVTTGG--TNLRDDILRLN---ETVHILVGTPGRVLDLASRKVAD-----LSDCSLF 192   
SUB2   99   ----------TDVLCQAKSGLGKTAVFVLSTLQQLD---------------PVPGEVAVVVICNARELAYQIRNEYLRFS-----KYMPDVKTAVFYGG--TPISKDAELLKNKDTAPHIVVATPGRLKALVREKYID-----LSHVKNF 212   
IF4A   59   ----------HDVLAQAQSGTGKTGTFSIAALQRID---------------TSVKAPQALMLAPTRELALQIQKVVMALA-----FHM-DIKVHACIGG--TSFVEDAEGLR----DAQIVVGTPGRVFDNIQRRRFR-----TDKIKMF 167   
FAL1   60   ----------KDVIAQAQSGTGKTATFTIGLLQAID---------------LRKKDLQALILSPTRELASQIGQVVKNLG-----DYM-NVNAFAITGG--KTLKDDLKKMQK--HGCQAVSGTPGRVLDMIKKQMLQ-----TRNVQML 170   
IF4A   59   ----------HDVLAQAQSGTGKTGTFSIAALQRID---------------TSVKAPQALMLAPTRELALQIQKVVMALA-----FHM-DIKVHACIGG--TSFVEDAEGLR----DAQIVVGTPGRVFDNIQRRRFR-----TDKIKMF 167   
DBP9   55   ----------RDIIAKAATGSGKTLAYLIPVIETILEYKKTID-------NGEENGTLGIILVPTRELAQQVYNVLEKLVLY----CSKDIRTLNISSD--MSDSVLSTLLMDQ---PEIIVGTPGKLLDLLQTKINS---ISLNELKFL 176   
SPB4   44   ----------KDVVVDSVTGSGKTAAFVIPVLEKVVKEEAN-------TSKFKKAHFHSLIIAPTRELSRQIESVVLSFLEHYP-SDLFPIKCQLLVGTNEATVRDDVSNFLRN--RPQILIGTPGRVLDFLQMPAVK-----TSACSMV 169   
DBP8   39   ----------RDCIGGAKTGSGKTIAFAGPMLTKWS-EDP-----------SGMFG---VVLTPTRELAMQIAEQFTALG-----SSMN-IRVSVIVGG--ESIVQQALDLQRK---PHFIIATPGRLAHHIMSSGDDT-VGGLMRAKYL 152   
       Motif I     Motif Ia    GG   Motif Ib 
 
                    460       470       480       490       500       510       520       530       540       550       560       570       580       590       600               
            ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
DBP5   237  VLDEADNMLDQQ-GLGDQCIRVKRFLP-------------KDTQLVLFSATFADAVRQYAKKIVPNANTLELQ-TNEVNVDA------------------IKQLYMDCKNEADKFDV--------------------------------- 320   
PRP5   413  VMDEADRLFDLG--FEPQITQIMKTVR-------------PDKQCVLFSATFPNKLRSFAVRVLHSPISITINSKGMVNENVKQKFRICHSEDE-----KFDNLVQLIHERSEFFDEVQSE----------------------------- 513   
DRS1   383  VMDEADRMLEEG--FQDELNEIMGLLP-------------SNRQNLLFSATMNSKIKSLVSLSLKKPVRIMIDPPKKAAT------KL-----------TQEFVRIRKRDHLKPALL--------------------------------- 467   
DED1   304  VLDEADRMLDMG--FEPQIRHIVEDCDMTPV---------GERQTLMFSATFPADIQHLARDFLSDYIFLSVGRVG-STSEN------------------ITQKVLYVENQDKKSAL--------------------------------- 390   
DBP6   339  IIDEADRLLNQS--FQGWCPKLMSHLKTDKLDTLP-----GNVIKMIFSATLTTNTEKLNGLNLYKPKLFLKQTDKLYQLPN-----------------KLNEFNINIPTAKSVYKPLILLYS--------------------------- 437   
DBP2   265  VLDEADRMLDMG--FEPQIRKIVDQIRP-------------DRQTLMWSATWPKEVKQLAADYLNDPIQVQVGSLELSASHN------------------ITQIVEVVSDFEKRDRLNK------------------------------- 350   
DBP1   316  VLDEADRMLDMG--FEPQIRHIVEECDMPSV---------ENRQTLMFSATFPVDIQHLARDFLDNYIFLSVGRVG-STSEN------------------ITQRILYVDDMDKKSAL--------------------------------- 402   
DBP3   260  VLDEADRMLEKG--FEEDIKNIIRETDAS------------KRQTLMFTATWPKEVRELASTFMNNPIKVSIGNTDQLTANKR-----------------ITQIVEVVDPRGKERKLLE------------------------------- 347   
PRP28  339  VLDEADKMIDLG--FEDQVTNILTKVDINADS-------AVNRQTLMFTATMTPVIEKIAAGYMQKPVYATIGVET--GSEPL-----------------IQQVVEYADNDEDKFKK--------------------------------- 427   
MAK5   331  ILDEADRLLQDG-HFDEFEKIIKHLLVERRKNRENSEGSSKIWQTLIFSATFSIDLFDKLSSSRQVKDRRFKNNEDELNAVIQHLMSKIHFN--------SKPVIIDTNPESKVSSQIKESLIECPPLER-------------------- 451   
DBP7   305  VLDEGDKLMELG--FDETISEIIKIVHDIPINSEKFPKLPHKLVHMLCSATLTDGVNRLRNVALKDYKLISNGTKKDSDIVTVAP-------------DQLLQRITIVPPKLRLVTLAATLNN-------------------------IT 414   
DBP10  286  VFDEADRLFEMG--FQEQLNELLASLP-------------TTRQTLLFSATLPNSLVDFVKAGLVNPVLVRLDAETKVSENLEMLFLSSKNADREANLLYILQEIIKIPLATSEQLQKLQNSNNEADSDSDDENDRQKKRRNFKKEKFRK 420   
MRH4   285  VLDEADTLLDRS--WLEETHSAIKRIP-------------NINHLIFCSATIPQEFNKTMQRLFPTVVPIMTPRLHKLPFALDFK--------------VINSALSPFKGSKIKALAQTLY----------------------------- 376   
MS116  265  VLDEADRLLEIG--FRDDLETISGILNEKNSKS------ADNIKTLLFSATLDDKVQKLANNIMNKKECLFLDTVDKNEPEAHER---------------IDQSVVISEKFANSIFAAVEH----------------------------- 362   
RRP3   229  VMDEADRLLDME--FGPVLDRILKIIP-T-----------QERTTYLFSATMTSKIDKLQRASLTNPVKCAVSNKYQTVD-------------------TLVQTLMVVPGGLKNTYL--------------------------------- 312   
DBP4   192  VLDEADRCLDMG--FKKTLDAIVSTLS-------------PSRQTLLFSATQSQSVADLARLSLTDYKTVGTHDVMDGSVNKEASTPE-----------TLQQFYIEVPLADKLDIL--------------------------------- 282   
HAS1   194  IIDEADRILEIG--FEDEMRQIIKILPN------------EDRQSMLFSATQTTKVEDLARISLRPGPLF-----INVVPETDNSTAD-----------GLEQGYVVCDSDKRFLLL--------------------------------- 280   
DHH1   193  IMDEADKMLSR--DFKTIIEQILSFLP-------------PTHQSLLFSATFPLTVKEFMVKHLHKPYEINL--MEELTLKG------------------ITQYYAFVE-ERQKLHC--------------------------------- 273   
SUB2   213  VIDECDKVLEEL-DMRRDVQEIFRATP-------------RDKQVMMFSATLSQEIRPICRRFLQNPLEIFVDDEAKLTLHG------------------LQQYYIKLE-EREKNRK--------------------------------- 296   
IF4A   168  ILDEADEMLSS--GFKEQIYQIFTLLP-------------PTTQVVLLSATMPNDVLEVTTKFMRNPVRILVK-KDELTLEG------------------IKQFYVNVEEEEYKYEC--------------------------------- 250   
FAL1   171  VLDEADELLSETLGFKQQIYDIFAKLP-------------KNCQVVVVSATMNKDILEVTRKFMNDPVKILVK-RDEISLEG------------------IKQYVVNVDKEEWKFDT--------------------------------- 255   
IF4A   168  ILDEADEMLSS--GFKEQIYQIFTLLP-------------PTTQVVLLSATMPNDVLEVTTKFMRNPVRILVK-KDELTLEG------------------IKQFYVNVEEEEYKYEC--------------------------------- 250   
DBP9   177  VVDEVDLVLTFG--YQDDLNKIGEYLPLK-----------KNLQTFLMSATLNDDIQALKQKFCRSPAILKFNDEEINKNQNK-----------------LLQYYVKVSEFDKFLLC--------------------------------- 263   
SPB4   170  VMDEADRLLDMS--FIKDTEKILRLLP-------------KQRRTGLFSATMRSAGSDIFKTGLRNPVRITVNSKNQAPSS-------------------LKLNYCVVNPAEKLQLL--------------------------------- 252   
DBP8   153  VLDEADILLTST--FADHLATCISALPPK-----------DKRQTLLFTATITDQVKSLQNAPVQKGKPPLFAYQVESVDNVAI--PS-----------TLKIEYILVPEHVKEAYL--------------------------------- 243   
             Motif II           Motif III      
   610       620       630       640       650       660       670       680       690       700       710       720       730       740       750               
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Appendix 
109 
DBP5   321  LTELYGLMTIG--SSIIFVATKKTANVLYGKLK-SEG------------------------------HEVSILHGDLQTQERDRLIDDFR----------------EGRSKVLITTN--------------------------------- 388   
PRP5   514  NDGQSSDVEEVDAKAIIFVSSQNICDFISKKLL-NAG------------------------------IVTCAIHAGKPYQERLMNLEKFK----------------REKNSILLCTE--------------------------------- 583   
DRS1   468  FNLIRKLDPTGQKRIVVFVARKETAHRLRIIMG-LLG------------------------------MSVGELHGSLTQEQRLDSVNKFK----------------NLEVPVLICTD--------------------------------- 537   
DED1   390  -LDLLSA--STDGLTLIFVETKRMADQLTDFLI-MQN------------------------------FRATAIHGDRTQSERERALAAFR----------------SGAATLLVATA--------------------------------- 457   
DBP6   437  -ICQFMAHSPIAAKILIFVKSNESSIRLSKLLQLICESRSQSSVLKN---------------LQNLAVSINSVNSNNSKAENKKIVANFSHHS------------ESAGITILITTD--------------------------------- 526   
DBP2   351  YLETASQ--DNEYKTLIFASTKRMCDDITKYLR-EDG------------------------------WPALAIHGDKDQRERDWVLQEFR----------------NGRSPIMVATD--------------------------------- 418   
DBP1   402  -LDLLSA--EHKGLTLIFVETKRMADQLTDFLI-MQN------------------------------FKATAIHGDRTQAERERALSAFK----------------ANVADILVATA--------------------------------- 469   
DBP3   348  LLKKYHSGPKKNEKVLIFALYKKEAARVERNLK-YNG------------------------------YNVAAIHGDLSQQQRTQALNEFK----------------SGKSNLLLATD--------------------------------- 417   
PRP28  427  -LKPIVA--KYDPPIIIFINYKQTADWLAEKFQ-KETN-----------------------------MKVTILHGSKSQEQREHSLQLFR----------------TNKVQIMIATN--------------------------------- 495   
MAK5   452  DLYCYYFLTMFPGTTLIFCNAIDSVKKLTVYLN-NLG------------------------------IPAFQIHSSMTQKNRLKSLERFKQQSAKQKTINHSNPDSVQLSTVLIASD--------------------------------- 537   
DBP7   415  KDFIASGQQSKTLRTIVFVSCSDSVEFHYDAFSGSDGHHKNLTGDSVRLLTKGNTMFPCFSDSRDPDVVIYKLHGSLSQQMRTSTLQHFARD----------NEATKGKHLIMFCTD--------------------------------- 521   
DBP10  421  QKMPAANELPSEKATILFVPTRHHVEYISQLLR-DCG------------------------------YLISYIYGTLDQHARKRQLYNFR----------------AGLTSILVVTD--------------------------------- 490   
MRH4   377  AISNDDTEPGFEKRCIIFVNEKKNVPEIVNLLNKKFG------------------------------HNAIGLTGEDTFEERSEKIMPFLSPP-------------RPLSEVVAQSTSP------------------------------- 452   
MS116  362  -IKKQIKERDSNYKAIIFAPTVKFTSFLCSILKNEFKK----------------------------DLPILEFHGKITQNKRTSLVKRFK----------------KDESGILVCTD--------------------------------- 434   
RRP3   313  IYLLN--EFIG-KTMIIFTRTKANAERLSGLCN-LLE------------------------------FSATALHGDLNQNQRMGSLDLFK----------------AGKRSILVATD--------------------------------- 379   
DBP4   283  FSFIKSHLKCK---MIVFLSSSKQVHFVYETFR-KMQP----------------------------GISLMHLHGRQKQRARTETLDKFN----------------RAQQVCLFATD--------------------------------- 351   
HAS1   281  FSFLKRNQKKK---IIVFLSSCNSVKYYAELLN-YID------------------------------LPVLELHGKQKQQKRTNTFFEFC----------------NAERGILICTD--------------------------------- 347   
DHH1   274  LNTLFSKLQIN--QAIIFCNSTNRVELLAKKIT-DLG------------------------------YSCYYSHARMKQQERNKVFHEFR----------------QGKVRTLVCSD--------------------------------- 341   
SUB2   297  LAQLLDDLEFN--QVIIFVKSTTRANELTKLLN-ASN------------------------------FPAITVHGHMKQEERIARYKAFK----------------DFEKRICVSTD--------------------------------- 364   
IF4A   251  LTDLYDSISVT--QAVIFCNTRRKVEELTTKLR-NDK------------------------------FTVSAIYSDLPQQERDTIMKEFR----------------SGSSRILISTD--------------------------------- 318   
FAL1   256  LCDIYDSLTIT--QCVIFCNTKKKVDWLSQRLI-QSN------------------------------FAVVSMHGDMKQEERDKVMNDFR----------------TGHSRVLISTD--------------------------------- 323   
IF4A   251  LTDLYDSISVT--QAVIFCNTRRKVEELTTKLR-NDK------------------------------FTVSAIYSDLPQQERDTIMKEFR----------------SGSSRILISTD--------------------------------- 318   
DBP9   263  --YVIFKLNLIKGKTLIFVNNIDRGYRLKLVME-QFG------------------------------IKSCILNSELPVNSRQHIVDQFN----------------KNVYQLLIATDDTEYIKEEDDEIEEGHNTENQEEKSLEGEPEND 364   
SPB4   252  ---VSILNNYKFKKCIVYFPTCVSVSYFYSFIQYLGKRNILVN-----------------------EVEIFSLHGKLQTSARTKTLTAFT----------------DSLSNSVLFTT--------------------------------- 327   
DBP8   244  YQLLTCEEYEN-KTAIIFVNRTMTAEILRRTLK-QLE------------------------------VRVASLHSQMPQQERTNSLHRFR----------------ANAARILIATD--------------------------------- 312   
   Motif IV             QxxR 
 
                    760       770       780       790       800       810       820       830       840       850       860       870       880       890       900               
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DBP5   388  -----------------VLARGIDIPTVSMVVNYDLPTLANGQADPATYIHRIGRTGRFGR-KGVAISFVHDKNSFN------ILSAIQKYFGDIEMTRVP----TDDWDEVEKIVKKVLKD---------------------------- 482   
PRP5   583  -----------------VLSRGLNVPEVSLVIIYNAVKTFA------QYVHTTGRTARGSR-SGTAITLLLHDELSGAYILSKAMRDEEIKALDPLQAKELQEMSAKFESGMKKGKFRLSKGFGGKGLENIKSKREEAQNKDLELKKNDK 709   
DRS1   537  -----------------LASRGLDIPKIEVVINYDMPKSYE------IYLHRVGRTARAGR-EGRSVTFVGESSQDRSIVR-AAIKSVEENKSLT-QGKAL----GRNVDWVQIEETNKLVESMNDTIEDILVEEKEEKEILRAEMQLRK 657   
DED1   457  -----------------VAARGLDIPNVTHVINYDLPSDVD------DYVHRIGRTGRAGN-TGLATAFFNSE-NSNIVK---GLHEILTEANQEVPSFLK----DAMMS-APGSRSNSRRGGFGRNNN--RDYRKAGGASAGGWGSSRS 572   
DBP6   526  -----------------IMSRGIDINDITQVINYDPPMSSQ------QYVHRVGRTARANE-LGSAYNLLVGRGERT------FFDDLNKDLDRDGKSVQP------LELDFTLLESDSELYTSSLESLKNYHNNTAQA----------- 629   
DBP2   418  -----------------VAARGIDVKGINYVINYDMPGNIE------DYVHRIGRTGRAGA-TGTAISFFTEQ-NKGLGA---KLISIMREANQNIPPELL----KYDRRSYGGGHPRYGGGRGGRGGYG-RRGGYGGGR--GGYGGNRQ 533   
DBP1   469  -----------------VAARGLDIPNVTHVINYDLPSDID------DYVHRIGRTGRAGN-TGVATSFFNSN-NQNIVK---GLMEILNEANQEVPTFLS----DLSRQNSRGGRTRGGGGFFNSRNNGSRDYRKHGGN--GSFGSTRP 585   
DBP3   417  -----------------VAARGLDIPNVKTVINLTFPLTVE------DYVHRIGRTGRAGQ-TGTAHTLFTEQ-EKHLAG---GLVNVLNGANQPVPEDLI----KFGTHTKKKEHSAYG--SFFKDVDLTKKPKKITFD---------- 523   
PRP28  495  -----------------VAARGLDIPNVSLVVNFQISKKMD------DYIHRIGRTGRAAN-EGTAVSFVSAAEDESLIR---ELYKYVRKHDPLNSNIFS----EAVKNKYNVGKQLSNEIIY-------------------------- 588   
MAK5   537  -----------------VAARGLDIPGVQHVIHYHLPRSTD------IYIHRSGRTARAGS-EGVSAMICSPQESMGPLRKLRKTLATKNSVSTDLNSRSTNRKPIKWQNTVPLLPIETDILSQLRERSRLAGELADHEIASNSLRKDDN 663   
DBP7   521  -----------------VASRGLDLPHVGSVIELDPPFAVE------DHLHRVGRTARAGE-KGESLLFLLPGEEEKYMDYIQPYHPMGWELLKFDKEILMPAFKDVNVNRNDKFIRKDEKSSKNKDVGDKEYEWDTNATTWHLNIERRV 647   
DBP10  490  -----------------VAARGVDIPMLANVINYTLPGSSK------IFVHRVGRTARAGN-KGWAYSIVAENELPYLLDL-ELFLGKKILLTPMYDSLVD----VMKKRWIDEGKPEYQFQPPKLSYTKRLVLGSCPRLDVEGLGDLYK 611   
MRH4   452  ----------------PTSLKKFEIPDSNIVIGKLKNTNSN------------GTAPSNKSLHVLVTTDLMARGLNFKGVRNVVLYDVPKTSIDLIHRVGR------TARMKQGGRVFMLTDSKTKSWAKALPKIIKKHQRLS------- 561   
MS116  434  -----------------VGARGMDFPNVHEVLQIGVPSELAN------YIHRIGRTARSGK-EGSSVLFICKDELPFVREL-EDAKNIVIAKQEKYEPSEE----IKSEVLEAVTEEPEDISDIVISLISSYRSCIKEYRFSERRILPEI 555   
RRP3   379  -----------------VAARGLDIPSVDIVVNYDIPVDSK------SYIHRVGRTARAGR-SGKSISLVSQYDLEL-------ILRIEEV-----LGKKL----PKE--SVDKNIILTLRDSVDKANGEVVMEMNRRNKEKIARGKGRR 487   
DBP4   351  -----------------VVARGIDFPAVDWVVQVDCPEDVD------TYIHRVGRCARYGK-KGKSLIMLTPQEQEAFLKR-LNARKIEPGKLNIKQSKKK----SIKPQLQSLLFKDPELKYLGQKAFISYVRSIYVQKDKQVFKFDEL 472   
HAS1   347  -----------------VAARGLDIPAVDWIIQFDPPDDPR------DYIHRVGRTARGTKGKGKSLMFLTPN-ELGFLRY-LKASKVPLNEYEFPENKIA----NVQSQLEKLIKSNYYLHQTAKDGYRSYLQAYASHSLKTVYQIDKL 468   
DHH1   341  -----------------LLTRGIDIQAVNVVINFDFPKTAE------TYLHRIGRSGRFGH-LGLAINLIN-WNDRF------NLYKIEQEL-GTEIAAIP----ATIDKSLYVAENDETVPVPFPIEQQSYHQQAIPQQQLPSQQQFAI 455   
SUB2   364  -----------------VFGRGIDIERINLAINYDLTNEAD------QYLHRVGRAGRFGT-KGLAISFVSSKEDEE------VLAKIQERF-DVKIAEFP----EEGIDPSTYLNN--------------------------------- 446   
IF4A   318  -----------------LLARGIDVQQVSLVINYDLPANKE------NYIHRIGRGGRFGR-KGVAINFVT-NEDVG------AMRELEKFY-STQIEELP----SDIATLLN------------------------------------- 395   
FAL1   323  -----------------VWARGIDVQQVSLVINYDLPEIIE------NYIHRIGRSGRFGR-KGVAINFIT-KADLA------KLREIEKFY-SIKINPMP----ANFAELS-------------------------------------- 399   
IF4A   318  -----------------LLARGIDVQQVSLVINYDLPANKE------NYIHRIGRGGRFGR-KGVAINFVT-NEDVG------AMRELEKFY-STQIEELP----SDIATLLN------------------------------------- 395   
DBP9   365  KKPSKKKKVQVKKDKEYGVSRGVDFKNVACVLNFDLPTTAK------SYVHRVGRTARGGK-TGTAISFVVPLKEFGKHKP--SMLQTAKKDERILSRIIK----QQSKLGLELQPYKFDQKQVEAFRYRMEDGFRAVTQVAIREARVKE 501   
SPB4   327  ----------------DVAARGIDIPDVDLVIQLDPPTNTD------MFMHRCGRTGRANR-VGKAITFLNEGREEDFIPF-MQVKNVELEELDLEVKGITTNFYEDFRNWILEDRDRFDKGVKAYVAFIKYYSNHSATSIFRLQSLDYV 453   
DBP8   312  -----------------VASRGLDIPTVELVVNYDIPSDPD------VFIHRSGRTARAGR-IGDAISFVTQRDVSR-------IQAIEDR-----INKKM----TETNKVHDTAVIRKALTKVTKAKRESLMAMQ---KENFGERK-RQ 418   
                      Motif V      Motif VI 
 
                    910       920       930       940       950       960       970       980       990       1000      1010      1020      1030      1040      1050              
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DBP5   482  ------------------------------------------------------------------------------------------------------------------------------------------------------ 482   
PRP5   710  RSDDLEKKISNPREGHDSVSESSALIPRLNYELFKESTDGSIIFYAKVYINDLPQIVRWEATKNTTLLFIKHETGCSITNKGKFYPEGKEPKNENDEPKLYLLIEGQDEKDIQLSIELLEQKVKEGVVKAASLSLKSTKY---------- 849   
DRS1   658  GENMLKHKKEIQARPRRTWFQSESDKKNSKVLG----------------ALSRNKKVTNSKKRKREEAKADGNGARSYRKTKTDRIADQERTFKKQKSTNSNKKKGFKSRR--------------------------------------- 752   
DED1   573  RDN--SFRG--GSGWGSDSKSSGWGNSGGSNNSSWW------------------------------------------------------------------------------------------------------------------ 604   
DBP6   629  ------------------------------------------------------------------------------------------------------------------------------------------------------ 629   
DBP2   534  RDG----------GWGNRGRSNY------------------------------------------------------------------------------------------------------------------------------- 546   
DBP1   586  RNTGTSNWGSIGGGFRNDNEKNGYGNS----NASWW------------------------------------------------------------------------------------------------------------------ 617   
DBP3   523  ------------------------------------------------------------------------------------------------------------------------------------------------------ 523   
PRP28  588  ------------------------------------------------------------------------------------------------------------------------------------------------------ 588   
MAK5   664  WLKKAADELGIDVDSDEDDISKSNSDTFLLKNKNKKMQKTINKDKVKAMRATLNELLSVPIRKDRRQKYLTGGLVNLADNLVKKRGHNSIIGHEKTNALETLKKKKKRNN---------------------------------------- 773   
DBP7   648  VGDSAFKNLAVKGFISHVRAYATHISQEKKFFNVKFLHLGHLAKSFGLRERPKAMGLQSSKDGNSEKKPTKENSKNKMFRMARMAEKQIASEFNY------------------------------------------------------- 742   
DBP10  612  NLMSSNFDLQLAKKTAMKAEKLYYRTRTSASPESLKRSKEIISSGWDAQNAFFGKNEEKEKLDFLAKLQNRRNKETVFEFTRNPDDEMAVFMKRRRKQLAPIQRKATERRELLEKERMAGLHILSKMKFWKGDDVETGYTVSEDALKEFE 761   
MRH4   561  ------------------------------------------------------------------------------------------------------------------------------------------------------ 561   
MS116  556  ASTYGVLLNDPQLKIPVSRRFLDKLGLSRSPIGKAMFEIRDYSSRDGNNKSYDYDDDSEISFRGNKNYNNRSQNRDYDDEPFRRSNNNRRSFSRSNDKNNYSSRNSNIY----------------------------------------- 664   
RRP3   488  GRMMTRENMDMGER---------------------------------------------------------------------------------------------------------------------------------------- 501   
DBP4   473  PTEEFAYSLGLPGAPKIKMKGMKTIEQAKERKNAPRQLAFLSKANEDGEVIEDKSKQPRTKYDKMFERKNQTILSEHYLNITKAQAQEDEDDDFISVKRKDHEINEAELPALTLPTSRR----AQKKALSKKASLASKGNASKLIFDDEG 618   
HAS1   469  DLAKVAKSYGFPVPPKVNIT------------------------------IGASGKTPNTK------------------------------------RRKTHK----------------------------------------------- 505   
DHH1   456  PPQQHHPQFMVPPSHQQQQAYPPPQMPSQQGYPPQQEHFMAMPPGQSQPQY--------------------------------------------------------------------------------------------------- 506   
SUB2   446  ------------------------------------------------------------------------------------------------------------------------------------------------------ 446   
IF4A   395  ------------------------------------------------------------------------------------------------------------------------------------------------------ 395   
FAL1   399  ------------------------------------------------------------------------------------------------------------------------------------------------------ 399   
IF4A   395  ------------------------------------------------------------------------------------------------------------------------------------------------------ 395   
DBP9   502  LKQELLASEKLKRHFEENPKELQSLRHDKELHPARVQQHLKRVPDYLLPESARGNGTKVKFVPFHNAKKRHSHKKGRVSKPKNGKVDPLKNFK--------------------------------------------------------- 594   
SPB4   454  GIAKLYGLFRLPRMPEITKYLATEKQEGIFPGNWLVDPPVNMDEYKYKDKKREKERQETLKNISLINDKKKLKSELKKKNLAWSDKTLTKERKLERKEKMSLKRKAIEEELKAEELDENAEEERIKEDWKEIVLQNKRKKVSSKAIQGNF 603   
DBP8   419  QKKKQNDGKSLRS----------------------------------------------------------------------------------------------------------------------------------------- 431   
 
 
                    1060      1070      1080      1090      1100      1110      1120      1130      1140      1150      1160      1170      1180      1190      1200              
            ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
DBP5   482  ------------------------------------------------------------------------------------------------------------------------------------------------------ 482   
PRP5   849  ------------------------------------------------------------------------------------------------------------------------------------------------------ 849   
DRS1   752  ------------------------------------------------------------------------------------------------------------------------------------------------------ 752   
DED1   604  ------------------------------------------------------------------------------------------------------------------------------------------------------ 604   
DBP6   629  ------------------------------------------------------------------------------------------------------------------------------------------------------ 629   
DBP2   546  ------------------------------------------------------------------------------------------------------------------------------------------------------ 546   
DBP1   617  ------------------------------------------------------------------------------------------------------------------------------------------------------ 617   
DBP3   523  ------------------------------------------------------------------------------------------------------------------------------------------------------ 523   
PRP28  588  ------------------------------------------------------------------------------------------------------------------------------------------------------ 588   
MAK5   773  ------------------------------------------------------------------------------------------------------------------------------------------------------ 773   
DBP7   742  ------------------------------------------------------------------------------------------------------------------------------------------------------ 742   
DBP10  762  DAHQLLEAQENENKKKKKPKSFKDPTFFLSHYAPAGDIQDKQLQITNGFANDAAQAAYDLNSDDKVQVHKQTATVKWDKKRKKYVNTQGIDNKKYIIGESGQKIAASFRSGRFDDWSKARNLKPLKVGSRETSIPSNLLEDPSQGPAANG 911   
MRH4   561  ------------------------------------------------------------------------------------------------------------------------------------------------------ 561   
MS116  664  ------------------------------------------------------------------------------------------------------------------------------------------------------ 664   
RRP3   501  ------------------------------------------------------------------------------------------------------------------------------------------------------ 501   
DBP4   619  EAHPVYELEDEEEFHKRGDAEVQKTEFLTKESAVMADIDNIDKQVAKEKKQEKKRKRLEAMRREMEAAMEEEISGDEEEGKTVAYLGTGNLSDDMSDGDMPDSEGHLKKKARTVDYSHGHNPSNSVDDDIIEVEEPQTLEDLESLTAKLI 768   
HAS1   505  ------------------------------------------------------------------------------------------------------------------------------------------------------ 505   
DHH1   506  ------------------------------------------------------------------------------------------------------------------------------------------------------ 506   
SUB2   446  ------------------------------------------------------------------------------------------------------------------------------------------------------ 446   
IF4A   395  ------------------------------------------------------------------------------------------------------------------------------------------------------ 395   
FAL1   399  ------------------------------------------------------------------------------------------------------------------------------------------------------ 399   
IF4A   395  ------------------------------------------------------------------------------------------------------------------------------------------------------ 395   
DBP9   594  ------------------------------------------------------------------------------------------------------------------------------------------------------ 594   
SPB4   604  DDL--------------------------------------------------------------------------------------------------------------------------------------------------- 606   
DBP8   431  ------------------------------------------------------------------------------------------------------------------------------------------------------ 431   
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DBP5   482  ------------------------------------------------------------------------------------ 482   
PRP5   849  ------------------------------------------------------------------------------------ 849   
DRS1   752  ------------------------------------------------------------------------------------ 752   
DED1   604  ------------------------------------------------------------------------------------ 604   
DBP6   629  ------------------------------------------------------------------------------------ 629   
DBP2   546  ------------------------------------------------------------------------------------ 546   
DBP1   617  ------------------------------------------------------------------------------------ 617   
DBP3   523  ------------------------------------------------------------------------------------ 523   
PRP28  588  ------------------------------------------------------------------------------------ 588   
MAK5   773  ------------------------------------------------------------------------------------ 773   
DBP7   742  ------------------------------------------------------------------------------------ 742   
DBP10  912  RTVRGKFKHKQMKAPKMPDKHRDNYYSQKKKVEKALQSGISVKGYNNAPGLRSELKSTEQIRKDRIIAEKKRAKNARPSKKRKF 995   
MRH4   561  ------------------------------------------------------------------------------------ 561   
MS116  664  ------------------------------------------------------------------------------------ 664   
RRP3   501  ------------------------------------------------------------------------------------ 501   
DBP4   769  QG---------------------------------------------------------------------------------- 770   
HAS1   505  ------------------------------------------------------------------------------------ 505   
DHH1   506  ------------------------------------------------------------------------------------ 506   
SUB2   446  ------------------------------------------------------------------------------------ 446   
IF4A   395  ------------------------------------------------------------------------------------ 395   
FAL1   399  ------------------------------------------------------------------------------------ 399   
IF4A   395  ------------------------------------------------------------------------------------ 395   
DBP9   594  ------------------------------------------------------------------------------------ 594   
SPB4   606  ------------------------------------------------------------------------------------ 606   
DBP8   431  ------------------------------------------------------------------------------------ 431   
 
  
Appendix 
112 
6.6 Suppliers 
Supplier Location Website 
Art Robbins Instruments Sunnyvale, USA http://www.artrobbinsinstruments.com 
Avestin Mannheim, Germany http://www.avestin.com/ 
Beckman Coulter Fullerton, USA http://www.beckman.com 
Biorad Hercules, USA http://www.bio-rad.com 
Dharmacon Lafayette, USA http://www.dharmacon.com 
Dynal Karlsruhe, Germany http://www.invitrogen.com/site/us/en/home/br
ands/Dynal.html 
Edmund Bühler Hechingen, Germany http://www.edmund-buehler.de/ 
Eppendorf Wesseling-Berzdorf, Germany http://www.eppendorf.de 
EUROSCARF Frankfurt, Germany http://web.uni-
frankfurt.de/fb15/mikro/euroscarf 
Finnzymes Espoo, Finland http://www.finnzymes.fi 
Fluka Hamburg, Germany http://www.sigmaaldrich.com/analytical-
chromatography.html 
GE Healthcare München, Germany http://www.gehealthcare.com 
Hampton  Aliso Viejo, USA http://hamptonresearch.com 
Invitrogen Karlsruhe, Germany http://www.invitrogen.com 
Jena Bioscience Jena, Germany http://www.jenabioscience.com 
Kühner Birsfelden, Switzerland http://www.kuhner.com 
Memert Schwabach , Germany http://www.memmert.com 
Molecular Dimensions Suffolk, UK http://www.moleculardimensions.com/ 
New England Biolabs Ipswich, USA http://www.neb.com 
Novagen San Diego, USA http://www.emdbiosciences.com/html/NVG/ 
Oxford Diffraction Oxfordshire, UK http://www.oxford-diffraction.com/ 
Packard Waltham, USA http://www.perkinelmer.de/ 
Peqlab Erlangen, Germany http://www.peqlab.de 
Promega Mannheim, Germany http://www.promega.com 
Qiagen Hilden, Germany http://www.qiagen.com 
Sartorius Goettingen, Germany http://www.sartorius.de 
Schott Mainz, Germany http://www.schott.com 
Sigma-Aldrich Hamburg, Germany http://www.sigmaaldrich.com 
Sorvall Waltham, USA http://www.thermo.com/com/cda/landingpage
/0,,128,00.html 
Stratagene La Jolla, USA http://www.stratagene.com 
SwissCI Zug, Switzerland http://www.swissci.com/ 
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6.7 Protein sequences 
Human Dbp5 (UniprotKB/Swiss-prot entry Q9UMR2) 
MATDSWALAVDEQEAAAESLSNLHLKEEKIKPDTNGAVVKTNANAEKTDEEEKEDRAAQSLLNKLIRSNLVDNTN
QVEVLQRDPNSPLYSVKSFEELRLKPQLLQGVYAMGFNRPSKIQENALPLMLAEPPQNLIAQSQSGTGKTAAFVL
AMLSQVEPANKYPQCLCLSPTYELALQTGKVIEQMGKFYPELKLAYAVRGNKLERGQKISEQIVIGTPGTVLDWC
SKLKFIDPKKIKVFVLDEADVMIATQGHQDQSIRIQRMLPRNCQMLLFSATFEDSVWKFAQKVVPDPNVIKLKRE
EETLDTIKQYYVLCSSRDEKFQALCNLYGAITIAQAMIFCHTRKTASWLAAELSKEGHQVALLSGEMMVEQRAAV
IERFREGKEKVLVTTNVCARGIDVEQVSVVINFDLPVDKDGNPDNETYLHRIGRTGRFGKRGLAVNMVDSKHSMN
ILNRIQEHFNKKIERLDTDDLDEIEKIAN 
Human Nup214 (UniprotKB/Swiss-prot entry P35658) 
MGDEMDAMIPEREMKDFQFRALKKVRIFDSPEELPKERSSLLAVSNKYGLVFAGGASGLQIFPTKNLLIQNKPGD
DPNKIVDKVQGLLVPMKFPIHHLALSCDNLTLSACMMSSEYGSIIAFFDVRTFSNEAKQQKRPFAYHKLLKDAGG
MVIDMKWNPTVPSMVAVCLADGSIAVLQVTETVKVCATLPSTVAVTSVCWSPKGKQLAVGKQNGTVVQYLPTLQE
KKVIPCPPFYESDHPVRVLDVLWIGTYVFAIVYAAADGTLETSPDVVMALLPKKEEKHPEIFVNFMEPCYGSCTE
RQHHYYLSYIEEWDLVLAASAASTEVSILARQSDQINWESWLLEDSSRAELPVTDKSDDSLPMGVVVDYTNQVEI
TISDEKTLPPAPVLMLLSTDGVLCPFYMINQNPGVKSLIKTPERLSLEGERQPKSPGSTPTTPTSSQAPQKLDAS
AAAAPASLPPSSPAAPIATFSLLPAGGAPTVFSFGSSSLKSSATVTGEPPSYSSGSDSSKAAPGPGPSTFSFVPP
SKASLAPTPAASPVAPSAASFSFGSSGFKPTLESTPVPSVSAPNIAMKPSFPPSTSAVKVNLSEKFTAAATSTPV
SSSQSAPPMSPFSSASKPAASGPLSHPTPLSAPPSSVPLKSSVLPSPSGRSAQGSSSPVPSMVQKSPRITPPAAK
PGSPQAKSLQPAVAEKQGHQWKDSDPVMAGIGEEIAHFQKELEELKARTSKACFQVGTSEEMKMLRTESDDLHTF
LLEIKETTESLHGDISSLKTTLLEGFAGVEEAREQNERNRDSGYLHLLYKRPLDPKSEAQLQEIRRLHQYVKFAV
QDVNDVLDLEWDQHLEQKKKQRHLLVPERETLFNTLANNREIINQQRKRLNHLVDSLQQLRLYKQTSLWSLSSAV
PSQSSIHSFDSDLESLCNALLKTTIESHTKSLPKVPAKLSPMKQAQLRNFLAKRKTPPVRSTAPASLSRSAFLSQ
RYYEDLDEVSSTSSVSQSLESEDARTSCKDDEAVVQAPRHAPVVRTPSIQPSLLPHAAPFAKSHLVHGSSPGVMG
TSVATSASKIIPQGADSTMLATKTVKHGAPSPSHPISAPQAAAAAALRRQMASQAPAVNTLTESTLKNVPQVVNV
QELKNNPATPSTAMGSSVPYSTAKTPHPVLTPVAANQAKQGSLINSLKPSGPTPASGQLSSGDKASGTAKIETAV
TSTPSASGQFSKPFSFSPSGTGFNFGIITPTPSSNFTAAQGATPSTKESSQPDAFSSGGGSKPSYEAIPESSPPS
GITSASNTTPGEPAASSSRPVAPSGTALSTTSSKLETPPSKLGELLFPSSLAGETLGSFSGLRVGQADDSTKPTN
KASSTSLTSTQPTKTSGVPSGFNFTAPPVLGKHTEPPVTSSATTTSVAPPAATSTSSTAVFGSLPVTSAGSSGVI
SFGGTSLSAGKTSFSFGSQQTNSTVPPSAPPPTTAATPLPTSFPTLSFGSLLSSATTPSLPMSAGRSTEEATSSA
LPEKPGDSEVSASAASLLEEQQSAQLPQAPPQTSDSVKKEPVLAQPAVSNSGTAASSTSLVALSAEATPATTGVP
DARTEAVPPASSFSVPGQTAVTAAAISSAGPVAVETSSTPIASSTTSIVAPGPSAEAAAFGTVTSGSSVFAQPPA
ASSSSAFNQLTNNTATAPSATPVFGQVAASTAPSLFGQQTGSTASTAAATPQVSSSGFSSPAFGTTAPGVFGQTT
FGQASVFGQSASSAASVFSFSQPGFSSVPAFGQPASSTPTSTSGSVFGAASSTSSSSSFSFGQSSPNTGGGLFGQ
SNAPAFGQSPGFGQGGSVFGGTSAATTTAATSGFSFCQASGFGSSNTGSVFGQAASTGGIVFGQQSSSSSGSVFG
SGNTGRGGGFFSGLGGKPSQDAANKNPFSSASGGFGSTATSNTSNLFGNSGAKTFGGFASSSFGEQKPTGTFSSG
GGSVASQGFGFSSPNKTGGFGAAPVFGSPPTFGGSPGFGGVPAFGSAPAFTSPLGSTGGKVFGEGTAAASAGGFG
FGSSSNTTSFGTLASQNAPTFGSLSQQTSGFGTQSSGFSGFGSGTGGFSFGSNNSSVQGFGGWRS 
Yeast Dbp5 (UniprotKB/Swiss-prot entry P20449) 
MSDTKRDPADLLASLKIDNEKEDTSEVSTKETVKSQPEKTADSIKPAEKLVPKVEEKKTKQEDSNLISSEYEVKV
KLADIQADPNSPLYSAKSFDELGLAPELLKGIYAMKFQKPSKIQERALPLLLHNPPRNMIAQSQSGTGKTAAFSL
TMLTRVNPEDASPQAICLAPSRELARQTLEVVQEMGKFTKITSQLIVPDSFEKNKQINAQVIVGTPGTVLDLMRR
KLMQLQKIKIFVLDEADNMLDQQGLGDQCIRVKRFLPKDTQLVLFSATFADAVRQYAKKIVPNANTLELQTNEVN
VDAIKQLYMDCKNEADKFDVLTELYGLMTIGSSIIFVATKKTANVLYGKLKSEGHEVSILHGDLQTQERDRLIDD
FREGRSKVLITTNVLARGIDIPTVSMVVNYDLPTLANGQADPATYIHRIGRTGRFGRKGVAISFVHDKNSFNILS
AIQKYFGDIEMTRVPTDDWDEVEKIVKKVLKD 
Yeast Nup159 (Swiss-prot entryP40477) 
MSSLKDEVPTETSEDFGFKFLGQKQILPSFNEKLPFASLQNLDISNSKSLFVAASGSKAVVGELQLLRDHITSDS
TPLTFKWEKEIPDVIFVCFHGDQVLVSTRNALYSLDLEELSEFRTVTSFEKPVFQLKNVNNTLVILNSVNDLSAL
DLRTKSTKQLAQNVTSFDVTNSQLAVLLKDRSFQSFAWRNGEMEKQFEFSLPSELEELPVEEYSPLSVTILSPQD
FLAVFGNVISETDDEVSYDQKMYIIKHIDGSASFQETFDITPPFGQIVRFPYMYKVTLSGLIEPDANVNVLASSC
SSEVSIWDSKQVIEPSQDSERAVLPISEETDKDTNPIGVAVDVVTSGTILEPCSGVDTIERLPLVYILNNEGSLQ
IVGLFHVAAIKSGHYSINLESLEHEKSLSPTSEKIPIAGQEQEEKKKNNESSKALSENPFTSANTSGFTFLKTQP
AAANSLQSQSSSTFGAPSFGSSAFKIDLPSVSSTSTGVASSEQDATDPASAKPVFGKPAFGAIAKEPSTSEYAFG
KPSFGAPSFGSGKSSVESPASGSAFGKPSFGTPSFGSGNSSVEPPASGSAFGKPSFGTPSFGSGNSSAEPPASGS
AFGKPSFGTSAFGTASSNETNSGSIFGKAAFGSSSFAPANNELFGSNFTISKPTVDSPKEVDSTSPFPSSGDQSE
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DESKSDVDSSSTPFGTKPNTSTKPKTNAFDFGSSSFGSGFSKALESVGSDTTFKFGTQASPFSSQLGNKSPFSSF
TKDDTENGSLSKGSTSEINDDNEEHESNGPNVSGNDLTDSTVEQTSSTRLPETPSDEDGEVVEEEAQKSPIGKLT
ETIKKSANIDMAGLKNPVFGNHVKAKSESPFSAFATNITKPSSTTPAFSFGNSTMNKSNTSTVSPMEEADTKETS
EKGPITLKSVENPFLPAKEERTGESSKKDHNDDPKDGYVSGSEISVRTSESAFDTTANEEIPKSQDVNNHEKSET
DPKYSQHAVVDHDNKSKEMNETSKNNERSGQPNHGVQGDGIALKKDNEKENFDSNMAIKQFEDHQSSEEDASEKD
SRQSSEVKESDDNMSLNSDRDESISESYDKLEDINTDELPHGGEAFKAREVSASADFDVQTSLEDNYAESGIQTD
LSESSKENEVQTDAIPVKHNSTQTVKKEAVDNGLQTEPVETCNFSVQTFEGDENYLAEQCKPKQLKEYYTSAKVS
NIPFVSQNSTLRLIESTFQTVEAEFTVLMENIRNMDTFFTDQSSIPLVKRTVRSINNLYTWRIPEAEILLNIQNN
IKCEQMQITNANIQDLKEKVTDYVRKDIAQITEDVANAKEEYLFLMHFDDASSGYVKDLSTHQFRMQKTLRQKLF
DVSAKINHTEELLNILKLFTVKNKRLDDNPLVAKLAKESLARDGLLKEIKLLREQVSRLQLEEKGKKASSFDASS
SITKDMKGFKVVEVGLAMNTKKQIGDFFKNLNMAK 
 
6.8 Vector sequences 
pETMC_Ka_TEV_His 
TTCCCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCCAAAAAACTTGATTAGGGTGATGG
TTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGACGTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGA
ACAACACTCAACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGATTTTGCCGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAA
AATTTAACGCGAATTTTAACAAAATATTAACGTTTACAATTTCAGGTGGCACTTTTCGGGGAAATGTGCGCGGAACCCCTATTTGTTTATTTTT
CTAAATACATTCAAATATGTATCCGCTCATGAATTAATTCTTAGAAAAACTCATCGAGCATCAAATGAAACTGCAATTTATTCATATCAGGATT
ATCAATACCATATTTTTGAAAAAGCCGTTTCTGTAATGAAGGAGAAAACTCACCGAGGCAGTTCCATAGGATGGCAAGATCCTGGTATCGGTCT
GCGATTCCGACTCGTCCAACATCAATACAACCTATTAATTTCCCCTCGTCAAAAATAAGGTTATCAAGTGAGAAATCACCATGAGTGACGACTG
AATCCGGTGAGAATGGCAAAAGTTTATGCATTTCTTTCCAGACTTGTTCAACAGGCCAGCCATTACGCTCGTCATCAAAATCACTCGCATCAAC
CAAACCGTTATTCATTCGTGATTGCGCCTGAGCGAGACGAAATACGCGATCGCTGTTAAAAGGACAATTACAAACAGGAATCGAATGCAACCGG
CGCAGGAACACTGCCAGCGCATCAACAATATTTTCACCTGAATCAGGATATTCTTCTAATACCTGGAATGCTGTTTTCCCGGGGATCGCAGTGG
TGAGTAACCATGCATCATCAGGAGTACGGATAAAATGCTTGATGGTCGGAAGAGGCATAAATTCCGTCAGCCAGTTTAGTCTGACCATCTCATC
TGTAACATCATTGGCAACGCTACCTTTGCCATGTTTCAGAAACAACTCTGGCGCATCGGGCTTCCCATACAATCGATAGATTGTCGCACCTGAT
TGCCCGACATTATCGCGAGCCCATTTATACCCATATAAATCAGCATCCATGTTGGAATTTAATCGCGGCCTAGAGCAAGACGTTTCCCGTTGAA
TATGGCTCATAACACCCCTTGTATTACTGTTTATGTAAGCAGACAGTTTTATTGTTCATGACCAAAATCCCTTAACGTGAGTTTTCGTTCCACT
GAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTGAGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCT
ACCAGCGGTGGTTTGTTTGCCGGATCAAGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTCCTT
CTAGTGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCTGCCA
GTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCAGCGGTCGGGCTGAACGGGGGGTTCGTGCACACA
GCCCAGCTTGGAGCGAACGACCTACACCGAACTGAGATACCTACAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGAC
AGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGAAACGCCTGGTATCTTTATAGTCCTGTCGGGTTTC
GCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCT
GGCCTTTTGCTGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTACCGCCTTTGAGTGAGCTGATACC
GCTCGCCGCAGCCGAACGACCGAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAGAGCGCCTGATGCGGTATTTTCTCCTTACGCATCTGTGCG
GTATTTCACACCGCATATATGGTGCACTCTCAGTACAATCTGCTCTGATGCCGCATAGTTAAGCCAGTATACACTCCGCTATCGCTACGTGACT
GGGTCATGGCTGCGCCCCGACACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCGGCATCCGCTTACAGACAAGCTGTGAC
CGTCTCCGGGAGCTGCATGTGTCAGAGGTTTTCACCGTCATCACCGAAACGCGCGAGGCAGCTGCGGTAAAGCTCATCAGCGTGGTCGTGAAGC
GATTCACAGATGTCTGCCTGTTCATCCGCGTCCAGCTCGTTGAGTTTCTCCAGAAGCGTTAATGTCTGGCTTCTGATAAAGCGGGCCATGTTAA
GGGCGGTTTTTTCCTGTTTGGTCACTGATGCCTCCGTGTAAGGGGGATTTCTGTTCATGGGGGTAATGATACCGATGAAACGAGAGAGGATGCT
CACGATACGGGTTACTGATGATGAACATGCCCGGTTACTGGAACGTTGTGAGGGTAAACAACTGGCGGTATGGATGCGGCGGGACCAGAGAAAA
ATCACTCAGGGTCAATGCCAGCGCTTCGTTAATACAGATGTAGGTGTTCCACAGGGTAGCCAGCAGCATCCTGCGATGCAGATCCGGAACATAA
TGGTGCAGGGCGCTGACTTCCGCGTTTCCAGACTTTACGAAACACGGAAACCGAAGACCATTCATGTTGTTGCTCAGGTCGCAGACGTTTTGCA
GCAGCAGTCGCTTCACGTTCGCTCGCGTATCGGTGATTCATTCTGCTAACCAGTAAGGCAACCCCGCCAGCCTAGCCGGGTCCTCAACGACAGG
AGCACGATCATGCGCACCCGTGGGGCCGCCATGCCGGCGATAATGGCCTGCTTCTCGCCGAAACGTTTGGTGGCGGGACCAGTGACGAAGGCTT
GAGCGAGGGCGTGCAAGATTCCGAATACCGCAAGCGACAGGCCGATCATCGTCGCGCTCCAGCGAAAGCGGTCCTCGCCGAAAATGACCCAGAG
CGCTGCCGGCACCTGTCCTACGAGTTGCATGATAAAGAAGACAGTCATAAGTGCGGCGACGATAGTCATGCCCCGCGCCCACCGGAAGGAGCTG
ACTGGGTTGAAGGCTCTCAAGGGCATCGGTCGAGATCCCGGTGCCTAATGAGTGAGCTAACTTACATTAATTGCGTTGCGCTCACTGCCCGCTT
TCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCCAGGGTGGTTTTTC
TTTTCACCAGTGAGACGGGCAACAGCTGATTGCCCTTCACCGCCTGGCCCTGAGAGAGTTGCAGCAAGCGGTCCACGCTGGTTTGCCCCAGCAG
GCGAAAATCCTGTTTGATGGTGGTTAACGGCGGGATATAACATGAGCTGTCTTCGGTATCGTCGTATCCCACTACCGAGATATCCGCACCAACG
CGCAGCCCGGACTCGGTAATGGCGCGCATTGCGCCCAGCGCCATCTGATCGTTGGCAACCAGCATCGCAGTGGGAACGATGCCCTCATTCAGCA
TTTGCATGGTTTGTTGAAAACCGGACATGGCACTCCAGTCGCCTTCCCGTTCCGCTATCGGCTGAATTTGATTGCGAGTGAGATATTTATGCCA
GCCAGCCAGACGCAGACGCGCCGAGACAGAACTTAATGGGCCCGCTAACAGCGCGATTTGCTGGTGACCCAATGCGACCAGATGCTCCACGCCC
AGTCGCGTACCGTCTTCATGGGAGAAAATAATACTGTTGATGGGTGTCTGGTCAGAGACATCAAGAAATAACGCCGGAACATTAGTGCAGGCAG
CTTCCACAGCAATGGCATCCTGGTCATCCAGCGGATAGTTAATGATCAGCCCACTGACGCGTTGCGCGAGAAGATTGTGCACCGCCGCTTTACA
GGCTTCGACGCCGCTTCGTTCTACCATCGACACCACCACGCTGGCACCCAGTTGATCGGCGCGAGATTTAATCGCCGCGACAATTTGCGACGGC
GCGTGCAGGGCCAGACTGGAGGTGGCAACGCCAATCAGCAACGACTGTTTGCCCGCCAGTTGTTGTGCCACGCGGTTGGGAATGTAATTCAGCT
CCGCCATCGCCGCTTCCACTTTTTCCCGCGTTTTCGCAGAAACGTGGCTGGCCTGGTTCACCACGCGGGAAACGGTCTGATAAGAGACACCGGC
ATACTCTGCGACATCGTATAACGTTACTGGTTTCACATTCACCACCCTGAATTGACTCTCTTCCGGGCGCTATCATGCCATACCGCGAAAGGTT
TTGCGCCATTCGATGGTGTCCGGGATCTCGACGCTCTCCCTTATGCGACTCCTGCATTAGGAAGCAGCCCAGTAGTAGGTTGAGGCCGTTGAGC
ACCGCCGCCGCAAGGAATGGTGCATGCAAGGAGATGGCGCCCAACAGTCCCCCGGCCACGGGGCCTGCCACCATACCCACGCCGAAACAAGCGC
TCATGAGCCCGAAGTGGCGAGCCCGATCTTCCCCATCGGTGATGTCGGCGATATAGGCGCCAGCAACCGCACCTGTGGCGCCGGTGATGCCGGC
CACGATGCGTCCGGCGTAGAGGATCGAGATCTCGGCCGCGATCCCGCGAAATTAATACGACTCACTATAGGGGAATTGTGAGCGGATAACAATT
CCCCCCTAGGGCTAGCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACCATGGGCAGCAGCCATCATCATCATCATCACGATTACG
ATATCCCAACGACCGAAAACCTTTACTTCCAGGGCCATATGCTCGAGGGTACCCTTAAGCAATTGGGATCCTAAGGCTGCTAACAAAGCCCGAA
AGGAAGCTGAGTTGGCTGCTGCCACCGCACTAGTATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGGCGCGCAG
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GCCGGCCTGTCGAGCACCACCACCACCACCACTGAGATCCGGCTGCTAACAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCA
ATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAAGGAGGAACTATATCCGGAT 
 
pEC-K.Hi-sumo 
AGATCTCGATCCCGCGAAATTAATACGACTCACTATAGGGGAATTGTGAGCGGATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAAG
AAGGAGATATACATATGCACCATCACCACCATCACCATGGAATGGAAGGTGAATATATTAAACTCAAAGTCATTGGACAGGATAGCAGTGAGAT
TCACTTCAAAGTGAAAATGACAACACATCTCAAGAAACTCAAAGAATCATACTGTCAAAGACAGGGTGTTCCAATGAATTCACTCAGGTTTCTC
TTTGAGGGTCAGAGAATTGCTGATAATCATACTCCAAAAGAACTGGGAATGGAGGAAGAAGATGTGATTGAAGTCTACCAGGAACAAACCGGCG
GCCGCGGCCGGTGCTTTGCAGGATCCGAATTCGAGCTCCGTCGACAAGCTTGCGGCCGCACTCGAGCACCACCACCACCACCACTGAGATCCGG
CTGCTAACAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAG
GGGTTTTTTGCTGAAAGGAGGAACTATATCCGGATTGGCGAATGGGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGC
GCAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCA
AGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCCAAAAAACTTGATTAGGGTGATGGTTCACGTAGT
GGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGACGTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGAACAACACTCA
ACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGATTTTGCCGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAAAATTTAACGC
GAATTTTAACAAAATATTAACGTTTACAATTTCAGGTGGCACTTTTCGGGGAAATGTGCGCGGAACCCCTATTTGTTTATTTTTCTAAATACAT
TCAAATATGTATCCGCTCATGAATTAATTCTTAGAAAAACTCATCGAGCATCAAATGAAACTGCAATTTATTCATATCAGGATTATCAATACCA
TATTTTTGAAAAAGCCGTTTCTGTAATGAAGGAGAAAACTCACCGAGGCAGTTCCATAGGATGGCAAGATCCTGGTATCGGTCTGCGATTCCGA
CTCGTCCAACATCAATACAACCTATTAATTTCCCCTCGTCAAAAATAAGGTTATCAAGTGAGAAATCACCATGAGTGACGACTGAATCCGGTGA
GAATGGCAAAAGTTTATGCATTTCTTTCCAGACTTGTTCAACAGGCCAGCCATTACGCTCGTCATCAAAATCACTCGCATCAACCAAACCGTTA
TTCATTCGTGATTGCGCCTGAGCGAGACGAAATACGCGATCGCTGTTAAAAGGACAATTACAAACAGGAATCGAATGCAACCGGCGCAGGAACA
CTGCCAGCGCATCAACAATATTTTCACCTGAATCAGGATATTCTTCTAATACCTGGAATGCTGTTTTCCCGGGGATCGCAGTGGTGAGTAACCA
TGCATCATCAGGAGTACGGATAAAATGCTTGATGGTCGGAAGAGGCATAAATTCCGTCAGCCAGTTTAGTCTGACCATCTCATCTGTAACATCA
TTGGCAACGCTACCTTTGCCATGTTTCAGAAACAACTCTGGCGCATCGGGCTTCCCATACAATCGATAGATTGTCGCACCTGATTGCCCGACAT
TATCGCGAGCCCATTTATACCCATATAAATCAGCATCCATGTTGGAATTTAATCGCGGCCTAGAGCAAGACGTTTCCCGTTGAATATGGCTCAT
AACACCCCTTGTATTACTGTTTATGTAAGCAGACAGTTTTATTGTTCATGACCAAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTCAGA
CCCCGTAGAAAAGATCAAAGGATCTTCTTGAGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTG
GTTTGTTTGCCGGATCAAGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTCCTTCTAGTGTAGC
CGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAA
GTCGTGTCTTACCGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCAGCGGTCGGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTG
GAGCGAACGACCTACACCGAACTGAGATACCTACAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGG
TAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGAAACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTG
ACTTGAGCGTCGATTTTTGTGATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTGC
TGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTACCGCCTTTGAGTGAGCTGATACCGCTCGCCGCA
GCCGAACGACCGAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAGAGCGCCTGATGCGGTATTTTCTCCTTACGCATCTGTGCGGTATTTCACA
CCGCATATATGGTGCACTCTCAGTACAATCTGCTCTGATGCCGCATAGTTAAGCCAGTATACACTCCGCTATCGCTACGTGACTGGGTCATGGC
TGCGCCCCGACACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCGGCATCCGCTTACAGACAAGCTGTGACCGTCTCCGGG
AGCTGCATGTGTCAGAGGTTTTCACCGTCATCACCGAAACGCGCGAGGCAGCTGCGGTAAAGCTCATCAGCGTGGTCGTGAAGCGATTCACAGA
TGTCTGCCTGTTCATCCGCGTCCAGCTCGTTGAGTTTCTCCAGAAGCGTTAATGTCTGGCTTCTGATAAAGCGGGCCATGTTAAGGGCGGTTTT
TTCCTGTTTGGTCACTGATGCCTCCGTGTAAGGGGGATTTCTGTTCATGGGGGTAATGATACCGATGAAACGAGAGAGGATGCTCACGATACGG
GTTACTGATGATGAACATGCCCGGTTACTGGAACGTTGTGAGGGTAAACAACTGGCGGTATGGATGCGGCGGGACCAGAGAAAAATCACTCAGG
GTCAATGCCAGCGCTTCGTTAATACAGATGTAGGTGTTCCACAGGGTAGCCAGCAGCATCCTGCGATGCAGATCCGGAACATAATGGTGCAGGG
CGCTGACTTCCGCGTTTCCAGACTTTACGAAACACGGAAACCGAAGACCATTCATGTTGTTGCTCAGGTCGCAGACGTTTTGCAGCAGCAGTCG
CTTCACGTTCGCTCGCGTATCGGTGATTCATTCTGCTAACCAGTAAGGCAACCCCGCCAGCCTAGCCGGGTCCTCAACGACAGGAGCACGATCA
TGCGCACCCGTGGGGCCGCCATGCCGGCGATAATGGCCTGCTTCTCGCCGAAACGTTTGGTGGCGGGACCAGTGACGAAGGCTTGAGCGAGGGC
GTGCAAGATTCCGAATACCGCAAGCGACAGGCCGATCATCGTCGCGCTCCAGCGAAAGCGGTCCTCGCCGAAAATGACCCAGAGCGCTGCCGGC
ACCTGTCCTACGAGTTGCATGATAAAGAAGACAGTCATAAGTGCGGCGACGATAGTCATGCCCCGCGCCCACCGGAAGGAGCTGACTGGGTTGA
AGGCTCTCAAGGGCATCGGTCGAGATCCCGGTGCCTAATGAGTGAGCTAACTTACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGG
AAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCCAGGGTGGTTTTTCTTTTCACCAG
TGAGACGGGCAACAGCTGATTGCCCTTCACCGCCTGGCCCTGAGAGAGTTGCAGCAAGCGGTCCACGCTGGTTTGCCCCAGCAGGCGAAAATCC
TGTTTGATGGTGGTTAACGGCGGGATATAACATGAGCTGTCTTCGGTATCGTCGTATCCCACTACCGAGATATCCGCACCAACGCGCAGCCCGG
ACTCGGTAATGGCGCGCATTGCGCCCAGCGCCATCTGATCGTTGGCAACCAGCATCGCAGTGGGAACGATGCCCTCATTCAGCATTTGCATGGT
TTGTTGAAAACCGGACATGGCACTCCAGTCGCCTTCCCGTTCCGCTATCGGCTGAATTTGATTGCGAGTGAGATATTTATGCCAGCCAGCCAGA
CGCAGACGCGCCGAGACAGAACTTAATGGGCCCGCTAACAGCGCGATTTGCTGGTGACCCAATGCGACCAGATGCTCCACGCCCAGTCGCGTAC
CGTCTTCATGGGAGAAAATAATACTGTTGATGGGTGTCTGGTCAGAGACATCAAGAAATAACGCCGGAACATTAGTGCAGGCAGCTTCCACAGC
AATGGCATCCTGGTCATCCAGCGGATAGTTAATGATCAGCCCACTGACGCGTTGCGCGAGAAGATTGTGCACCGCCGCTTTACAGGCTTCGACG
CCGCTTCGTTCTACCATCGACACCACCACGCTGGCACCCAGTTGATCGGCGCGAGATTTAATCGCCGCGACAATTTGCGACGGCGCGTGCAGGG
CCAGACTGGAGGTGGCAACGCCAATCAGCAACGACTGTTTGCCCGCCAGTTGTTGTGCCACGCGGTTGGGAATGTAATTCAGCTCCGCCATCGC
CGCTTCCACTTTTTCCCGCGTTTTCGCAGAAACGTGGCTGGCCTGGTTCACCACGCGGGAAACGGTCTGATAAGAGACACCGGCATACTCTGCG
ACATCGTATAACGTTACTGGTTTCACATTCACCACCCTGAATTGACTCTCTTCCGGGCGCTATCATGCCATACCGCGAAAGGTTTTGCGCCATT
CGATGGTGTCCGGGATCTCGACGCTCTCCCTTATGCGACTCCTGCATTAGGAAGCAGCCCAGTAGTAGGTTGAGGCCGTTGAGCACCGCCGCCG
CAAGGAATGGTGCATGCAAGGAGATGGCGCCCAACAGTCCCCCGGCCACGGGGCCTGCCACCATACCCACGCCGAAACAAGCGCTCATGAGCCC
GAAGTGGCGAGCCCGATCTTCCCCATCGGTGATGTCGGCGATATAGGCGCCAGCAACCGCACCTGTGGCGCCGGTGATGCCGGCCACGATGCGT
CCGGCGTAGAGGATCG  
 
pEGFP-C1 
TAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGC
TGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGG
AGTATTTACGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAATGGCCCGC
CTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTT
TGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACC
AAAATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAG
AGCTGGTTTAGTGAACCGTCAGATCCGCTAGCGCTACCGGTCGCCACCATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCC
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TGGTCGAGCTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAGCTGACCCTGAAGTT
CATCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGACCAC
ATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCC
GCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACAA
GCTGGAGTACAACTACAACAGCCACAACGTCTATATCATGGCCGACAAGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATC
GAGGACGGCAGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGACAACCACTACCTGAGCA
CCCAGTCCGCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTCGGCATGGA
CGAGCTGTACAAGTCCGGACTCAGATCTCGAGCTCAAGCTTCGAATTCTGCAGTCGACGGTACCGCGGGCCCGGGATCCACCGGATCTAGATAA
CTGATCATAATCAGCCATACCACATTTGTAGAGGTTTTACTTGCTTTAAAAAACCTCCCACACCTCCCCCTGAACCTGAAACATAAAATGAATG
CAATTGTTGTTGTTAACTTGTTTATTGCAGCTTATAATGGTTACAAATAAAGCAATAGCATCACAAATTTCACAAATAAAGCATTTTTTTCACT
GCATTCTAGTTGTGGTTTGTCCAAACTCATCAATGTATCTTAACGCGTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTG
TTAAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCA
GTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCAT
CACCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCC
GGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACA
CCCGCCGCGCTTAATGCGCCGCTACAGGGCGCGTCAGGTGGCACTTTTCGGGGAAATGTGCGCGGAACCCCTATTTGTTTATTTTTCTAAATAC
ATTCAAATATGTATCCGCTCATGAGACAATAACCCTGATAAATGCTTCAATAATATTGAAAAAGGAAGAGTCCTGAGGCGGAAAGAACCAGCTG
TGGAATGTGTGTCAGTTAGGGTGTGGAAAGTCCCCAGGCTCCCCAGCAGGCAGAAGTATGCAAAGCATGCATCTCAATTAGTCAGCAACCAGGT
GTGGAAAGTCCCCAGGCTCCCCAGCAGGCAGAAGTATGCAAAGCATGCATCTCAATTAGTCAGCAACCATAGTCCCGCCCCTAACTCCGCCCAT
CCCGCCCCTAACTCCGCCCAGTTCCGCCCATTCTCCGCCCCATGGCTGACTAATTTTTTTTATTTATGCAGAGGCCGAGGCCGCCTCGGCCTCT
GAGCTATTCCAGAAGTAGTGAGGAGGCTTTTTTGGAGGCCTAGGCTTTTGCAAAGATCGATCAAGAGACAGGATGAGGATCGTTTCGCATGATT
GAACAAGATGGATTGCACGCAGGTTCTCCGGCCGCTTGGGTGGAGAGGCTATTCGGCTATGACTGGGCACAACAGACAATCGGCTGCTCTGATG
CCGCCGTGTTCCGGCTGTCAGCGCAGGGGCGCCCGGTTCTTTTTGTCAAGACCGACCTGTCCGGTGCCCTGAATGAACTGCAAGACGAGGCAGC
GCGGCTATCGTGGCTGGCCACGACGGGCGTTCCTTGCGCAGCTGTGCTCGACGTTGTCACTGAAGCGGGAAGGGACTGGCTGCTATTGGGCGAA
GTGCCGGGGCAGGATCTCCTGTCATCTCACCTTGCTCCTGCCGAGAAAGTATCCATCATGGCTGATGCAATGCGGCGGCTGCATACGCTTGATC
CGGCTACCTGCCCATTCGACCACCAAGCGAAACATCGCATCGAGCGAGCACGTACTCGGATGGAAGCCGGTCTTGTCGATCAGGATGATCTGGA
CGAAGAGCATCAGGGGCTCGCGCCAGCCGAACTGTTCGCCAGGCTCAAGGCGAGCATGCCCGACGGCGAGGATCTCGTCGTGACCCATGGCGAT
GCCTGCTTGCCGAATATCATGGTGGAAAATGGCCGCTTTTCTGGATTCATCGACTGTGGCCGGCTGGGTGTGGCGGACCGCTATCAGGACATAG
CGTTGGCTACCCGTGATATTGCTGAAGAGCTTGGCGGCGAATGGGCTGACCGCTTCCTCGTGCTTTACGGTATCGCCGCTCCCGATTCGCAGCG
CATCGCCTTCTATCGCCTTCTTGACGAGTTCTTCTGAGCGGGACTCTGGGGTTCGAAATGACCGACCAAGCGACGCCCAACCTGCCATCACGAG
ATTTCGATTCCACCGCCGCCTTCTATGAAAGGTTGGGCTTCGGAATCGTTTTCCGGGACGCCGGCTGGATGATCCTCCAGCGCGGGGATCTCAT
GCTGGAGTTCTTCGCCCACCCTAGGGGGAGGCTAACTGAAACACGGAAGGAGACAATACCGGAAGGAACCCGCGCTATGACGGCAATAAAAAGA
CAGAATAAAACGCACGGTGTTGGGTCGTTTGTTCATAAACGCGGGGTTCGGTCCCAGGGCTGGCACTCTGTCGATACCCCACCGAGACCCCATT
GGGGCCAATACGCCCGCGTTTCTTCCTTTTCCCCACCCCACCCCCCAAGTTCGGGTGAAGGCCCAGGGCTCGCAGCCAACGTCGGGGCGGCAGG
CCCTGCCATAGCCTCAGGTTACTCATATATACTTTAGATTGATTTAAAACTTCATTTTTAATTTAAAAGGATCTAGGTGAAGATCCTTTTTGAT
AATCTCATGACCAAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTGAGATCCTTTTT
TTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTTGCCGGATCAAGAGCTACCAACTCTTTTTCCGAA
GGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTCCTTCTAGTGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCT
ACATACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATAGTTACCGG
ATAAGGCGCAGCGGTCGGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACCTACACCGAACTGAGATACCTACAGCGTGA
GCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTT
CCAGGGGGAAACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCGTCAGGGGGGCGGA
GCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGA
TTCTGTGGATAACCGTATTACCGCCATGCAT 
 
pCLneo-lamdaD 
TCAATATTGGCCATTAGCCATATTATTCATTGGTTATATAGCATAAATCAATATTGGCTATTGGCCATTGCATACGTTGTATCTATATCATAAT
ATGTACATTTATATTGGCTCATGTCCAATATGACCGCCATGTTGGCATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCATTAG
TTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAAT
AATGACGTATGTTCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTACAT
CAAGTGTATCATATGCCAAGTCCGCCCCCTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGACCTTACGGGACT
TTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTACACCAATGGGCGTGGATAGCGGTTTGA
CTCACGGGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATGTCGTAACAAC
TGCGATCGCCCGCCCCGTTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCAC
TAGAAGCTTTATTGCGGTAGTTTATCACAGTTAAATTGCTAACGCAGTCAGTGCTTCTGACACAACAGTCTCGAACTTAAGCTGCAGTGACTCT
CTTAAGGTAGCCTTGCAGAAGTTGGTCGTGAGGCACTGGGCAGGTAAGTATCAAGGTTACAAGACAGGTTTAAGGAGACCAATAGAAACTGGGC
TTGTCGAGACAGAGAAGACTCTTGCGTTTCTGATAGGCACCTATTGGTCTTACTGACATCCACTTTGCCTTTCTCTCCACAGGTGTCCACTCCC
AGTTCAATTACAGCTCTTAAGGCTAGAGTACTTAATACGACTCACTATAGGCTAGCACCATGGACGCACAAACACGACGACGTGAGCGTCGCGC
TGAGAAACAAGCTCAATGGAAAGCTGCAAACCCACCGCTCGAGAATTCACGCGTGGTACCTCTAGAGTCGACCCGGGCGGCCGCTTCCCTTTAG
TGAGGGTTAATGCTTCGAGCAGACATGATAAGATACATTGATGAGTTTGGACAAACCACAACTAGAATGCAGTGAAAAAAATGCTTTATTTGTG
AAATTTGTGATGCTATTGCTTTATTTGTAACCATTATAAGCTGCAATAAACAAGTTAACAACAACAATTGCATTCATTTTATGTTTCAGGTTCA
GGGGGAGATGTGGGAGGTTTTTTAAAGCAAGTAAAACCTCTACAAATGTGGTAAAATCCGATAAGGATCGATCCGGGCTGGCGTAATAGCGAAG
AGGCCCGCACCGATCGCCCTTCCCAACAGTTGCGCAGCCTGAATGGCGAATGGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTG
GTTACGCGCAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTC
CCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCCAAAAAACTTGATTAGGGTGATGGTTC
ACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGACGTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGAACA
ACACTCAACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGATTTTGCCGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAAAAT
TTAACGCGAATTTTAACAAAATATTAACGCTTACAATTTCCTGATGCGGTATTTTCTCCTTACGCATCTGTGCGGTATTTCACACCGCATACGC
GGATCTGCGCAGCACCATGGCCTGAAATAACCTCTGAAAGAGGAACTTGGTTAGGTACCTTCTGAGGCGGAAAGAACCAGCTGTGGAATGTGTG
TCAGTTAGGGTGTGGAAAGTCCCCAGGCTCCCCAGCAGGCAGAAGTATGCAAAGCATGCATCTCAATTAGTCAGCAACCAGGTGTGGAAAGTCC
CCAGGCTCCCCAGCAGGCAGAAGTATGCAAAGCATGCATCTCAATTAGTCAGCAACCATAGTCCCGCCCCTAACTCCGCCCATCCCGCCCCTAA
CTCCGCCCAGTTCCGCCCATTCTCCGCCCCATGGCTGACTAATTTTTTTTATTTATGCAGAGGCCGAGGCCGCCTCGGCCTCTGAGCTATTCCA
GAAGTAGTGAGGAGGCTTTTTTGGAGGCCTAGGCTTTTGCAAAAAGCTTGATTCTTCTGACACAACAGTCTCGAACTTAAGGCTAGAGCCACCA
TGATTGAACAAGATGGATTGCACGCAGGTTCTCCGGCCGCTTGGGTGGAGAGGCTATTCGGCTATGACTGGGCACAACAGACAATCGGCTGCTC
TGATGCCGCCGTGTTCCGGCTGTCAGCGCAGGGGCGCCCGGTTCTTTTTGTCAAGACCGACCTGTCCGGTGCCCTGAATGAACTGCAGGACGAG
GCAGCGCGGCTATCGTGGCTGGCCACGACGGGCGTTCCTTGCGCAGCTGTGCTCGACGTTGTCACTGAAGCGGGAAGGGACTGGCTGCTATTGG
Appendix 
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GCGAAGTGCCGGGGCAGGATCTCCTGTCATCTCACCTTGCTCCTGCCGAGAAAGTATCCATCATGGCTGATGCAATGCGGCGGCTGCATACGCT
TGATCCGGCTACCTGCCCATTCGACCACCAAGCGAAACATCGCATCGAGCGAGCACGTACTCGGATGGAAGCCGGTCTTGTCGATCAGGATGAT
CTGGACGAAGAGCATCAGGGGCTCGCGCCAGCCGAACTGTTCGCCAGGCTCAAGGCGCGCATGCCCGACGGCGAGGATCTCGTCGTGACCCATG
GCGATGCCTGCTTGCCGAATATCATGGTGGAAAATGGCCGCTTTTCTGGATTCATCGACTGTGGCCGGCTGGGTGTGGCGGACCGCTATCAGGA
CATAGCGTTGGCTACCCGTGATATTGCTGAAGAGCTTGGCGGCGAATGGGCTGACCGCTTCCTCGTGCTTTACGGTATCGCCGCTCCCGATTCG
CAGCGCATCGCCTTCTATCGCCTTCTTGACGAGTTCTTCTGAGCGGGACTCTGGGGTTCGAAATGACCGACCAAGCGACGCCCAACCTGCCATC
ACGATGGCCGCAATAAAATATCTTTATTTTCATTACATCTGTGTGTTGGTTTTTTGTGTGAATCGATAGCGATAAGGATCCGCGTATGGTGCAC
TCTCAGTACAATCTGCTCTGATGCCGCATAGTTAAGCCAGCCCCGACACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCG
GCATCCGCTTACAGACAAGCTGTGACCGTCTCCGGGAGCTGCATGTGTCAGAGGTTTTCACCGTCATCACCGAAACGCGCGAGACGAAAGGGCC
TCGTGATACGCCTATTTTTATAGGTTAATGTCATGATAATAATGGTTTCTTAGACGTCAGGTGGCACTTTTCGGGGAAATGTGCGCGGAACCCC
TATTTGTTTATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAGACAATAACCCTGATAAATGCTTCAATAATATTGAAAAAGGAAGAGT
ATGAGTATTCAACATTTCCGTGTCGCCCTTATTCCCTTTTTTGCGGCATTTTGCCTTCCTGTTTTTGCTCACCCAGAAACGCTGGTGAAAGTAA
AAGATGCTGAAGATCAGTTGGGTGCACGAGTGGGTTACATCGAACTGGATCTCAACAGCGGTAAGATCCTTGAGAGTTTTCGCCCCGAAGAACG
TTTTCCAATGATGAGCACTTTTAAAGTTCTGCTATGTGGCGCGGTATTATCCCGTATTGACGCCGGGCAAGAGCAACTCGGTCGCCGCATACAC
TATTCTCAGAATGACTTGGTTGAGTACTCACCAGTCACAGAAAAGCATCTTACGGATGGCATGACAGTAAGAGAATTATGCAGTGCTGCCATAA
CCATGAGTGATAACACTGCGGCCAACTTACTTCTGACAACGATCGGAGGACCGAAGGAGCTAACCGCTTTTTTGCACAACATGGGGGATCATGT
AACTCGCCTTGATCGTTGGGAACCGGAGCTGAATGAAGCCATACCAAACGACGAGCGTGACACCACGATGCCTGTAGCAATGGCAACAACGTTG
CGCAAACTATTAACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAATTAATAGACTGGATGGAGGCGGATAAAGTTGCAGGACCACTTCTGC
GCTCGGCCCTTCCGGCTGGCTGGTTTATTGCTGATAAATCTGGAGCCGGTGAGCGTGGGTCTCGCGGTATCATTGCAGCACTGGGGCCAGATGG
TAAGCCCTCCCGTATCGTAGTTATCTACACGACGGGGAGTCAGGCAACTATGGATGAACGAAATAGACAGATCGCTGAGATAGGTGCCTCACTG
ATTAAGCATTGGTAACTGTCAGACCAAGTTTACTCATATATACTTTAGATTGATTTAAAACTTCATTTTTAATTTAAAAGGATCTAGGTGAAGA
TCCTTTTTGATAATCTCATGACCAAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTG
AGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTTGCCGGATCAAGAGCTACCAACT
CTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTTCTTCTAGTGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTG
TAGCACCGCCTACATACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACG
ATAGTTACCGGATAAGGCGCAGCGGTCGGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACCTACACCGAACTGAGATAC
CTACAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCA
CGAGGGAGCTTCCAGGGGGAAACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCGTC
AGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGCCTTTTGCTCACATGGCTCGACAGATC
T 
 
pGEX-4T 
ACGTTATCGACTGCACGGTGCACCAATGCTTCTGGCGTCAGGCAGCCATCGGAAGCTGTGGTATGGCTGTGCAGGTCGTAAATCACTGCATAAT
TCGTGTCGCTCAAGGCGCACTCCCGTTCTGGATAATGTTTTTTGCGCCGACATCATAACGGTTCTGGCAAATATTCTGAAATGAGCTGTTGACA
ATTAATCATCGGCTCGTATAATGTGTGGAATTGTGAGCGGATAACAATTTCACACAGGAAACAGTATTCATGTCCCCTATACTAGGTTATTGGA
AAATTAAGGGCCTTGTGCAACCCACTCGACTTCTTTTGGAATATCTTGAAGAAAAATATGAAGAGCATTTGTATGAGCGCGATGAAGGTGATAA
ATGGCGAAACAAAAAGTTTGAATTGGGTTTGGAGTTTCCCAATCTTCCTTATTATATTGATGGTGATGTTAAATTAACACAGTCTATGGCCATC
ATACGTTATATAGCTGACAAGCACAACATGTTGGGTGGTTGTCCAAAAGAGCGTGCAGAGATTTCAATGCTTGAAGGAGCGGTTTTGGATATTA
GATACGGTGTTTCGAGAATTGCATATAGTAAAGACTTTGAAACTCTCAAAGTTGATTTTCTTAGCAAGCTACCTGAAATGCTGAAAATGTTCGA
AGATCGTTTATGTCATAAAACATATTTAAATGGTGATCATGTAACCCATCCTGACTTCATGTTGTATGACGCTCTTGATGTTGTTTTATACATG
GACCCAATGTGCCTGGATGCGTTCCCAAAATTAGTTTGTTTTAAAAAACGTATTGAAGCTATCCCACAAATTGATAAGTACTTGAAATCCAGCA
AGTATATAGCATGGCCTTTGCAGGGCTGGCAAGCCACGTTTGGTGGTGGCGACCATCCTCCAAAATCGGATCTGGTTCCGCGTGGATCCCCGGA
ATTCCCGGGTCGACTCGAGCGGCCGCATCGTGACTGACTGACGATCTGCCTCGCGCGTTTCGGTGATGACGGTGAAAACCTCTGACACATGCAG
CTCCCGGAGACGGTCACAGCTTGTCTGTAAGCGGATGCCGGGAGCAGACAAGCCCGTCAGGGCGCGTCAGCGGGTGTTGGCGGGTGTCGGGGCG
CAGCCATGACCCAGTCACGTAGCGATAGCGGAGTGTATAATTCTTGAAGACGAAAGGGCCTCGTGATACGCCTATTTTTATAGGTTAATGTCAT
GATAATAATGGTTTCTTAGACGTCAGGTGGCACTTTTCGGGGAAATGTGCGCGGAACCCCTATTTGTTTATTTTTCTAAATACATTCAAATATG
TATCCGCTCATGAGACAATAACCCTGATAAATGCTTCAATAATATTGAAAAAGGAAGAGTATGAGTATTCAACATTTCCGTGTCGCCCTTATTC
CCTTTTTTGCGGCATTTTGCCTTCCTGTTTTTGCTCACCCAGAAACGCTGGTGAAAGTAAAAGATGCTGAAGATCAGTTGGGTGCACGAGTGGG
TTACATCGAACTGGATCTCAACAGCGGTAAGATCCTTGAGAGTTTTCGCCCCGAAGAACGTTTTCCAATGATGAGCACTTTTAAAGTTCTGCTA
TGTGGCGCGGTATTATCCCGTGTTGACGCCGGGCAAGAGCAACTCGGTCGCCGCATACACTATTCTCAGAATGACTTGGTTGAGTACTCACCAG
TCACAGAAAAGCATCTTACGGATGGCATGACAGTAAGAGAATTATGCAGTGCTGCCATAACCATGAGTGATAACACTGCGGCCAACTTACTTCT
GACAACGATCGGAGGACCGAAGGAGCTAACCGCTTTTTTGCACAACATGGGGGATCATGTAACTCGCCTTGATCGTTGGGAACCGGAGCTGAAT
GAAGCCATACCAAACGACGAGCGTGACACCACGATGCCTGCAGCAATGGCAACAACGTTGCGCAAACTATTAACTGGCGAACTACTTACTCTAG
CTTCCCGGCAACAATTAATAGACTGGATGGAGGCGGATAAAGTTGCAGGACCACTTCTGCGCTCGGCCCTTCCGGCTGGCTGGTTTATTGCTGA
TAAATCTGGAGCCGGTGAGCGTGGGTCTCGCGGTATCATTGCAGCACTGGGGCCAGATGGTAAGCCCTCCCGTATCGTAGTTATCTACACGACG
GGGAGTCAGGCAACTATGGATGAACGAAATAGACAGATCGCTGAGATAGGTGCCTCACTGATTAAGCATTGGTAACTGTCAGACCAAGTTTACT
CATATATACTTTAGATTGATTTAAAACTTCATTTTTAATTTAAAAGGATCTAGGTGAAGATCCTTTTTGATAATCTCATGACCAAAATCCCTTA
ACGTGAGTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTGAGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTG
CAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTTGCCGGATCAAGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGC
AGATACCAAATACTGTCCTTCTAGTGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGCTCTGCTAATCCT
GTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCAGCGGTCGGGCTGA
ACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACCTACACCGAACTGAGATACCTACAGCGTGAGCTATGAGAAAGCGCCACGCTTC
CCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGAAACGCCTGGTATCT
TTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAAC
GCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTACCG
CCTTTGAGTGAGCTGATACCGCTCGCCGCAGCCGAACGACCGAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAGAGCGCCTGATGCGGTATTT
TCTCCTTACGCATCTGTGCGGTATTTCACACCGCATAAATTCCGACACCATCGAATGGTGCAAAACCTTTCGCGGTATGGCATGATAGCGCCCG
GAAGAGAGTCAATTCAGGGTGGTGAATGTGAAACCAGTAACGTTATACGATGTCGCAGAGTATGCCGGTGTCTCTTATCAGACCGTTTCCCGCG
TGGTGAACCAGGCCAGCCACGTTTCTGCGAAAACGCGGGAAAAAGTGGAAGCGGCGATGGCGGAGCTGAATTACATTCCCAACCGCGTGGCACA
ACAACTGGCGGGCAAACAGTCGTTGCTGATTGGCGTTGCCACCTCCAGTCTGGCCCTGCACGCGCCGTCGCAAATTGTCGCGGCGATTAAATCT
CGCGCCGATCAACTGGGTGCCAGCGTGGTGGTGTCGATGGTAGAACGAAGCGGCGTCGAAGCCTGTAAAGCGGCGGTGCACAATCTTCTCGCGC
AACGCGTCAGTGGGCTGATCATTAACTATCCGCTGGATGACCAGGATGCCATTGCTGTGGAAGCTGCCTGCACTAATGTTCCGGCGTTATTTCT
TGATGTCTCTGACCAGACACCCATCAACAGTATTATTTTCTCCCATGAAGACGGTACGCGACTGGGCGTGGAGCATCTGGTCGCATTGGGTCAC
CAGCAAATCGCGCTGTTAGCGGGCCCATTAAGTTCTGTCTCGGCGCGTCTGCGTCTGGCTGGCTGGCATAAATATCTCACTCGCAATCAAATTC
AGCCGATAGCGGAACGGGAAGGCGACTGGAGTGCCATGTCCGGTTTTCAACAAACCATGCAAATGCTGAATGAGGGCATCGTTCCCACTGCGAT
GCTGGTTGCCAACGATCAGATGGCGCTGGGCGCAATGCGCGCCATTACCGAGTCCGGGCTGCGCGTTGGTGCGGATATCTCGGTAGTGGGATAC
Appendix 
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GACGATACCGAAGACAGCTCATGTTATATCCCGCCGTTAACCACCATCAAACAGGATTTTCGCCTGCTGGGGCAAACCAGCGTGGACCGCTTGC
TGCAACTCTCTCAGGGCCAGGCGGTGAAGGGCAATCAGCTGTTGCCCGTCTCACTGGTGAAAAGAAAAACCACCCTGGCGCCCAATACGCAAAC
CGCCTCTCCCCGCGCGTTGGCCGATTCATTAATGCAGCTGGCACGACAGGTTTCCCGACTGGAAAGCGGGCAGTGAGCGCAACGCAATTAATGT
GAGTTAGCTCACTCATTAGGCACCCCAGGCTTTACACTTTATGCTTCCGGCTCGTATGTTGTGTGGAATTGTGAGCGGATAACAATTTCACACA
GGAAACAGCTATGACCATGATTACGGATTCACTGGCCGTCGTTTTACAACGTCGTGACTGGGAAAACCCTGGCGTTACCCAACTTAATCGCCTT
GCAGCACATCCCCCTTTCGCCAGCTGGCGTAATAGCGAAGAGGCCCGCACCGATCGCCCTTCCCAACAGTTGCGCAGCCTGAATGGCGAATGGC
GCTTTGCCTGGTTTCCGGCACCAGAAGCGGTGCCGGAAAGCTGGCTGGAGTGCGATCTTCCTGAGGCCGATACTGTCGTCGTCCCCTCAAACTG
GCAGATGCACGGTTACGATGCGCCCATCTACACCAACGTAACCTATCCCATTACGGTCAATCCGCCGTTTGTTCCCACGGAGAATCCGACGGGT
TGTTACTCGCTCACATTTAATGTTGATGAAAGCTGGCTACAGGAAGGCCAGACGCGAATTATTTTTGATGGCGTTGGAATT  
 
pProEx-HTa 
GTTTGACAGCTTATCATCGACTGCACGGTGCACCAATGCTTCTGGCGTCAGGCAGCCATCGGAAGCTGTGGTATGGCTGTGCAGGTCGTAAATC
ACTGCATAATTCGTGTCGCTCAAGGCGCACTCCCGTTCTGGATAATGTTTTTTGCGCCGACATCATAACGGTTCTGGCAAATATTCTGAAATGA
GCTGTTGACAATTAATCATCCGGTCCGTATAATCTGTGGAATTGTGAGCGGATAACAATTTCACACAGGAAACAGACCATGTCGTACTACCATC
ACCATCACCATCACGATTACGATATCCCAACGACCGAAAACCTGTATTTTCAGGGCGCCATGGATCCGGAATTCAAAGGCCTACGTCGACGAGC
TCAACTAGTGCGGCCGCTTTCGAATCTAGAGCCTGCAGTCTCGAGGCATGCGGTACCAAGCTTGGCTGTTTTGGCGGATGAGAGAAGATTTTCA
GCCTGATACAGATTAAATCAGAACGCAGAAGCGGTCTGATAAAACAGAATTTGCCTGGCGGCAGTAGCGCGGTGGTCCCACCTGACCCCATGCC
GAACTCAGAAGTGAAACGCCGTAGCGCCGATGGTAGTGTGGGGTCTCCCCATGCGAGAGTAGGGAACTGCCAGGCATCAAATAAAACGAAAGGC
TCAGTCGAAAGACTGGGCCTTTCGTTTTATCTGTTGTTTGTCGGTGAACGCTCTCCTGAGTAGGACAAATCCGCCGGGAGCGGATTTGAACGTT
GCGAAGCAACGGCCCGGAGGGTGGCGGGCAGGACGCCCGCCATAAACTGCCAGGCATCAAATTAAGCAGAAGGCCATCCTGACGGATGGCCTTT
TTGCGTTTCTACAAACTCTTTTTGTTTATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAGACAATAACCCTGATAAATGCTTCAATAA
TATTGAAAAAGGAAGAGTATGAGTATTCAACATTTCCGTGTCGCCCTTATTCCCTTTTTTGCGGCATTTTGCCTTCCTGTTTTTGCTCACCCAG
AAACGCTGGTGAAAGTAAAAGATGCTGAAGATCAGTTGGGTGCACGAGTGGGTTACATCGAACTGGATCTCAACAGCGGTAAGATCCTTGAGAG
TTTTCGCCCCGAAGAACGTTTTCCAATGATGAGCACTTTTAAAGTTCTGCTATGTGGCGCGGTATTATCCCGTGTTGACGCCGGGCAAGAGCAA
CTCGGTCGCCGCATACACTATTCTCAGAATGACTTGGTTGAGTACTCACCAGTCACAGAAAAGCATCTTACGGATGGCATGACAGTAAGAGAAT
TATGCAGTGCTGCCATAACCATGAGTGATAACACTGCGGCCAACTTACTTCTGACAACGATCGGAGGACCGAAGGAGCTAACCGCTTTTTTGCA
CAACATGGGGGATCATGTAACTCGCCTTGATCGTTGGGAACCGGAGCTGAATGAAGCCATACCAAACGACGAGCGTGACACCACGATGCCTACA
GCAATGGCAACAACGTTGCGCAAACTATTAACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAATTAATAGACTGGATGGAGGCGGATAAAG
TTGCAGGACCACTTCTGCGCTCGGCCCTTCCGGCTGGCTGGTTTATTGCTGATAAATCTGGAGCCGGTGAGCGTGGGTCTCGCGGTATCATTGC
AGCACTGGGGCCAGATGGTAAGCCCTCCCGTATCGTAGTTATCTACACGACGGGGAGTCAGGCAACTATGGATGAACGAAATAGACAGATCGCT
GAGATAGGTGCCTCACTGATTAAGCATTGGTAACTGTCAGACCAAGTTTACTCATATATACTTTAGATTGATTTAAAACTTCATTTTTAATTTA
AAAGGATCTAGGTGAAGATCCTTTTTGATAATCTCATGACCAAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAAAA
GATCAAAGGATCTTCTTGAGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTTGCCG
GATCAAGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTCCTTCTAGTGTAGCCGTAGTTAGGCC
ACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTAC
CGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCAGCGGTCGGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACC
TACACCGAACTGAGATACCTACAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGG
TCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGAAACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCG
ATTTTTGTGATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGCCTTTTGCT
CACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTACCGCCTTTGAGTGAGCTGATACCGCTCGCCGCAGCCGAACGACCG
AGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAGAGCGCCTGATGCGGTATTTTCTCCTTACGCATCTGTGCGGTATTTCACACCGCATAATTTT
GTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACC
GAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGG
GCGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCG
ATTTAGAGCTTGACGGGGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGCG
GTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCTATGGTGCACTCTCA
GTACAATCTGCTCTGATGCCGCATAGTTAAGCCAGTATACACTCCGCTATCGCTACGTGACTGGGTCATGGCTGCGCCCCGACACCCGCCAACA
CCCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCGGCATCCGCTTACAGACAAGCTGTGACCGTCTCCGGGAGCTGCATGTGTCAGAGGTTTT
CACCGTCATCACCGAAACGCGCGAGGCAGCAGATCAATTCGCGCGCGAAGGCGAAGCGGCATGCATTTACGTTGACACCATCGAATGGTGCAAA
ACCTTTCGCGGTATGGCATGATAGCGCCCGGAAGAGAGTCAATTCAGGGTGGTGAATGTGAAACCAGTAACGTTATACGATGTCGCAGAGTATG
CCGGTGTCTCTTATCAGACCGTTTCCCGCGTGGTGAACCAGGCCAGCCACGTTTCTGCGAAAACGCGGGAAAAAGTGGAAGCGGCGATGGCGGA
GCTGAATTACATTCCCAACCGCGTGGCACAACAACTGGCGGGCAAACAGTCGTTGCTGATTGGCGTTGCCACCTCCAGTCTGGCCCTGCACGCG
CCGTCGCAAATTGTCGCGGCGATTAAATCTCGCGCCGATCAACTGGGTGCCAGCGTGGTGGTGTCGATGGTAGAACGAAGCGGCGTCGAAGCCT
GTAAAGCGGCGGTGCACAATCTTCTCGCGCAACGCGTCAGTGGGCTGATCATTAACTATCCGCTGGATGACCAGGATGCCATTGCTGTGGAAGC
TGCCTGCACTAATGTTCCGGCGTTATTTCTTGATGTCTCTGACCAGACACCCATCAACAGTATTATTTTCTCCCATGAAGACGGTACGCGACTG
GGCGTGGAGCATCTGGTCGCATTGGGTCACCAGCAAATCGCGCTGTTAGCGGGCCCATTAAGTTCTGTCTCGGCGCGTCTGCGTCTGGCTGGCT
GGCATAAATATCTCACTCGCAATCAAATTCAGCCGATAGCGGAACGGGAAGGCGACTGGAGTGCCATGTCCGGTTTTCAACAAACCATGCAAAT
GCTGAATGAGGGCATCGTTCCCACTGCGATGCTGGTTGCCAACGATCAGATGGCGCTGGGCGCAATGCGCGCCATTACCGAGTCCGGGCTGCGC
GTTGGTGCGGATATCTCGGTAGTGGGATACGACGATACCGAAGACAGCTCATGTTATATCCCGCCGTTAACCACCATCAAACAGGATTTTCGCC
TGCTGGGGCAAACCAGCGTGGACCGCTTGCTGCAACTCTCTCAGGGCCAGGCGGTGAAGGGCAATCAGCTGTTGCCCGTCTCACTGGTGAAAAG
AAAAACCACCCTGGCACCCAATACGCAAACCGCCTCTCCCCGCGCGTTGGCCGATTCATTAATGCAGCTGGCACGACAGGTTTCCCGACTGGAA
AGCGGGCAGTGAGCGCAACGCAATTAATGTGAGTTAGCGCGAATTGATCTG 
 
pETM-14  
ATCCGGATATAGTTCCTCCTTTCAGCAAAAAACCCCTCAAGACCCGTTTAGAGGCCCCAAGGGGTTATGCTAGTTATTGCTCAGCGGTGGCAGC
AGCCAACTCAGCTTCCTTTCGGGCTTTGTTAGCAGCCGGATCTCAGTGGTGGTGGTGGTGGTGCTCGAGTGCGGCCGCAAGCTTGTCGACGGAG
CTCGAATTCGGATCCGGTACCTCATTAGTCCATGGGCCCCTGGAACAGAACTTCCAGACCCGCGGAGTGATGGTGATGGTGATGTTTCATGGTA
TATCTCCTTCTTAAAGTTAAACAAAATTATTTCTAGAGGGGAATTGTTATCCGCTCACAATTCCCCTATAGTGAGTCGTATTAATTTCGCGGGA
TCGAGATCTCGATCCTCTACGCCGGACGCATCGTGGCCGGCATCACCGGCGCCACAGGTGCGGTTGCTGGCGCCTATATCGCCGACATCACCGA
TGGGGAAGATCGGGCTCGCCACTTCGGGCTCATGAGCGCTTGTTTCGGCGTGGGTATGGTGGCAGGCCCCGTGGCCGGGGGACTGTTGGGCGCC
ATCTCCTTGCATGCACCATTCCTTGCGGCGGCGGTGCTCAACGGCCTCAACCTACTACTGGGCTGCTTCCTAATGCAGGAGTCGCATAAGGGAG
AGCGTCGAGATCCCGGACACCATCGAATGGCGCAAAACCTTTCGCGGTATGGCATGATAGCGCCCGGAAGAGAGTCAATTCAGGGTGGTGAATG
Appendix 
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TGAAACCAGTAACGTTATACGATGTCGCAGAGTATGCCGGTGTCTCTTATCAGACCGTTTCCCGCGTGGTGAACCAGGCCAGCCACGTTTCTGC
GAAAACGCGGGAAAAAGTGGAAGCGGCGATGGCGGAGCTGAATTACATTCCCAACCGCGTGGCACAACAACTGGCGGGCAAACAGTCGTTGCTG
ATTGGCGTTGCCACCTCCAGTCTGGCCCTGCACGCGCCGTCGCAAATTGTCGCGGCGATTAAATCTCGCGCCGATCAACTGGGTGCCAGCGTGG
TGGTGTCGATGGTAGAACGAAGCGGCGTCGAAGCCTGTAAAGCGGCGGTGCACAATCTTCTCGCGCAACGCGTCAGTGGGCTGATCATTAACTA
TCCGCTGGATGACCAGGATGCCATTGCTGTGGAAGCTGCCTGCACTAATGTTCCGGCGTTATTTCTTGATGTCTCTGACCAGACACCCATCAAC
AGTATTATTTTCTCCCATGAAGACGGTACGCGACTGGGCGTGGAGCATCTGGTCGCATTGGGTCACCAGCAAATCGCGCTGTTAGCGGGCCCAT
TAAGTTCTGTCTCGGCGCGTCTGCGTCTGGCTGGCTGGCATAAATATCTCACTCGCAATCAAATTCAGCCGATAGCGGAACGGGAAGGCGACTG
GAGTGCCATGTCCGGTTTTCAACAAACCATGCAAATGCTGAATGAGGGCATCGTTCCCACTGCGATGCTGGTTGCCAACGATCAGATGGCGCTG
GGCGCAATGCGCGCCATTACCGAGTCCGGGCTGCGCGTTGGTGCGGATATCTCGGTAGTGGGATACGACGATACCGAAGACAGCTCATGTTATA
TCCCGCCGTTAACCACCATCAAACAGGATTTTCGCCTGCTGGGGCAAACCAGCGTGGACCGCTTGCTGCAACTCTCTCAGGGCCAGGCGGTGAA
GGGCAATCAGCTGTTGCCCGTCTCACTGGTGAAAAGAAAAACCACCCTGGCGCCCAATACGCAAACCGCCTCTCCCCGCGCGTTGGCCGATTCA
TTAATGCAGCTGGCACGACAGGTTTCCCGACTGGAAAGCGGGCAGTGAGCGCAACGCAATTAATGTAAGTTAGCTCACTCATTAGGCACCGGGA
TCTCGACCGATGCCCTTGAGAGCCTTCAACCCAGTCAGCTCCTTCCGGTGGGCGCGGGGCATGACTATCGTCGCCGCACTTATGACTGTCTTCT
TTATCATGCAACTCGTAGGACAGGTGCCGGCAGCGCTCTGGGTCATTTTCGGCGAGGACCGCTTTCGCTGGAGCGCGACGATGATCGGCCTGTC
GCTTGCGGTATTCGGAATCTTGCACGCCCTCGCTCAAGCCTTCGTCACTGGTCCCGCCACCAAACGTTTCGGCGAGAAGCAGGCCATTATCGCC
GGCATGGCGGCCCCACGGGTGCGCATGATCGTGCTCCTGTCGTTGAGGACCCGGCTAGGCTGGCGGGGTTGCCTTACTGGTTAGCAGAATGAAT
CACCGATACGCGAGCGAACGTGAAGCGACTGCTGCTGCAAAACGTCTGCGACCTGAGCAACAACATGAATGGTCTTCGGTTTCCGTGTTTCGTA
AAGTCTGGAAACGCGGAAGTCAGCGCCCTGCACCATTATGTTCCGGATCTGCATCGCAGGATGCTGCTGGCTACCCTGTGGAACACCTACATCT
GTATTAACGAAGCGCTGGCATTGACCCTGAGTGATTTTTCTCTGGTCCCGCCGCATCCATACCGCCAGTTGTTTACCCTCACAACGTTCCAGTA
ACCGGGCATGTTCATCATCAGTAACCCGTATCGTGAGCATCCTCTCTCGTTTCATCGGTATCATTACCCCCATGAACAGAAATCCCCCTTACAC
GGAGGCATCAGTGACCAAACAGGAAAAAACCGCCCTTAACATGGCCCGCTTTATCAGAAGCCAGACATTAACGCTTCTGGAGAAACTCAACGAG
CTGGACGCGGATGAACAGGCAGACATCTGTGAATCGCTTCACGACCACGCTGATGAGCTTTACCGCAGCTGCCTCGCGCGTTTCGGTGATGACG
GTGAAAACCTCTGACACATGCAGCTCCCGGAGACGGTCACAGCTTGTCTGTAAGCGGATGCCGGGAGCAGACAAGCCCGTCAGGGCGCGTCAGC
GGGTGTTGGCGGGTGTCGGGGCGCAGCCATGACCCAGTCACGTAGCGATAGCGGAGTGTATACTGGCTTAACTATGCGGCATCAGAGCAGATTG
TACTGAGAGTGCACCATATATGCGGTGTGAAATACCGCACAGATGCGTAAGGAGAAAATACCGCATCAGGCGCTCTTCCGCTTCCTCGCTCACT
GACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAG
GAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGA
GCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGC
TCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATC
TCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCT
TGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAG
TTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTG
GTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGA
AGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAACAATAAAACTGTCTGCTTA
CATAAACAGTAATACAAGGGGTGTTATGAGCCATATTCAACGGGAAACGTCTTGCTCTAGGCCGCGATTAAATTCCAACATGGATGCTGATTTA
TATGGGTATAAATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACAATCTATCGATTGTATGGGAAGCCCGATGCGCCAGAGTTGTTTCTGA
AACATGGCAAAGGTAGCGTTGCCAATGATGTTACAGATGAGATGGTCAGACTAAACTGGCTGACGGAATTTATGCCTCTTCCGACCATCAAGCA
TTTTATCCGTACTCCTGATGATGCATGGTTACTCACCACTGCGATCCCCGGGAAAACAGCATTCCAGGTATTAGAAGAATATCCTGATTCAGGT
GAAAATATTGTTGATGCGCTGGCAGTGTTCCTGCGCCGGTTGCATTCGATTCCTGTTTGTAATTGTCCTTTTAACAGCGATCGCGTATTTCGTC
TCGCTCAGGCGCAATCACGAATGAATAACGGTTTGGTTGATGCGAGTGATTTTGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAA
AGAAATGCATAAACTTTTGCCATTCTCACCGGATTCAGTCGTCACTCATGGTGATTTCTCACTTGATAACCTTATTTTTGACGAGGGGAAATTA
ATAGGTTGTATTGATGTTGGACGAGTCGGAATCGCAGACCGATACCAGGATCTTGCCATCCTATGGAACTGCCTCGGTGAGTTTTCTCCTTCAT
TACAGAAACGGCTTTTTCAAAAATATGGTATTGATAATCCTGATATGAATAAATTGCAGTTTCATTTGATGCTCGATGAGTTTTTCTAAGAATT
AATTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTGAAATTGT
AAACGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAA
TCAAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAA
AAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCC
TAAAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCG
CTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCA 
 
pYES263 
TATGCACCATCACCATCACCATGCTAGCTTCATGTCCCCTATACTAGGTTATTGGAAAATTAAGGGCCTTGTGCAACCCACTCGACTTCTTTTG
GAATATCTTGAAGAAAAATATGAAGAGCATTTGTATGAGCGCGATGAAGGTGATAAATGGCGAAACAAAAAGTTTGAATTGGGTTTGGAGTTTC
CCAATCTTCCTTATTATATTGATGGTGATGTTAAATTAACACAGTCTATGGCCATCATACGTTATATAGCTGACAAGCACAACATGTTGGGTGG
TTGTCCAAAAGAGCGTGCAGAGATTTCAATGCTTGAAGGAGCGGTTTTGGATATTAGATACGGTGTTTCGAGAATTGCATATAGTAAAGACTTT
GAAACTCTCAAAGTTGATTTTCTTAGCAAGCTACCTGAAATGCTGAAAATGTTCGAAGATCGTTTATGTCATAAAACATATTTAAATGGTGATC
ATGTAACCCATCCTGACTTCATGTTGTATGACGCTCTTGATGTTGTTTTATACATGGACCCCATGTGCCTGGATGCGTTCCCAAAATTAGTTTG
TTTTAAAAAACGTATTGAAGCTATCCCACAAATTGATAAGTACTTGAAATCCAGCAAGTATATAGCATGGCCTTTGCAGGGCTGGCAAGCCACG
TTTGGTGGTGGCGACCATCACGAGAATCTTTATTTTCAGGGCGCCATGGTCTAGCATGACTGGTGGACAGCAAATGGGTCGGGGATCCACTAGT
AACGGCCGCCAGTGTGCTGGAATTCTGCAGATATCCATCACACTGGCGGCCGCTCGAGCATGCATCTAGAGGGCCGCATCATGTAATTAGTTAT
GTCACGCTTACATTCACGCCCTCCCCCCACATCCGCTCTAACCGAAAAGGAAGGAGTTAGACAACCTGAAGTCTAGGTCCCTATTTATTTTTTT
ATAGTTATGTTAGTATTAAGAACGTTATTTATATTTCAAATTTTTCTTTTTTTTCTGTACAGACGCGTGTACGCATGTAACATTATACTGAAAA
CCTTGCTTGAGAAGGTTTTGGGACGCTCGAAGGCTTTAATTTGCGGCCCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTA
TTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACG
GTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGCCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCG
TTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGG
CGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGC
GCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGAC
CGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCA
GAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCT
GAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAG
ATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTT
TGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTG
GTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAG
ATAACTACGATACGGGAGCGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAA
ACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATTCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAG
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TAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGGCATTGCTACAGGCATCGTGGTGTCACTCTCGTCGTTTGGTATGGCTTCATTCAGCTCC
GGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGT
TGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTA
CTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAATAGTGTATCACATAGCAGAACT
TTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTG
CACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGC
GACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATGGGTAATAACTGATATAATTAAATTGAAGCTCTAATTTGTGAGTTTAGTATAC
ATGCATTTACTTATAATACAGTTTTTTAGTTTTGCTGGCCGCATCTTCTCAAATATGCTTCCCAGCCTGCTTTTCTGTAACGTTCACCCTCTAC
CTTAGCATCCCTTCCCTTTGCAAATAGTCCTCTTCCAACAATAATAATGTCAGATCCTGTAGAGACCACATCATCCACGGTTCTATACTGTTGA
CCCAATGCGTCTCCCTTGTCATCTAAACCCACACCGGGTGTCATAATCAACCAATCGTAACCTTCATCTCTTCCACCCATGTCTCTTTGAGCAA
TAAAGCCGATAACAAAATCTTTGTCGCTCTTCGCAATGTCAACAGTACCCTTAGTATATTCTCCAGTAGATAGGGAGCCCTTGCATGACAATTC
TGCTAACATCAAAAGGCCTCTAGGTTCCTTTGTTACTTCTTCTGCCGCCTGCTTCAAACCGCTAACAATACCTGGGCCCACCACACCGTGTGCA
TTCGTAATGTCTGCCCATTCTGCTATTCTGTATACACCCGCAGAGTACTGCAATTTGACTGTATTACCAATGTCAGCAAATTTTCTGTCTTCGA
AGAGTAAAAAATTGTACTTGGCGGATAATGCCTTTAGCGGCTTAACTGTGCCCTCCATTGAAAAATCAGTCAAGATATCCACATGTGTTTTTAG
TAAACAAATTTTGGGACCTAATGCTTCAACTAACTCCAGTAATTCCTTGGTGGTACGAACATCCAATGAAGCACACAAGTTTGTTTGCTTTTCG
TGCATGATATTAAATAGCTTGGCAGCAACAGGACTAGGATGAGTAGCAGCACGTTCCTTATATGTAGCTTTCGACATGATTTATCTTCGTTTCC
TGCAGGTTTTTGTTCTGTGCAGTTGGGTTAAGAATACTGGGCAATTTCATGTTTCTTCAACACTACATATGCGTATATATACCAATCTAAGTCT
GTGCTCCTTCCTTCGTTCTTCCTTCTGTTCGGAGATTACCGAATCAAAAAAATTTCAAAGAAACCGAAATCAAAAAAAAGAATAAAAAAAAAAT
GATGAATTGAATTGAAAAGCTAGCTTATCGATGATAAGCTGTCAAAGATGAGAATTAATTCCACGGACTATAGACTATACTAGATACTCCGTCT
ACTGTACGATACACTTCCGCTCAGGTCCTTGTCCTTTAACGAGGCCTTACCACTCTTTTGTTACTCTATTGATCCAGCTCAGCAAAGGCAGTGT
GATCTAAGATTCTATCTTCGCGATGTAGTAAAACTAGCTAGACCGAGAAAGAGACTAGAAATGCAAAAGGCACTTCTACAATGGCTGCCATCAT
TATTATCCGATGTGACGCTGCAGCTTCTCAATGATATTCGAATACGCTTTGAGGAGATACAGCCTAATATCCGACAAACTGTTTTACAGATTTA
CGATCGTACTTGTTACCCATCATTGAATTTTGAACATCCGAACCTGGGAGTTTTCCCTGAAACAGATAGTATATTTGAACCTGTATAATAATAT
ATAGTCTAGCGCTTTACGGAAGACAATGTATGTATTTCGGTTCCTGGAGAAACTATTGCATCTATTGCATAGGTAATCTTGCACGTCGCATCCC
CGGTTCATTTTCTGCGTTTCCATCTTGCACTTCAATAGCATATCTTTGTTAACGAAGCATCTGTGCTTCATTTTGTAGAACAAAAATGCAACGC
GAGAGCGCTAATTTTTCAAACAAAGAATCTGAGCTGCATTTTTACAGAACAGAAATGCAACGCGAAAGCGCTATTTTACCAACGAAGAATCTGT
GCTTCATTTTTGTAAAACAAAAATGCAACGCGACGAGAGCGCTAATTTTTCAAACAAAGAATCTGAGCTGCATTTTTACAGAACAGAAATGCAA
CGCGAGAGCGCTATTTTACCAACAAAGAATCTATACTTCTTTTTTGTTCTACAAAAATGCATCCCGAGAGCGCTATTTTTCTAACAAAGCATCT
TAGATTACTTTTTTTCTCCTTTGTGCGCTCTATAATGCAGTCTCTTGATAACTTTTTGCACTGTAGGTCCGTTAAGGTTAGAAGAAGGCTACTT
TGGTGTCTATTTTCTCTTCCATAAAAAAAGCCTGACTCCACTTCCCGCGTTTACTGATTACTAGCGAAGCTGCGGGTGCATTTTTTCAAGATAA
AGGCATCCCCGATTATATTCTATACCGATGTGGATTGCGCATACTTTGTGAACAGAAAGTGATAGCGTTGATGATTCTTCATTGGTCAGAAAAT
TATGAACGGTTTCTTCTATTTTGTCTCTATATACTACGTATAGGAAATGTTTACATTTTCGTATTGTTTTCGATTCACTCTATGAATAGTTCTT
ACTACAATTTTTTTGTCTAAAGAGTAATACTAGAGATAAACATAAAAAATGTAGAGGTCGAGTTTAGATGCAAGTTCAAGGAGCGAAAGGTGGA
TGGGTAGGTTATATAGGGATATAGCACAGAGATATATAGCAAAGAGATACTTTTGAGCAATGTTTGTGGAAGCGGTATTCGCAATGGGAAGCTC
CACCCCGGTTGATAATCAGAAAAGCCCCAAAAACAGGAAGATTGTATAAGCAAATATTTAAATTGTAAACGTTAATATTTTGTTAAAATTCGCG
TTAAATTTTTGTTAAATCAGCTCATTTTTTAACGAATAGCCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTTGA
GTGTTGTTCCAGTTTCCAACAAGAGTCCACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAAGGGTCTATCAGGGCGATGGCCCACT
ACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCAGTAAATCGGAAGGGTAAACGGATGCCCCCATTTAGAGCTTGA
CGGGGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGGGGGCTAGGGCGGTGGGAAGTGTAGGGGTCACGCTGGGCG
TAACCACCACACCCGCCGCGCTTAATGGGGCGCTACAGGGCGCGTGGGGATGATCCACTAGTACGGATTAGAAGCCGCCGAGCGGGTGACAGCC
CTCCGAAGGAAGACTCTCCTCCGTGCGTCCTCGTCCTCACCGGTCGCGTTCCTGAAACGCAGATGTGCCTCGCGCCGCACTGCTCCGAACAATA
AAGATTCTACAATACTAGCTTTTATGGTTATGAAGAGGAAAAATTGGCAGTAACCTGGCCCCACAAACCTTCAAATGAACGAATCAAATTAACA
ACCATAGGATGATAATGCGATTAGTTTTTTAGCCTTATTTCTGGGGTAATTAATCAGCGAAGCGATGATTTTTGATCTATTAACAGATATATAA
ATGCAAAAACTGCATTAACCACTTTAACTAATACTTTCAACATTTTCGGTTTGTATTACTTCTTATTCAAATGTAATAAAAGTATCAACAAAAA
ATTGTTAATATACCTCTATACTTTAACGTCAAGGAGAAAAAACCCCGGATCGGACTACTAGCAGCTGTAATACGACTCACTATAGGGAATATTA
AGCT 
 
pYES260 
GGCCGCAAATTAAAGCCTTCGAGCGTCCCAAAACCTTCTCAAGCAAGGTTTTCAGTATAATGTTACATGCGTACACGCGTCTGTACAGAAAAAA
AAGAAAAATTTGAAATATAAATAACGTTCTTAATACTAACATAACTATAAAAAAATAAATAGGGACCTAGACTTCAGGTTGTCTAACTCCTTCC
TTTTCGGTTAGAGCGGATGTGGGGGGAGGGCGTGAATGTAAGCGTGACATAACTAATTACATGATGCGGCCCTCTAGATGCATGCTCGAGCGGC
CGCCAGTGTGATGGATATCTGCAGAATTCCAGCACACTGGCGGCCGTTACTAGTGGATCCCCGACCCATTTGCTGTCCACCAGTCATGCTAGAC
CATGGCGCCCTGAAAATAAAGATTCTCGCTAGCATGGTGATGGTGATGGTGCATAAGCTTAATATTCCCTATAGTGAGTCGTATTACAGCTGCT
AGTAGTCCGATCCGGGGTTTTTTCTCCTTGACGTTAAAGTATAGAGGTATATTAACAATTTTTTGTTGATACTTTTATTACATTTGAATAAGAA
GTAATACAAACCGAAAATGTTGAAAGTATTAGTTAAAGTGGTTAATGCAGTTTTTGCATTTATATATCTGTTAATAGATCAAAAATCATCGCTT
CGCTGATTAATTACCCCAGAAATAAGGCTAAAAAACTAATCGCATTATCATCCTATGGTTGTTAATTTGATTCGTTCATTTGAAGGTTTGTGGG
GCCAGGTTACTGCCAATTTTTCCTCTTCATAACCATAAAAGCTAGTATTGTAGAATCTTTATTGTTCGGAGCAGTGCGGCGCGAGGCACATCTG
CGTTTCAGGAACGCGACCGGTGAGGACGAGGACGCACGGAGGAGAGTCTTCCTTCGGAGGGCTGTCACCCGCTCGGCGGCTTCTAATCCGTACT
AGTGGATCATCCCCACGCGCCCTGTAGCGCCCCATTAAGCGCGGCGGGTGTGGTGGTTACGCCCAGCGTGACCCCTACACTTCCCACCGCCCTA
GCCCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATGGGGGCATCCGTTTACCCTTCC
GATTTACTGCTTTACGGCACCTCGACCCCAAAAAACTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACCCTTTTTCGCCC
TTTGACGTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTGGAAACTGGAACAACACTCAACCCTATCTCGGTCTATTCTTTTGATTTATAA
GGGATTTTGCCGATTTCGGGCTATTCGTTAAAAAATGAGCTGATTTAACAAAAATTTAACGCGAATTTTAACAAAATATTAACGTTTACAATTT
AAATATTTGCTTATACAATCTTCCTGTTTTTGGGGCTTTTCTGATTATCAACCGGGGTGGAGCTTCCCATTGCGAATACCGCTTCCACAAACAT
TGCTCAAAAGTATCTCTTTGCTATATATCTCTGTGCTATATCCCTATATAACCTACCCATCCACCTTTCGCTCCTTGAACTTGCATCTAAACTC
GACCTCTACATTTTTTATGTTTATCTCTAGTATTACTCTTTAGACAAAAAAATTGTAGTAAGAACTATTCATAGAGTGAATCGAAAACAATACG
AAAATGTAAACATTTCCTATACGTAGTATATAGAGACAAAATAGAAGAAACCGTTCATAATTTTCTGACCAATGAAGAATCATCAACGCTATCA
CTTTCTGTTCACAAAGTATGCGCAATCCACATCGGTATAGAATATAATCGGGGATGCCTTTATCTTGAAAAAATGCACCCGCAGCTTCGCTAGT
AATCAGTAAACGCGGGAAGTGGAGTCAGGCTTTTTTTATGGAAGAGAAAATAGACACCAAAGTAGCCTTCTTCTAACCTTAACGGACCTACAGT
GCAAAAAGTTATCAAGAGACTGCATTATAGAGCGCACAAAGGAGAAAAAAAGTAATCTAAGATGCTTTGTTAGAAAAATAGCGCTCTCGGGATG
CATTTTTGTAGAACAAAAAAGAAGTATAGATTCTTTGTTGGTAAAATAGCGCTCTCGCGTTGCATTTCTGTTCTGTAAAAATGCAGCTCAGATT
CTTTGTTTGAAAAATTAGCGCTCTCGTCGCGTTGCATTTTTGTTTTACAAAAATGAAGCACAGATTCTTCGTTGGTAAAATAGCGCTTTCGCGT
TGCATTTCTGTTCTGTAAAAATGCAGCTCAGATTCTTTGTTTGAAAAATTAGCGCTCTCGCGTTGCATTTTTGTTCTACAAAATGAAGCACAGA
TGCTTCGTTAACAAAGATATGCTATTGAAGTGCAAGATGGAAACGCAGAAAATGAACCGGGGATGCGACGTGCAAGATTACCTATGCAATAGAT
GCAATAGTTTCTCCAGGAACCGAAATACATACATTGTCTTCCGTAAAGCGCTAGACTATATATTATTATACAGGTTCAAATATACTATCTGTTT
CAGGGAAAACTCCCAGGTTCGGATGTTCAAAATTCAATGATGGGTAACAAGTACGATCGTAAATCTGTAAAACAGTTTGTCGGATATTAGGCTG
Appendix 
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TATCTCCTCAAAGCGTATTCGAATATCATTGAGAAGCTGCAGCGTCACATCGGATAATAATGATGGCAGCCATTGTAGAAGTGCCTTTTGCATT
TCTAGTCTCTTTCTCGGTCTAGCTAGTTTTACTACATCGCGAAGATAGAATCTTAGATCACACTGCCTTTGCTGAGCTGGATCAATAGAGTAAC
AAAAGAGTGGTAAGGCCTCGTTAAAGGACAAGGACCTGAGCGGAAGTGTATCGTACAGTAGACGGAGTATCTAGTATAGTCTATAGTCCGTGGA
ATTAATTCTCATCTTTGACAGCTTATCATCGATAAGCTAGCTTTTCAATTCAATTCATCATTTTTTTTTTATTCTTTTTTTTGATTTCGGTTTC
TTTGAAATTTTTTTGATTCGGTAATCTCCGAACAGAAGGAAGAACGAAGGAAGGAGCACAGACTTAGATTGGTATATATACGCATATGTAGTGT
TGAAGAAACATGAAATTGCCCAGTATTCTTAACCCAACTGCACAGAACAAAAACCTGCAGGAAACGAAGATAAATCATGTCGAAAGCTACATAT
AAGGAACGTGCTGCTACTCATCCTAGTCCTGTTGCTGCCAAGCTATTTAATATCATGCACGAAAAGCAAACAAACTTGTGTGCTTCATTGGATG
TTCGTACCACCAAGGAATTACTGGAGTTAGTTGAAGCATTAGGTCCCAAAATTTGTTTACTAAAAACACATGTGGATATCTTGACTGATTTTTC
AATGGAGGGCACAGTTAAGCCGCTAAAGGCATTATCCGCCAAGTACAATTTTTTACTCTTCGAAGACAGAAAATTTGCTGACATTGGTAATACA
GTCAAATTGCAGTACTCTGCGGGTGTATACAGAATAGCAGAATGGGCAGACATTACGAATGCACACGGTGTGGTGGGCCCAGGTATTGTTAGCG
GTTTGAAGCAGGCGGCAGAAGAAGTAACAAAGGAACCTAGAGGCCTTTTGATGTTAGCAGAATTGTCATGCAAGGGCTCCCTATCTACTGGAGA
ATATACTAAGGGTACTGTTGACATTGCGAAGAGCGACAAAGATTTTGTTATCGGCTTTATTGCTCAAAGAGACATGGGTGGAAGAGATGAAGGT
TACGATTGGTTGATTATGACACCCGGTGTGGGTTTAGATGACAAGGGAGACGCATTGGGTCAACAGTATAGAACCGTGGATGATGTGGTCTCTA
CAGGATCTGACATTATTATTGTTGGAAGAGGACTATTTGCAAAGGGAAGGGATGCTAAGGTAGAGGGTGAACGTTACAGAAAAGCAGGCTGGGA
AGCATATTTGAGAAGATGCGGCCAGCAAAACTAAAAAACTGTATTATAAGTAAATGCATGTATACTAAACTCACAAATTAGAGCTTCAATTTAA
TTATATCAGTTATTACCCATTGAAAAAGGAAGAGTATGAGTATTCAACATTTCCGTGTCGCCCTTATTCCCTTTTTTGCGGCATTTTGCCTTCC
TGTTTTTGCTCACCCAGAAACGCTGGTGAAAGTAAAAGATGCTGAAGATCAGTTGGGTGCACGAGTGGGTTACATCGAACTGGATCTCAACAGC
GGTAAGATCCTTGAGAGTTTTCGCCCCGAAGAACGTTTTCCAATGATGAGCACTTTTAAAGTTCTGCTATGTGATACACTATTATCCCGTATTG
ACGCCGGGCAAGAGCAACTCGGTCGCCGCATACACTATTCTCAGAATGACTTGGTTGAGTACTCACCAGTCACAGAAAAGCATCTTACGGATGG
CATGACAGTAAGAGAATTATGCAGTGCTGCCATAACCATGAGTGATAACACTGCGGCCAACTTACTTCTGACAACGATCGGAGGACCGAAGGAG
CTAACCGCTTTTTTGCACAACATGGGGGATCATGTAACTCGCCTTGATCGTTGGGAACCGGAGCTGAATGAAGCCATACCAAACGACGAGAGTG
ACACCACGATGCCTGTAGCAATGCCAACAACGTTGCGCAAACTATTAACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAATTAATAGACTG
AATGGAGGCGGATAAAGTTGCAGGACCACTTCTGCGCTCGGCCCTTCCGGCTGGCTGGTTTATTGCTGATAAATCTGGAGCCGGTGAGCGTGGG
TCTCGCGGTATCATTGCAGCACTGGGGCCAGATGGTAAGCGCTCCCGTATCGTAGTTATCTACACGACGGGGAGTCAGGCAACTATGGATGAAC
GAAATAGACAGATCGCTGAGATAGGTGCCTCACTGATTAAGCATTGGTAACTGTCAGACCAAGTTTACTCATATATACTTTAGATTGATTTAAA
ACTTCATTTTTAATTTAAAAGGATCTAGGTGAAGATCCTTTTTGATAATCTCATGACCAAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCG
TCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTGAGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAG
CGGTGGTTTGTTTGCCGGATCAAGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTCCTTCTAGT
GTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCTGCCAGTGGC
GATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCAGCGGTCGGGCTGAACGGGGGGTTCGTGCACACAGCCCA
GCTTGGAGCGAACGACCTACACCGAACTGAGATACCTACAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGACAGGTA
TCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGAAACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCAC
CTCTGACTTGAGCGTCGATTTTTGTGATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGGCT
TTTGCTGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTACCGCCTTTGAGTGAGCTGATACCGCTCG
CCGCAGCCGAACGACCGAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAGAGCGCCCAATACGCAAACCGCCTCTCCCCGCGCGTTGGCCGATT
CATTAATGCAG 
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